Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",A1BG,Alpha-1B-glycoprotein,10623,35,0.44 [0.07-2.56],0.3593921789045782
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AAMDC,Mth938 domain-containing protein,10348,34,1.55 [0.86-2.79],0.1443561980177849
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AARSD1,Alanyl-tRNA editing protein Aarsd1,12048,37,1.58 [0.96-2.58],0.0703388492633644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABCA2,ATP-binding cassette sub-family A member 2,10258,34,0.84 [0.33-2.17],0.7239241680419805
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABHD14B,Protein ABHD14B,11989,39,0.98 [0.60-1.60],0.9258510077188972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABL1,Tyrosine-protein kinase ABL1,12048,37,0.94 [0.60-1.46],0.7751209231074421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABO,Histo-blood group ABO system transferase,10602,33,1.22 [0.97-1.54],0.0842732338565269
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABRAXAS2,BRISC complex subunit Abraxas 2,10258,34,1.20 [0.80-1.78],0.374041191428296
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",11824,39,0.84 [0.58-1.22],0.3571886300611462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",10425,33,0.95 [0.57-1.57],0.8444424518651672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",10600,35,1.04 [0.73-1.48],0.8457744665843179
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACAN,Aggrecan core protein,11997,41,0.40 [0.15-1.08],0.071298310582295
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACE,Angiotensin-converting enzyme,10602,33,1.34 [0.39-4.66],0.644150306282198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACE2,Angiotensin-converting enzyme 2,11861,38,1.24 [0.73-2.09],0.4219716919447303
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACHE,Acetylcholinesterase,10388,35,1.90 [0.79-4.58],0.1508693947458539
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACOT13,Acyl-coenzyme A thioesterase 13,10538,34,0.96 [0.72-1.29],0.8048892796517101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,12108,41,0.71 [0.39-1.28],0.2538271663767445
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACP1,Low molecular weight phosphotyrosine protein phosphatase,10295,36,1.40 [0.74-2.65],0.2947063606445308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACP5,Tartrate-resistant acid phosphatase type 5,12170,39,1.32 [0.55-3.18],0.5293467171591708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACP6,Lysophosphatidic acid phosphatase type 6,12169,37,1.23 [0.77-1.96],0.3904692185695039
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACRBP,Acrosin-binding protein,10542,34,1.12 [0.50-2.47],0.7875496635892252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACRV1,Acrosomal protein SP-10,10295,36,1.10 [0.45-2.69],0.8427917548873778
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACSL1,Long-chain-fatty-acid--CoA ligase 1,10258,34,1.12 [0.53-2.38],0.766811525768667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACTA2,"Actin, aortic smooth muscle",11861,38,0.60 [0.28-1.31],0.2010099444132436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACTN2,Alpha-actinin-2,10258,34,1.34 [0.79-2.29],0.2747663836572183
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACTN4,Alpha-actinin-4,11857,37,1.08 [0.46-2.51],0.8673228788600302
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACVRL1,Serine/threonine-protein kinase receptor R3,12005,39,0.78 [0.24-2.55],0.6839195362550683
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACY1,Aminoacylase-1,12108,41,0.92 [0.57-1.48],0.7325293221047967
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,10258,34,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACYP1,Acylphosphatase-1,10346,35,1.28 [0.79-2.08],0.3100589470806612
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADA,Adenosine deaminase,12217,37,1.85 [0.90-3.82],0.0962340537581703
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADA2,Adenosine deaminase 2,12041,39,1.18 [0.61-2.28],0.6154574621793734
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,10295,36,1.36 [0.54-3.45],0.516021116532795
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,11861,38,1.50 [0.59-3.85],0.3958296674662669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,12020,39,0.45 [0.20-1.03],0.0588083111167749
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,12217,37,0.96 [0.43-2.14],0.9142228945429648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,12175,37,0.59 [0.23-1.49],0.2662523108227231
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,10538,34,0.70 [0.23-2.16],0.53705925953929
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,10295,36,1.17 [0.45-3.05],0.7415247760323271
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,12247,40,1.52 [0.44-5.19],0.5074292137248522
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,12048,37,0.84 [0.46-1.53],0.5695247542924952
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,11861,38,1.72 [0.99-2.97],0.0522769777193907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,10295,36,0.90 [0.36-2.27],0.8188869197531999
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,12159,39,1.18 [0.62-2.26],0.613535428902249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTSL2,ADAMTS-like protein 2,10617,36,1.51 [0.59-3.84],0.3892274799160324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTSL4,ADAMTS-like protein 4,10348,34,2.71 [0.67-10.91],0.1608335703428371
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTSL5,ADAMTS-like protein 5,10600,35,1.27 [0.55-2.94],0.5717662822394707
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,11824,39,1.25 [0.74-2.11],0.4049958747286384
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADD1,Alpha-adducin,10388,35,1.16 [0.73-1.84],0.526060889326104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRB3,Adhesion G protein-coupled receptor B3,12005,39,1.07 [0.46-2.49],0.8726262498837303
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRD1,Adhesion G-protein coupled receptor D1,10388,35,2.12 [0.92-4.87],0.0761893023199871
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRE1,Adhesion G protein-coupled receptor E1,10538,34,0.81 [0.44-1.48],0.4877862324189901
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRE2,Adhesion G protein-coupled receptor E2,12162,40,1.22 [0.45-3.34],0.6948640076710757
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRE5,Adhesion G protein-coupled receptor E5,12200,40,1.24 [0.50-3.05],0.6413163346799884
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRF5,Adhesion G protein-coupled receptor F5,10600,35,0.62 [0.21-1.86],0.3938439682404135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRG1,Adhesion G-protein coupled receptor G1,12048,37,1.21 [0.81-1.81],0.3608341350516266
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRG2,Adhesion G-protein coupled receptor G2,12108,41,0.94 [0.33-2.67],0.906649249254443
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRV1,Adhesion G-protein coupled receptor V1,10235,33,0.77 [0.43-1.36],0.367196254415743
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADH1B,All-trans-retinol dehydrogenase,10388,35,0.92 [0.58-1.46],0.7109078837974181
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,11861,38,0.88 [0.61-1.26],0.4842677619078045
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADIPOQ,Adiponectin,10623,35,1.36 [0.83-2.20],0.2181364732261818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADM,Pro-adrenomedullin,12195,37,0.57 [0.19-1.72],0.3218839067200648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADRA2A,Alpha-2A adrenergic receptor,10258,34,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AFAP1,Actin filament-associated protein 1,10388,35,0.68 [0.45-1.04],0.0788985224808465
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AFM,Afamin,10623,35,0.48 [0.09-2.55],0.3872666490494107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AFP,Alpha-fetoprotein,11983,39,1.09 [0.72-1.65],0.6799450791934826
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGBL2,Cytosolic carboxypeptidase 2,10235,33,0.88 [0.62-1.26],0.4914244537436759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGER,Advanced glycosylation end product-specific receptor,12085,40,0.71 [0.36-1.42],0.3322126935569984
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGR2,Anterior gradient protein 2 homolog,11706,37,1.25 [0.95-1.64],0.1068081583318417
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGR3,Anterior gradient protein 3,11800,39,0.92 [0.57-1.51],0.7468401208686689
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGRN,Agrin,12162,40,0.92 [0.40-2.11],0.8386231147036909
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGRP,Agouti-related protein,12217,37,0.67 [0.39-1.16],0.1571722654067396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGT,Angiotensinogen,10602,33,0.96 [0.23-4.07],0.9573067457070468
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGXT,Serine--pyruvate aminotransferase,12108,41,0.93 [0.64-1.35],0.6841813740110252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHCY,Adenosylhomocysteinase,12108,41,1.17 [0.78-1.73],0.4506459613115354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHNAK,Neuroblast differentiation-associated protein AHNAK,10348,34,1.81 [0.81-4.05],0.1475683596106403
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHNAK2,Protein AHNAK2,10348,34,0.87 [0.26-2.95],0.819929616446124
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,10542,34,1.02 [0.63-1.65],0.9384847553178624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHSG,Alpha-2-HS-glycoprotein,10602,33,1.38 [0.41-4.67],0.6068480464179669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHSP,Alpha-hemoglobin-stabilizing protein,12094,38,0.98 [0.70-1.36],0.8894023542929014
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AIDA,"Axin interactor, dorsalization-associated protein",10316,33,0.74 [0.44-1.24],0.2535278649185807
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AIF1,Allograft inflammatory factor 1,11824,39,1.01 [0.58-1.74],0.9850107140773408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AIF1L,Allograft inflammatory factor 1-like,10348,34,1.32 [0.88-1.99],0.179360944190016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",12029,37,1.04 [0.79-1.37],0.7591581318525925
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AK1,Adenylate kinase isoenzyme 1,12108,41,1.11 [0.73-1.69],0.6388350584777613
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AK2,"Adenylate kinase 2, mitochondrial",10586,35,1.08 [0.79-1.47],0.6303006986804505
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKAP12,A-kinase anchor protein 12,10388,35,1.35 [0.38-4.85],0.643187060071212
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKR1B1,Aldo-keto reductase family 1 member B1,11824,39,0.92 [0.62-1.35],0.6571080544309686
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKR1B10,Aldo-keto reductase family 1 member B10,10316,33,0.83 [0.47-1.49],0.5341193868509186
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKR1C4,Aldo-keto reductase family 1 member C4,11861,38,0.74 [0.39-1.40],0.3541317364824941
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKR7L,Aflatoxin B1 aldehyde reductase member 4,10295,36,1.09 [0.70-1.70],0.6963553669842426
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKT1S1,Proline-rich AKT1 substrate 1,11815,37,1.04 [0.66-1.62],0.8715834423994062
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKT2,RAC-beta serine/threonine-protein kinase,10578,34,1.05 [0.80-1.37],0.726781934891203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKT3,RAC-gamma serine/threonine-protein kinase,11769,39,0.72 [0.43-1.22],0.2266297602999414
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALCAM,CD166 antigen,12247,40,1.05 [0.25-4.54],0.9428149791463996
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALDH1A1,Retinal dehydrogenase 1,12112,38,1.03 [0.61-1.73],0.918883287754298
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALDH2,"Aldehyde dehydrogenase, mitochondrial",10542,34,0.67 [0.29-1.56],0.3575597377051265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",12054,37,1.00 [0.65-1.53],0.9848068929645046
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",10578,34,1.02 [0.52-2.01],0.9495711740100794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALMS1,Alstrom syndrome protein 1,10425,33,1.07 [0.51-2.24],0.8512117951806037
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALPI,Intestinal-type alkaline phosphatase,10295,36,0.92 [0.70-1.21],0.5511962956275607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALPP,"Alkaline phosphatase, placental type",12048,37,1.16 [0.88-1.53],0.2860891744472631
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMBN,Ameloblastin,11857,37,0.80 [0.26-2.46],0.6973353061411427
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMBP,Protein AMBP,12174,37,0.35 [0.08-1.45],0.1480593866866862
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,10617,36,0.91 [0.26-3.18],0.884054232616426
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMFR,E3 ubiquitin-protein ligase AMFR,11815,37,1.25 [0.84-1.85],0.2641066034173095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMIGO1,Amphoterin-induced protein 1,10316,33,1.33 [0.84-2.12],0.220424979925805
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMIGO2,Amphoterin-induced protein 2,12048,37,0.77 [0.22-2.70],0.6837013262201284
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMN,Protein amnionless,11857,37,1.84 [1.08-3.13],0.0241447013858795
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMOT,Angiomotin,10388,35,1.44 [0.65-3.19],0.3715830889794033
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMOTL2,Angiomotin-like protein 2,10499,34,0.59 [0.25-1.40],0.2294093772540495
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMPD3,AMP deaminase 3,10586,35,1.14 [0.73-1.78],0.5550235008582449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,9894,26,0.98 [0.45-2.14],0.963708635291271
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMY2A,Pancreatic alpha-amylase,11610,39,0.88 [0.48-1.61],0.6761385656603389
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMY2B,Alpha-amylase 2B,11282,38,0.90 [0.49-1.67],0.746144002462199
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANG,Angiogenin,12083,39,1.03 [0.45-2.35],0.9505354877578924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPT1,Angiopoietin-1,12052,40,0.81 [0.59-1.12],0.2063589225962692
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPT2,Angiopoietin-2,12195,37,1.19 [0.55-2.59],0.6569388303788137
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL1,Angiopoietin-related protein 1,11947,39,1.44 [0.54-3.80],0.4667841504876139
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL2,Angiopoietin-related protein 2,12124,40,0.99 [0.50-1.97],0.9706537654442516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL3,Angiopoietin-related protein 3,12116,39,0.84 [0.38-1.85],0.6669714365595439
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL4,Angiopoietin-related protein 4,12139,40,0.77 [0.41-1.47],0.4346651246021284
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL7,Angiopoietin-related protein 7,12195,37,0.56 [0.25-1.22],0.1434160870483981
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANK2,Ankyrin-2,10258,34,1.17 [0.81-1.70],0.3993829246782788
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,10295,36,1.06 [0.71-1.59],0.7841144763108275
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANKRA2,Ankyrin repeat family A protein 2,10208,34,1.02 [0.58-1.80],0.9387799360699528
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANKRD54,Ankyrin repeat domain-containing protein 54,11824,39,1.29 [0.85-1.95],0.2285069992607669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,10348,34,1.24 [0.66-2.32],0.5011657550822802
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANPEP,Aminopeptidase N,12150,39,1.75 [0.71-4.32],0.2231275634793116
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA1,Annexin A1,10325,35,1.47 [0.87-2.49],0.1520760111095496
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA10,Annexin A10,11815,37,1.03 [0.73-1.45],0.8835223549328474
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA11,Annexin A11,12063,37,1.10 [0.70-1.72],0.6863878954926335
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA2,Annexin A2,10186,33,1.36 [0.96-1.92],0.0789241524005775
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA3,Annexin A3,12175,37,1.06 [0.70-1.61],0.7748350190819451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA4,Annexin A4,12054,41,1.17 [0.81-1.69],0.4108713296780933
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA5,Annexin A5,11784,37,0.78 [0.29-2.11],0.6198843440494296
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AOC1,Amiloride-sensitive amine oxidase [copper-containing],11857,37,1.13 [0.73-1.73],0.5872765688353312
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AOC3,Membrane primary amine oxidase,12165,39,1.32 [0.52-3.40],0.5598427968237563
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AP1G2,AP-1 complex subunit gamma-like 2,10542,34,1.04 [0.69-1.55],0.860375849081956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AP2B1,AP-2 complex subunit beta,10316,33,1.03 [0.52-2.03],0.9268204693911472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AP3B1,AP-3 complex subunit beta-1,10538,34,1.19 [0.78-1.80],0.4244604303412441
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AP3S2,AP-3 complex subunit sigma-2,10586,35,1.56 [0.85-2.88],0.1529807083532157
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,12048,37,1.66 [1.04-2.64],0.032309710941306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APCS,Serum amyloid P-component,10520,35,1.06 [0.42-2.69],0.9073697515487412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,12146,37,1.68 [1.10-2.54],0.015255331776118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APLP1,Amyloid-like protein 1,12108,41,1.27 [0.75-2.15],0.3762976814573608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOA1,Apolipoprotein A-I,10623,35,1.14 [0.36-3.58],0.8265834976950089
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOA2,Apolipoprotein A-II,10602,33,0.75 [0.38-1.49],0.4143517953970469
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOA4,Apolipoprotein A-IV,10623,35,0.55 [0.20-1.52],0.2502459030344831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOB,Apolipoprotein B-100,10602,33,2.17 [0.50-9.35],0.2995918981566842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOBR,Apolipoprotein B receptor,10348,34,0.67 [0.32-1.43],0.3029776456561646
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOC1,Apolipoprotein C-I,10602,35,1.32 [0.55-3.14],0.5375309697126739
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOD,Apolipoprotein D,10146,34,1.27 [0.68-2.36],0.4473260861025486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOE,Apolipoprotein E,10623,35,0.90 [0.53-1.52],0.697746888751964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOF,Apolipoprotein F,10602,33,1.54 [0.28-8.52],0.6175728927926547
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOH,Beta-2-glycoprotein 1,12112,38,0.60 [0.26-1.40],0.2348308106118792
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOL1,Apolipoprotein L1,10602,33,0.77 [0.42-1.42],0.4000986401506523
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOM,Apolipoprotein M,12139,39,0.91 [0.31-2.65],0.8629172661893959
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APP,Amyloid-beta precursor protein,12101,38,0.91 [0.59-1.40],0.6690686275355151
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APPL2,DCC-interacting protein 13-beta,10388,35,1.04 [0.77-1.41],0.7867804216375426
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APRT,Adenine phosphoribosyltransferase,12002,39,0.92 [0.51-1.66],0.7788836886013086
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARAF,Serine/threonine-protein kinase A-Raf,10425,33,0.84 [0.49-1.44],0.5313813260202084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AREG,Amphiregulin,12048,37,0.95 [0.48-1.89],0.8805615266534973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARF6,ADP-ribosylation factor 6,10538,34,1.18 [0.86-1.64],0.3093143005154642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARFIP1,Arfaptin-1,10578,34,1.11 [0.69-1.77],0.6719521728468094
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARG1,Arginase-1,12029,37,1.67 [0.96-2.90],0.070440769489491
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARG2,"Arginase-2, mitochondrial",10542,34,0.84 [0.38-1.87],0.6715312814596182
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP1,Rho GTPase-activating protein 1,11824,39,0.73 [0.39-1.38],0.3350263580457441
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP25,Rho GTPase-activating protein 25,11824,39,1.47 [0.97-2.22],0.0660915426429236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP30,Rho GTPase-activating protein 30,10425,33,0.92 [0.37-2.29],0.852921310239121
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP45,Rho GTPase-activating protein 45,10388,35,1.20 [0.81-1.79],0.3665249677538085
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP5,Rho GTPase-activating protein 5,10208,34,0.73 [0.43-1.22],0.2239636762905977
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGEF1,Rho guanine nucleotide exchange factor 1,10586,35,1.20 [0.83-1.72],0.3370820436107669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGEF10,Rho guanine nucleotide exchange factor 10,10578,34,1.14 [0.80-1.61],0.4755083022116728
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGEF12,Rho guanine nucleotide exchange factor 12,12076,37,1.05 [0.78-1.40],0.765714501248412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGEF5,Rho guanine nucleotide exchange factor 5,10235,33,1.30 [0.90-1.88],0.1549198107965109
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARID3A,AT-rich interactive domain-containing protein 3A,10235,33,1.39 [0.71-2.73],0.3355937718234671
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARID4B,AT-rich interactive domain-containing protein 4B,11815,37,1.27 [0.78-2.08],0.337152560839299
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARL13B,ADP-ribosylation factor-like protein 13B,10258,34,1.29 [0.85-1.94],0.2315394122994886
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,10258,34,1.60 [0.75-3.40],0.2222575668081925
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARMCX2,Armadillo repeat-containing X-linked protein 2,10235,33,1.00 [0.59-1.68],0.9900892957070108
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARNT,Aryl hydrocarbon receptor nuclear translocator,11857,37,1.01 [0.47-2.18],0.9767414025059504
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,10258,34,1.28 [0.78-2.11],0.3240713845722638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARSA,Arylsulfatase A,12112,38,1.43 [0.78-2.64],0.2489029953993738
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARSB,Arylsulfatase B,12048,37,1.36 [0.81-2.26],0.2424618248405298
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ART3,Ecto-ADP-ribosyltransferase 3,12165,39,0.76 [0.32-1.81],0.5377265751888853
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ART5,Ecto-ADP-ribosyltransferase 5,10235,33,0.82 [0.44-1.53],0.5273729761100512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARTN,Artemin,11857,37,0.65 [0.28-1.50],0.3123835198974365
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASAH1,Acid ceramidase,10499,35,1.00 [0.49-2.04],0.9992175004672978
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASAH2,Neutral ceramidase,12020,39,1.23 [0.68-2.21],0.4953024228346353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASGR1,Asialoglycoprotein receptor 1,12020,39,0.47 [0.17-1.32],0.1518482770718519
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASGR2,Asialoglycoprotein receptor 2,10602,33,0.54 [0.15-1.93],0.3451510235491437
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASPN,Asporin,10600,35,1.68 [0.58-4.87],0.3386854306212336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASPSCR1,Tether containing UBX domain for GLUT4,10578,34,1.29 [0.80-2.08],0.2936882742800157
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASRGL1,Isoaspartyl peptidase/L-asparaginase,10348,34,1.21 [0.88-1.66],0.2495810946614425
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASS1,Argininosuccinate synthase,10258,34,1.04 [0.68-1.58],0.8645857638900438
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATF2,Cyclic AMP-dependent transcription factor ATF-2,11815,37,1.14 [0.81-1.62],0.4482319352454467
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATF4,Cyclic AMP-dependent transcription factor ATF-4,10208,34,1.23 [0.53-2.87],0.6336138362414561
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATG16L1,Autophagy-related protein 16-1,10538,34,1.10 [0.74-1.63],0.6302935123497917
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATG4A,Cysteine protease ATG4A,11824,39,0.98 [0.60-1.59],0.9236646571821404
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATOX1,Copper transport protein ATOX1,12159,39,0.96 [0.64-1.44],0.8262618653844385
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,10258,34,1.14 [0.66-1.98],0.6411933234131811
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,10258,34,1.38 [0.56-3.38],0.4790417626154477
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,10258,34,1.48 [0.79-2.77],0.2171675474669731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP1B4,Protein ATP1B4,10208,34,1.00 [0.46-2.17],0.998480604675527
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP2B4,Plasma membrane calcium-transporting ATPase 4,10258,34,1.21 [0.77-1.89],0.4062464075764704
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP5F1D,"ATP synthase subunit delta, mitochondrial",10258,34,1.55 [1.15-2.09],0.0040924287288488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP5IF1,"ATPase inhibitor, mitochondrial",12162,40,0.94 [0.74-1.21],0.6573237263124088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP5PO,"ATP synthase subunit O, mitochondrial",11815,37,0.74 [0.35-1.58],0.4422913259632119
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6AP2,Renin receptor,11824,39,0.84 [0.39-1.81],0.6573880167478365
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6V1D,V-type proton ATPase subunit D,12048,37,1.39 [0.56-3.42],0.4747556502410898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6V1F,V-type proton ATPase subunit F,11794,37,1.21 [0.79-1.85],0.3849901383745974
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6V1G1,V-type proton ATPase subunit G 1,10348,34,1.30 [0.84-2.02],0.2418821256430289
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6V1G2,V-type proton ATPase subunit G 2,10258,34,0.88 [0.62-1.25],0.4763904653199204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATRAID,All-trans retinoic acid-induced differentiation factor,10538,34,0.57 [0.16-2.03],0.3847499484030154
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATRN,"Attractin, Isoform 2",10623,35,4.88 [0.66-35.87],0.1194680302498894
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATXN10,Ataxin-10,11815,37,1.00 [0.66-1.51],0.9825488822257794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATXN2,Ataxin-2,10235,33,0.98 [0.73-1.34],0.922013426782942
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATXN2L,Ataxin-2-like protein,10578,34,1.37 [0.78-2.40],0.268519167394349
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATXN3,Ataxin-3,10586,35,1.42 [0.86-2.35],0.1676275310554867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AXIN1,Axin-1,12076,37,0.97 [0.71-1.33],0.8579100792654701
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AXL,Tyrosine-protein kinase receptor UFO,12165,39,1.16 [0.41-3.26],0.782629421723937
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AZI2,5-azacytidine-induced protein 2,10578,34,1.40 [0.82-2.42],0.2194591120940164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AZU1,Azurocidin,11719,37,1.35 [1.02-1.79],0.0345249259824324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B2M,Beta-2-microglobulin,10623,35,0.91 [0.31-2.68],0.8597273266685086
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,10258,34,1.05 [0.21-5.15],0.9527670812359617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",10348,34,1.09 [0.43-2.74],0.8546823206251167
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B4GALT1,"Beta-1,4-galactosyltransferase 1",12162,40,0.60 [0.21-1.69],0.3342380904700182
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B4GAT1,"Beta-1,4-glucuronyltransferase 1",12112,38,1.15 [0.34-3.89],0.8244292876266595
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BABAM1,BRISC and BRCA1-A complex member 1,10295,36,1.39 [0.56-3.41],0.4771614957372048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BACH1,Transcription regulator protein BACH1,12076,37,1.10 [0.74-1.64],0.6409890978441596
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAG3,BAG family molecular chaperone regulator 3,12005,39,0.61 [0.33-1.12],0.1078078842918786
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAG4,BAG family molecular chaperone regulator 4,10295,36,1.39 [0.78-2.45],0.2633255563752851
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAG6,Large proline-rich protein BAG6,11861,38,1.41 [0.64-3.13],0.3960926009121579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,11824,39,1.51 [1.03-2.19],0.0330247773577159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAMBI,BMP and activin membrane-bound inhibitor homolog,11824,39,0.51 [0.18-1.43],0.2037175739438924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BANK1,B-cell scaffold protein with ankyrin repeats,12076,37,0.98 [0.74-1.30],0.8887549296030431
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAP18,Chromatin complexes subunit BAP18,10586,35,1.47 [1.09-2.00],0.0121609763204594
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BATF,Basic leucine zipper transcriptional factor ATF-like,10316,33,0.92 [0.60-1.42],0.7105354091734672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAX,Apoptosis regulator BAX,11799,37,0.92 [0.66-1.30],0.6465940361481927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAM,Basal cell adhesion molecule,12112,38,2.71 [0.95-7.70],0.0613949169471596
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAN,Brevican core protein,12020,39,1.31 [0.57-3.04],0.526753892109491
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",10600,35,0.98 [0.35-2.77],0.9740062359784736
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",10235,33,1.59 [1.06-2.41],0.0261361580770382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCHE,Cholinesterase,10418,33,0.92 [0.28-3.01],0.8844857511787165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL2,Apoptosis regulator Bcl-2,10538,34,1.38 [0.91-2.10],0.1346532047371344
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL2L1,Bcl-2-like protein 1,10586,35,1.10 [0.80-1.53],0.55211193078492
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",12076,37,0.78 [0.43-1.42],0.4214050175371867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL2L15,Bcl-2-like protein 15,10295,36,1.16 [0.71-1.90],0.5585683516212192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL7A,B-cell CLL/lymphoma 7 protein family member A,10208,34,1.16 [0.74-1.80],0.5199335046607259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL7B,B-cell CLL/lymphoma 7 protein family member B,10542,34,1.24 [0.65-2.37],0.5111345176644924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCR,Breakpoint cluster region protein,12076,37,1.04 [0.75-1.44],0.8219854085938184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BDNF,Brain-derived neurotrophic factor,10617,36,0.75 [0.52-1.07],0.1127764234302536
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BECN1,Beclin-1,10348,34,1.62 [1.01-2.61],0.0455901488329286
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BEX3,Protein BEX3,10208,34,1.20 [0.65-2.22],0.5546066295755143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BGLAP,Osteocalcin,10617,36,0.65 [0.47-0.89],0.0080610803951112
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BGN,Biglycan,11796,39,1.22 [0.97-1.53],0.08722593329286
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BHLHE40,Class E basic helix-loop-helix protein 40,10235,33,0.95 [0.57-1.57],0.8354811071128785
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,10258,34,1.95 [0.54-7.05],0.3106740284784725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BID,BH3-interacting domain death agonist,12076,37,1.04 [0.68-1.58],0.8577507263575045
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BIN2,Bridging integrator 2,12112,38,1.04 [0.76-1.42],0.8170902709413274
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BIRC2,Baculoviral IAP repeat-containing protein 2,11824,39,0.81 [0.50-1.29],0.3724930396269316
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLMH,Bleomycin hydrolase,12247,40,2.30 [1.26-4.19],0.0064093077657129
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLNK,B-cell linker protein,10295,36,1.04 [0.46-2.32],0.9311867131804972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,10235,33,1.04 [0.66-1.63],0.8649310638122562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,10586,35,1.25 [0.58-2.70],0.5725682454135027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLVRB,Flavin reductase,12112,38,1.27 [0.86-1.88],0.2327695076380614
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BMP10,Bone morphogenetic protein 10,10388,35,0.57 [0.19-1.76],0.3321197356606276
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BMP4,Bone morphogenetic protein 4,12005,39,1.12 [0.60-2.07],0.7223791015932959
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BMP6,Bone morphogenetic protein 6,11845,38,0.78 [0.41-1.51],0.4643328892759925
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BMPER,BMP-binding endothelial regulator protein,10388,35,1.94 [0.50-7.50],0.3374540514627545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,10600,35,1.37 [0.60-3.12],0.4481728268711259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,10295,36,0.92 [0.44-1.93],0.8214137744389801
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BOC,Brother of CDO,11861,38,0.76 [0.22-2.65],0.6639265048420784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BOLA1,BolA-like protein 1,10235,33,1.06 [0.58-1.95],0.8500501409598356
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BOLA2_BOLA2B,BolA-like protein 2,10348,34,1.33 [0.73-2.43],0.3577617578510663
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BPIFA2,BPI fold-containing family A member 2,9966,32,1.00 [0.73-1.36],0.9913370559481444
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BPIFB1,BPI fold-containing family B member 1,12053,39,0.88 [0.56-1.40],0.6020019241888767
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BPIFB2,BPI fold-containing family B member 2,10577,35,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRAP,BRCA1-associated protein,10440,34,1.14 [0.83-1.56],0.432810096306956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRD1,Bromodomain-containing protein 1,10425,33,0.72 [0.22-2.35],0.5916698840196575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRD2,Bromodomain-containing protein 2,10235,33,1.28 [0.59-2.75],0.5315644895505758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRD3,Bromodomain-containing protein 3,10258,34,1.53 [1.02-2.29],0.0398727040882728
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRDT,Bromodomain testis-specific protein,10258,34,1.50 [0.64-3.53],0.3548088973497153
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRK1,Protein BRICK1,11815,37,0.95 [0.48-1.86],0.875291042636141
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRME1,Break repair meiotic recombinase recruitment factor 1,10235,33,1.07 [0.54-2.13],0.8393409906655107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRSK2,Serine/threonine-protein kinase BRSK2,10578,34,1.08 [0.50-2.36],0.8405304068137722
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BSG,Basigin,12201,37,0.70 [0.21-2.28],0.5502090459624259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BSND,Barttin,10208,34,1.55 [0.78-3.05],0.207901926430575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,12201,37,0.74 [0.47-1.17],0.1997564947137325
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BST2,Bone marrow stromal antigen 2,12201,37,1.05 [0.62-1.79],0.8511857271982717
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTC,Probetacellulin,11824,39,0.92 [0.62-1.38],0.685685532910518
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTD,Biotinidase,10623,35,1.40 [0.28-6.97],0.6810873229764427
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTLA,B- and T-lymphocyte attenuator,10208,34,1.23 [0.95-1.59],0.1220365842747808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTN1A1,Butyrophilin subfamily 1 member A1,10520,34,0.88 [0.35-2.20],0.7874017052248456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTN2A1,Butyrophilin subfamily 2 member A1,12162,40,0.33 [0.11-0.99],0.0474003815659678
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTN3A2,Butyrophilin subfamily 3 member A2,12076,37,0.68 [0.31-1.46],0.3209702392370893
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTNL10,Butyrophilin-like protein 10,10208,34,1.23 [0.67-2.25],0.5108476084761799
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C19orf12,Protein C19orf12,11815,37,0.79 [0.46-1.35],0.3958047471944391
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1GALT1C1,C1GALT1-specific chaperone 1,10258,34,2.26 [1.24-4.12],0.0076628101690157
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QA,Complement C1q subcomponent subunit A,12159,37,1.54 [0.40-5.95],0.5281045292732902
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",10578,34,0.85 [0.48-1.50],0.5668963441456697
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QL2,Complement C1q-like protein 2,10295,36,0.70 [0.32-1.53],0.3680878302298259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,12165,39,1.43 [0.77-2.65],0.2582618355683179
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,10388,35,0.62 [0.29-1.32],0.2195671733940615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,10578,34,1.42 [0.58-3.50],0.4442065890705324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,10366,35,1.22 [0.60-2.48],0.590036217367021
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1R,Complement C1r subcomponent,10623,35,0.18 [0.02-1.46],0.1093973180057505
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1RL,Complement C1r subcomponent-like protein,10607,35,0.71 [0.14-3.55],0.6752656842144249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1S,Complement C1s subcomponent,10623,35,0.31 [0.09-1.13],0.0757078009541285
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C2,Complement C2,12139,39,0.58 [0.21-1.60],0.2946021562209233
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C2CD2L,Phospholipid transfer protein C2CD2L,11794,37,1.26 [0.68-2.32],0.4583968909934163
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C2orf69,UPF0565 protein C2orf69,10316,33,1.03 [0.59-1.78],0.9291325198875628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C3,Complement C3,10072,33,0.72 [0.30-1.73],0.4684684009549921
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C4BPB,C4b-binding protein beta chain,12159,39,1.05 [0.53-2.08],0.8977871785642051
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C5,Complement C5,10623,35,1.71 [0.25-11.99],0.5871580681774686
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C7,Complement component C7,10358,35,0.90 [0.32-2.51],0.8358143415353028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C7orf50,Uncharacterized protein C7orf50,10586,35,2.89 [1.77-4.69],1.926091010244064e-05
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C8B,Complement component C8 beta chain,10623,35,0.73 [0.25-2.11],0.5549180990456213
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C9,Complement component C9,10602,33,0.68 [0.36-1.27],0.2244420063363004
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C9orf40,Uncharacterized protein C9orf40,10538,34,1.19 [0.81-1.74],0.3830514058876351
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA1,Carbonic anhydrase 1,11842,38,1.37 [0.87-2.13],0.1713496269740611
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA11,Carbonic anhydrase-related protein 11,11824,39,0.45 [0.13-1.58],0.2144870683591028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA12,Carbonic anhydrase 12,12048,37,1.35 [0.56-3.24],0.5078064448712083
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA13,Carbonic anhydrase 13,12000,41,1.02 [0.78-1.34],0.8870130466864982
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA14,Carbonic anhydrase 14,12195,37,1.11 [0.48-2.56],0.8153458644887144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA2,Carbonic anhydrase 2,12068,38,1.14 [0.77-1.68],0.5254102285177612
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA3,Carbonic anhydrase 3,12225,40,1.19 [0.77-1.85],0.4316698337075503
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA4,Carbonic anhydrase 4,12247,40,1.35 [0.41-4.44],0.6212033242938948
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA5A,"Carbonic anhydrase 5A, mitochondrial",11861,38,0.77 [0.54-1.09],0.1400144220899679
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA6,Carbonic anhydrase 6,12071,38,0.75 [0.47-1.18],0.209741056996866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA7,Carbonic anhydrase 7,10425,33,1.34 [0.60-2.97],0.4755978844411972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA8,Carbonic anhydrase-related protein,10295,36,0.97 [0.30-3.20],0.9635998453583104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA9,Carbonic anhydrase 9,12195,37,1.39 [0.78-2.48],0.264936949394294
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CABP2,Calcium-binding protein 2,10316,33,0.83 [0.47-1.45],0.5102559323505717
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,10235,33,0.98 [0.36-2.67],0.9638333828416636
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,10258,34,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,10235,33,0.89 [0.50-1.60],0.7033452756453671
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,10578,34,1.04 [0.70-1.53],0.8482085305780367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACYBP,Calcyclin-binding protein,10372,35,1.01 [0.73-1.40],0.9370745496765582
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CADPS,Calcium-dependent secretion activator 1,10316,33,0.56 [0.20-1.60],0.2795857403384625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALB1,Calbindin,12048,37,0.63 [0.37-1.08],0.0950447465294862
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALB2,Calretinin,11815,37,0.44 [0.16-1.23],0.1169253953662965
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALCA,Calcitonin,11999,39,1.10 [0.67-1.82],0.7003294842826804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALCB,Calcitonin gene-related peptide 2,10586,35,0.50 [0.18-1.39],0.1832170444040727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,12150,37,0.96 [0.72-1.28],0.7974604681420407
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,10348,34,1.31 [0.88-1.97],0.1873314293055755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALY,Neuron-specific vesicular protein calcyon,10258,34,1.40 [0.79-2.50],0.2496772234175593
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,11824,39,1.15 [0.61-2.14],0.6716929343664697
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,10316,33,1.28 [0.73-2.22],0.3865772989905435
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,10578,34,1.05 [0.78-1.42],0.74940065586626
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CANT1,Soluble calcium-activated nucleotidase 1,12067,41,0.58 [0.15-2.32],0.445650987875534
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAPG,Macrophage-capping protein,11990,37,0.95 [0.58-1.58],0.8490564367636156
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAPN3,Calpain-3,10542,34,1.64 [1.01-2.69],0.0476414106486144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAPS,Calcyphosin,10586,35,0.84 [0.54-1.30],0.4322741713929652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CARHSP1,Calcium-regulated heat-stable protein 1,11815,37,1.12 [0.66-1.92],0.6745492272421092
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASC3,Protein CASC3,10316,33,1.88 [0.94-3.73],0.0723181511477065
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP1,Caspase-1,11815,37,1.31 [0.93-1.85],0.1273983371133418
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP10,Caspase-10,11815,37,0.96 [0.64-1.46],0.8570718760330971
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP2,Caspase-2,12076,37,0.97 [0.63-1.49],0.8825252949552918
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP3,Caspase-3,12247,40,1.03 [0.75-1.43],0.8435419548241629
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP4,Caspase-4,10425,33,1.03 [0.85-1.24],0.7708931011198193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP7,Caspase-7,10586,35,1.10 [0.75-1.63],0.6165447568305744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP8,Caspase-8,12148,37,1.38 [0.90-2.11],0.1385653244993044
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP9,Caspase-9,10295,36,0.89 [0.52-1.52],0.6717293827815423
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASQ2,Calsequestrin-2,10258,34,0.83 [0.38-1.82],0.6375004750394874
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAT,Catalase,10446,32,1.26 [0.70-2.26],0.4426833216974135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBLIF,Cobalamin binding intrinsic factor,12085,41,1.34 [0.92-1.94],0.1230709640059689
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBLN1,Cerebellin-1,10235,33,0.94 [0.64-1.36],0.7310641318264371
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBLN4,Cerebellin-4,12195,37,1.88 [0.81-4.38],0.1436210599771202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBS,Cystathionine beta-synthase,10348,34,0.80 [0.39-1.64],0.5482857695769552
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBX2,Chromobox protein homolog 2,10258,34,1.25 [0.62-2.51],0.5367608915859107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,12020,39,0.99 [0.67-1.46],0.9498002234428146
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCAR2,Cell cycle and apoptosis regulator protein 2,10586,35,1.78 [1.41-2.25],1.4557770262269955e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCDC134,Coiled-coil domain-containing protein 134,10542,34,1.21 [0.65-2.26],0.5464537511358438
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCDC28A,Coiled-coil domain-containing protein 28A,10316,33,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCDC50,Coiled-coil domain-containing protein 50,10578,34,0.98 [0.64-1.51],0.9435629575210628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCDC80,Coiled-coil domain-containing protein 80,12108,41,0.91 [0.42-1.96],0.802063152276036
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,10348,34,0.63 [0.36-1.10],0.103330324771056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL11,Eotaxin,12217,37,0.98 [0.44-2.18],0.9596876303415725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL13,C-C motif chemokine 13,12194,37,0.94 [0.62-1.43],0.7629833976927038
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL14,C-C motif chemokine 14,12083,39,0.96 [0.47-1.97],0.9080849881969872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL15,C-C motif chemokine 15,12247,40,0.72 [0.36-1.44],0.3560619521337484
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL16,C-C motif chemokine 16,12247,40,1.00 [0.57-1.72],0.988028602647352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL17,C-C motif chemokine 17,12092,40,0.95 [0.70-1.30],0.7652742830246457
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL18,C-C motif chemokine 18,11940,38,0.94 [0.61-1.45],0.778917262303173
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL19,C-C motif chemokine 19,12201,37,0.90 [0.70-1.16],0.4172152539469141
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL2,C-C motif chemokine 2,12005,39,1.21 [0.72-2.02],0.4684422739748307
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL20,C-C motif chemokine 20,12217,37,0.95 [0.68-1.33],0.7704631371805326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL21,C-C motif chemokine 21,12162,40,0.70 [0.34-1.44],0.3255220614296991
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL22,C-C motif chemokine 22,12009,40,0.82 [0.47-1.42],0.4703285215998343
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL23,C-C motif chemokine 23,12162,40,0.61 [0.31-1.22],0.1637980410217431
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL24,C-C motif chemokine 24,12139,40,1.34 [0.97-1.85],0.0790193888340595
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL25,C-C motif chemokine 25,12217,37,0.68 [0.36-1.25],0.2138349035773262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL26,C-C motif chemokine 26,12076,37,0.79 [0.55-1.14],0.2135273880916903
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL27,C-C motif chemokine 27,12108,41,0.93 [0.58-1.51],0.7808716950757295
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL28,C-C motif chemokine 28,12032,37,0.68 [0.39-1.18],0.1667344271982602
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL3,C-C motif chemokine 3,12076,37,0.75 [0.39-1.43],0.3820755885018615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL4,C-C motif chemokine 4,12129,40,0.84 [0.53-1.33],0.4549455499626524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL5,C-C motif chemokine 5,12165,39,0.98 [0.74-1.30],0.8968235238916581
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL7,C-C motif chemokine 7,12076,37,0.68 [0.39-1.20],0.1868442877129834
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL8,C-C motif chemokine 8,12174,37,0.92 [0.58-1.48],0.7458343724288203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN1,CCN family member 1,12020,37,0.77 [0.53-1.12],0.1774866139739842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN2,CCN family member 2,12089,40,0.67 [0.40-1.11],0.1191183840670641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN3,CCN family member 3,12227,40,0.44 [0.18-1.07],0.0710693545513571
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN4,CCN family member 4,12195,37,0.59 [0.28-1.28],0.1843224858863617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN5,CCN family member 5,12112,38,1.02 [0.48-2.15],0.960982629374776
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCND2,G1/S-specific cyclin-D2,10425,33,2.01 [0.78-5.16],0.1466483647310287
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCNE1,G1/S-specific cyclin-E1,10295,36,1.20 [0.93-1.55],0.1555524362075748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCS,Copper chaperone for superoxide dismutase,12020,39,1.05 [0.58-1.90],0.8661485831165796
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCT5,T-complex protein 1 subunit epsilon,11824,39,0.86 [0.44-1.67],0.6491737417205046
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD101,Immunoglobulin superfamily member 2,10538,34,0.93 [0.44-1.97],0.8454574755666638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD109,CD109 antigen,12112,38,1.36 [0.56-3.29],0.4932009943766019
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD14,Monocyte differentiation antigen CD14,11876,37,0.61 [0.29-1.27],0.1860029367468066
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD160,CD160 antigen,12217,37,0.60 [0.32-1.13],0.1137672381813736
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD163,Scavenger receptor cysteine-rich type 1 protein M130,12165,39,1.26 [0.66-2.42],0.4800979961356056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD164,Sialomucin core protein 24,12112,38,1.20 [0.49-2.92],0.6881598863235581
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD164L2,CD164 sialomucin-like 2 protein,10316,33,0.55 [0.20-1.50],0.2447768929424367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD177,CD177 antigen,12096,38,1.11 [0.87-1.41],0.3909180107068725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD1C,T-cell surface glycoprotein CD1c,12159,39,0.92 [0.29-2.94],0.8846915420057488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD2,T-cell surface antigen CD2,10258,34,0.90 [0.36-2.22],0.8202271052771831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD200,OX-2 membrane glycoprotein,12076,37,1.17 [0.39-3.53],0.7799974614276294
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD200R1,Cell surface glycoprotein CD200 receptor 1,12039,37,0.58 [0.24-1.40],0.221785033788429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD207,C-type lectin domain family 4 member K,11824,35,0.93 [0.43-2.03],0.852784026069653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD209,CD209 antigen,12135,40,1.32 [0.65-2.67],0.439492296627663
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD22,B-cell receptor CD22,12217,37,0.92 [0.45-1.87],0.8143293941527906
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD226,CD226 antigen,10295,36,1.13 [0.53-2.39],0.7590603798854818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD244,Natural killer cell receptor 2B4,12217,37,1.25 [0.42-3.70],0.6852354043106503
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD248,Endosialin,10617,36,0.99 [0.44-2.21],0.9813237958111568
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD27,CD27 antigen,12159,39,0.49 [0.24-1.03],0.0582852472168732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD274,Programmed cell death 1 ligand 1,12020,39,1.23 [0.56-2.66],0.6065382730345817
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD276,CD276 antigen,12105,40,1.47 [0.67-3.19],0.3355400743653002
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD28,T-cell-specific surface glycoprotein CD28,11824,39,0.85 [0.38-1.89],0.6841095733364897
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD2AP,CD2-associated protein,12108,41,1.11 [0.73-1.70],0.6123105371869488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300A,CMRF35-like molecule 8,10388,35,0.70 [0.23-2.08],0.5163891019492063
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300C,CMRF35-like molecule 6,12201,37,0.47 [0.19-1.14],0.0933448721712767
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300E,CMRF35-like molecule 2,12144,37,1.24 [0.63-2.45],0.5401587580015823
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300LF,CMRF35-like molecule 1,12195,37,0.87 [0.55-1.38],0.5671068549860696
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300LG,CMRF35-like molecule 9,12112,38,1.18 [0.55-2.53],0.6721749304302342
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD302,CD302 antigen,12048,37,0.88 [0.33-2.33],0.7941531962121142
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD33,Myeloid cell surface antigen CD33,12159,39,1.01 [0.71-1.44],0.9354004207311132
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD34,Hematopoietic progenitor cell antigen CD34,12170,37,0.43 [0.12-1.46],0.1746973112030229
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD36,Platelet glycoprotein 4,10295,36,0.89 [0.42-1.89],0.7600169787015318
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,12048,37,1.03 [0.41-2.60],0.9427720746794052
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD3D,T-cell surface glycoprotein CD3 delta chain,10235,33,0.73 [0.23-2.29],0.5872238003437827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD3E,T-cell surface glycoprotein CD3 epsilon chain,10425,33,1.35 [0.69-2.65],0.3760217286782193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD3G,T-cell surface glycoprotein CD3 gamma chain,10295,36,1.28 [0.99-1.64],0.058293776498821
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD4,T-cell surface glycoprotein CD4,12054,37,0.49 [0.16-1.46],0.1991428647924562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD40,Tumor necrosis factor receptor superfamily member 5,12106,40,1.04 [0.59-1.83],0.8814926267189624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD40LG,CD40 ligand,12217,37,0.72 [0.50-1.05],0.0896247329062445
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD46,Membrane cofactor protein,12045,39,0.55 [0.19-1.60],0.2700409065148057
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD48,CD48 antigen,12139,40,0.72 [0.28-1.87],0.4997168222166293
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD5,T-cell surface glycoprotein CD5,12174,37,0.50 [0.20-1.23],0.1288041296881559
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD55,Complement decay-accelerating factor,11696,38,1.24 [0.41-3.73],0.7081254927406859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD58,Lymphocyte function-associated antigen 3,12094,40,1.03 [0.21-5.04],0.9724586119695868
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD59,CD59 glycoprotein,11679,38,0.58 [0.15-2.28],0.4376509929184835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD5L,CD5 antigen-like,10558,35,0.75 [0.37-1.52],0.4291133576378091
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD6,T-cell differentiation antigen CD6,12201,37,0.55 [0.32-0.96],0.0341574710737803
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD63,CD63 antigen,12005,39,0.99 [0.57-1.72],0.9603391933533704
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD69,Early activation antigen CD69,12060,41,0.95 [0.69-1.31],0.7715572903915666
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD7,T-cell antigen CD7,10267,36,1.05 [0.51-2.19],0.8918699416169944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD70,CD70 antigen,12076,37,0.95 [0.47-1.90],0.8823558266866588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD72,B-cell differentiation antigen CD72,10388,35,1.08 [0.51-2.31],0.8413549364793194
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD74,HLA class II histocompatibility antigen gamma chain,12201,37,0.36 [0.14-0.90],0.0283146769795662
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD79B,B-cell antigen receptor complex-associated protein beta chain,12217,37,0.72 [0.37-1.41],0.3409945960750242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD80,T-lymphocyte activation antigen CD80,10600,35,0.56 [0.20-1.56],0.2673469226052412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD82,CD82 antigen,10425,33,1.40 [0.78-2.52],0.2534689135120459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD83,CD83 antigen,12076,37,0.62 [0.26-1.52],0.2957301725554692
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD84,SLAM family member 5,12076,37,0.92 [0.36-2.37],0.863870336766978
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD86,T-lymphocyte activation antigen CD86,10538,34,0.60 [0.20-1.74],0.3440820156487899
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD8A,T-cell surface glycoprotein CD8 alpha chain,12201,37,0.54 [0.30-0.98],0.0421096392333468
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD93,Complement component C1q receptor,11651,38,0.48 [0.18-1.27],0.1393096906129123
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD99,CD99 antigen,12112,38,0.49 [0.11-2.22],0.3527553996385804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD99L2,CD99 antigen-like protein 2,12112,38,0.60 [0.17-2.09],0.4204077323049081
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDA,Cytidine deaminase,10574,35,1.57 [0.89-2.77],0.1168691179914103
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDAN1,Codanin-1,10586,35,1.05 [0.31-3.60],0.9334093666383312
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC123,Cell division cycle protein 123 homolog,10208,34,0.99 [0.60-1.63],0.9550457170719554
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC25A,M-phase inducer phosphatase 1,10208,34,0.63 [0.25-1.63],0.3447669263332361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC26,Anaphase-promoting complex subunit CDC26,10515,34,1.12 [0.70-1.78],0.6433606429865368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC27,Cell division cycle protein 27 homolog,11824,39,0.92 [0.57-1.50],0.749477526892429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC37,Hsp90 co-chaperone Cdc37,12159,39,0.99 [0.70-1.38],0.9324603636441976
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC42BPB,Serine/threonine-protein kinase MRCK beta,10538,34,0.99 [0.72-1.36],0.944081318202703
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDCP1,CUB domain-containing protein 1,12020,39,1.53 [0.91-2.57],0.1096589267328159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH1,Cadherin-1,11731,39,1.04 [0.51-2.14],0.9140307287406748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH15,Cadherin-15,12180,37,1.15 [0.66-2.02],0.614509473804647
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH17,Cadherin-17,12108,41,0.92 [0.61-1.39],0.682831649110587
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH2,Cadherin-2,12108,41,0.68 [0.32-1.47],0.3274855186956894
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH22,Cadherin-22,10425,33,1.25 [0.45-3.44],0.6698294268627476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH23,Cadherin-23,10586,35,1.39 [0.45-4.34],0.5676203539721181
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH3,Cadherin-3,12201,37,0.61 [0.26-1.44],0.2602981791723249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH4,Cadherin-4,10235,33,1.01 [0.51-2.02],0.9704714845596586
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH5,Cadherin-5,12247,40,1.08 [0.43-2.73],0.8682250169672316
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH6,Cadherin-6,12108,41,0.97 [0.46-2.03],0.9344788273470106
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDHR1,Cadherin-related family member 1,11815,37,1.07 [0.56-2.04],0.8400062622925798
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDHR2,Cadherin-related family member 2,12048,37,0.96 [0.65-1.41],0.8298094510307341
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDHR5,Cadherin-related family member 5,12108,41,0.65 [0.34-1.25],0.1965133977205541
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDK1,Cyclin-dependent kinase 1,10208,34,2.01 [0.86-4.70],0.1051910022442104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,10578,34,1.16 [0.69-1.97],0.5762677976652777
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDKL5,Cyclin-dependent kinase-like 5,10235,33,1.16 [0.69-1.94],0.5663880234703236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDKN1A,Cyclin-dependent kinase inhibitor 1,12048,37,0.83 [0.62-1.10],0.1953560286366791
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,12048,37,0.90 [0.66-1.22],0.5043319909854519
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDNF,Cerebral dopamine neurotrophic factor,12048,37,0.80 [0.32-1.99],0.6329531334609511
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,12125,40,1.22 [0.40-3.68],0.7278193413037343
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDSN,Corneodesmosin,12173,36,0.93 [0.47-1.83],0.8315593087339623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,12138,39,1.13 [0.28-4.48],0.8656032187058401
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,10538,34,0.82 [0.54-1.27],0.3758846764318958
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,10425,33,1.09 [0.70-1.68],0.7011888807842099
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,10538,34,0.82 [0.36-1.87],0.6357096095106141
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,10425,33,1.55 [0.92-2.61],0.0985975294682879
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,12076,37,0.74 [0.51-1.08],0.120193913903965
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,11824,39,0.97 [0.53-1.76],0.9163463904230916
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,11681,39,1.22 [0.82-1.80],0.3282486228022382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,10617,36,1.45 [0.67-3.14],0.3480413694234481
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,11861,38,1.49 [0.90-2.46],0.1233509900941095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEBPA,CCAAT/enhancer-binding protein alpha,10295,36,1.89 [1.31-2.72],0.0006197031767183
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEBPB,CCAAT/enhancer-binding protein beta,11861,38,1.75 [1.01-3.05],0.0474061930650652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CELA2A,Chymotrypsin-like elastase family member 2A,10617,36,1.34 [0.78-2.30],0.2879967960538169
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CELA3A,Chymotrypsin-like elastase family member 3A,12225,40,1.55 [0.96-2.51],0.0731893355458245
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,10388,35,1.14 [0.38-3.43],0.8126848648185285
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEMIP2,Cell surface hyaluronidase,10295,36,1.03 [0.43-2.47],0.9555312507890458
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEND1,Cell cycle exit and neuronal differentiation protein 1,10235,33,0.99 [0.57-1.75],0.9846640356020808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CENPF,Centromere protein F,10425,33,1.58 [0.96-2.59],0.0707222558984368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CENPJ,Centromere protein J,10425,33,0.94 [0.57-1.55],0.798573581221659
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP112,Centrosomal protein of 112 kDa,10258,34,1.05 [0.51-2.15],0.8993027440984702
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP152,Centrosomal protein of 152 kDa,10208,34,1.39 [0.74-2.63],0.3085114730540181
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP164,Centrosomal protein of 164 kDa,11857,37,1.10 [0.74-1.63],0.6540783228435326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP170,Centrosomal protein of 170 kDa,10348,34,1.37 [0.93-2.00],0.1075402965466792
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP20,Centrosomal protein 20,11824,39,0.89 [0.60-1.33],0.5792933323047753
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP290,Centrosomal protein of 290 kDa,10425,33,1.34 [0.84-2.14],0.2147051203358003
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP350,Centrosome-associated protein 350,10208,34,2.13 [1.31-3.46],0.0023003716385203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP43,Centrosomal protein 43,11764,38,1.04 [0.68-1.59],0.8502645113958611
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP85,Centrosomal protein of 85 kDa,11824,39,0.98 [0.62-1.54],0.93155158405258
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CERT,Ceramide transfer protein,11815,37,1.12 [0.69-1.81],0.6552712415500186
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CES1,Liver carboxylesterase 1,12142,40,0.93 [0.65-1.34],0.6969547100273064
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CES2,Cocaine esterase,12048,37,0.79 [0.45-1.41],0.4328488054941835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CES3,Carboxylesterase 3,12048,37,1.24 [0.86-1.78],0.2483033913511407
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CETN2,Centrin-2,11815,37,1.01 [0.65-1.56],0.9799498484053124
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CETN3,Centrin-3,10538,34,1.16 [0.75-1.78],0.5062350412912755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFB,Complement factor B,10423,35,1.70 [0.61-4.78],0.3121300765866363
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFC1,Cryptic protein,11824,39,1.53 [0.97-2.41],0.0706208898983415
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFD,Complement factor D,10623,35,1.67 [0.38-7.39],0.4971801521182746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFH,Complement factor H,9974,33,0.70 [0.16-3.12],0.6352254060616929
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFHR2,Complement factor H-related protein 2,10535,35,0.60 [0.38-0.95],0.0295044426170938
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFHR4,Complement factor H-related protein 4,10604,35,0.54 [0.37-0.79],0.0015492071841769
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFHR5,Complement factor H-related protein 5,10449,33,0.62 [0.33-1.16],0.1357923345037907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFI,Complement factor I,10623,35,0.63 [0.12-3.18],0.5751918259686752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFP,Properdin,10623,35,0.53 [0.11-2.57],0.4266665793520372
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGA,Glycoprotein hormones alpha chain,12112,38,0.93 [0.58-1.49],0.7581551562834681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,10602,33,0.94 [0.40-2.21],0.889511732234802
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGN,Cingulin,10316,33,1.05 [0.51-2.17],0.88671591993648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGREF1,Cell growth regulator with EF hand domain protein 1,12108,41,0.41 [0.21-0.82],0.0111825773550046
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,11824,39,0.96 [0.59-1.54],0.8538014936915821
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHAD,Chondroadherin,10388,35,0.72 [0.40-1.29],0.2702431282449877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",10586,35,1.32 [0.62-2.78],0.4733509625299469
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHCHD6,MICOS complex subunit MIC25,10542,34,1.33 [0.46-3.89],0.5975293487351532
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHEK2,Serine/threonine-protein kinase Chk2,11861,38,1.32 [0.60-2.92],0.4873854074167727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHGA,Chromogranin-A,10617,36,0.98 [0.70-1.37],0.8986481865116237
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHGB,Secretogranin-1,12161,37,0.90 [0.44-1.86],0.7801768535648198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHI3L1,Chitinase-3-like protein 1,11861,37,1.11 [0.77-1.60],0.5849452679972786
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHIT1,Chitotriosidase-1,12156,40,1.01 [0.84-1.23],0.8997742126304821
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHL1,Neural cell adhesion molecule L1-like protein,12148,39,0.80 [0.31-2.06],0.6369322993851618
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHM,Rab proteins geranylgeranyltransferase component A 1,10316,33,1.20 [0.72-2.00],0.4811161603882261
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHMP1A,Charged multivesicular body protein 1a,12020,39,0.95 [0.66-1.36],0.7756360454325744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHMP6,Charged multivesicular body protein 6,10600,35,0.96 [0.53-1.72],0.8807408325778923
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHP1,Calcineurin B homologous protein 1,10235,33,1.00 [0.62-1.59],0.9882279675965134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHRDL1,Chordin-like protein 1,12139,40,1.29 [0.52-3.21],0.585669739357453
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHRDL2,Chordin-like protein 2,12108,41,1.05 [0.60-1.86],0.8593347757318689
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHRM1,Muscarinic acetylcholine receptor M1,10316,33,1.33 [0.62-2.85],0.4636085775986248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CIAPIN1,Anamorsin,12159,39,0.95 [0.60-1.48],0.8072333366636855
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CILP,Cartilage intermediate layer protein 1,10617,36,0.76 [0.44-1.31],0.3214760578210535
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CINP,Cyclin-dependent kinase 2-interacting protein,10425,33,0.69 [0.27-1.72],0.4217140993609449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CIRBP,Cold-inducible RNA-binding protein,10538,34,1.03 [0.72-1.47],0.8648791474893727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CIT,Citron Rho-interacting kinase,10316,33,1.69 [1.00-2.87],0.0519734631668989
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CKAP4,Cytoskeleton-associated protein 4,12169,37,0.65 [0.21-2.03],0.4611889901406466
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CKB,Creatine kinase B-type,10617,36,1.37 [0.82-2.31],0.2323112653018487
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",12075,40,0.75 [0.57-0.99],0.0440517816073655
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLASP1,CLIP-associating protein 1,10208,34,0.98 [0.62-1.57],0.9383735756808402
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLC,Galectin-10,12087,41,0.83 [0.53-1.30],0.4098881481848164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC10A,C-type lectin domain family 10 member A,12020,39,1.14 [0.51-2.53],0.751614513815786
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC11A,C-type lectin domain family 11 member A,12091,38,0.76 [0.43-1.36],0.3571530086554174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC12A,C-type lectin domain family 12 member A,10295,36,1.06 [0.23-4.86],0.944269297591228
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC14A,C-type lectin domain family 14 member A,12112,38,0.43 [0.17-1.10],0.0766808148747555
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC1A,C-type lectin domain family 1 member A,11861,38,0.61 [0.25-1.49],0.2789103578051107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC1B,C-type lectin domain family 1 member B,12201,37,0.92 [0.67-1.24],0.5732696163860758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC2L,C-type lectin domain family 2 member L,10316,33,0.86 [0.41-1.79],0.6870080732523469
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC3B,Tetranectin,10358,35,0.32 [0.07-1.46],0.1405246450271984
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4A,C-type lectin domain family 4 member A,12076,37,1.62 [0.67-3.93],0.2834940525686835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4C,C-type lectin domain family 4 member C,12076,37,0.72 [0.39-1.32],0.2871241809141114
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4D,C-type lectin domain family 4 member D,12076,37,0.94 [0.58-1.53],0.815269411560005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4G,C-type lectin domain family 4 member G,12076,37,1.03 [0.42-2.52],0.9522520338860636
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4M,C-type lectin domain family 4 member M,10599,36,1.37 [0.72-2.61],0.332579974176911
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC5A,C-type lectin domain family 5 member A,12076,41,1.26 [0.50-3.15],0.6219920673082282
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC6A,C-type lectin domain family 6 member A,11824,39,0.96 [0.52-1.77],0.8956307779673942
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC7A,C-type lectin domain family 7 member A,12217,37,0.86 [0.58-1.29],0.4697853853584377
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLGN,Calmegin,10316,33,1.65 [0.91-3.00],0.0969921395481757
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLIC5,Chloride intracellular channel protein 5,10316,33,1.13 [0.44-2.90],0.8052407583741911
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLINT1,Clathrin interactor 1,10208,34,0.54 [0.23-1.30],0.1716357701497007
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLIP2,CAP-Gly domain-containing linker protein 2,12076,37,0.94 [0.72-1.23],0.6569205500860211
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLMP,CXADR-like membrane protein,12195,37,1.29 [0.31-5.39],0.7289798905728431
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLNS1A,Methylosome subunit pICln,10316,33,2.36 [1.08-5.16],0.0314052878593681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",11999,39,0.99 [0.74-1.34],0.9719912421771052
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLPS,Colipase,12094,38,0.73 [0.49-1.09],0.1188705800472242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLSPN,Claspin,11794,37,0.86 [0.33-2.26],0.7557757467409726
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLSTN1,Calsyntenin-1,11815,37,1.12 [0.69-1.83],0.6495988032441818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLSTN2,Calsyntenin-2,12217,37,1.23 [0.60-2.51],0.5686245580102078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLSTN3,Calsyntenin-3,10586,35,0.99 [0.34-2.90],0.98362217759867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLTA,Clathrin light chain A,11861,38,1.30 [0.78-2.15],0.3101084492516499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLU,Clusterin,10623,35,0.54 [0.10-2.97],0.4798415712534073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLUL1,Clusterin-like protein 1,12089,41,1.49 [0.82-2.69],0.1894503147214516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CMC1,COX assembly mitochondrial protein homolog,10600,35,0.98 [0.69-1.40],0.918938381010717
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CMIP,C-Maf-inducing protein,10542,34,1.10 [0.74-1.63],0.6297833135180615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNDP1,Beta-Ala-His dipeptidase,12165,39,0.71 [0.40-1.24],0.2293094437349412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNGB3,Cyclic nucleotide-gated cation channel beta-3,10235,33,0.87 [0.42-1.77],0.6904798798507688
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",10329,34,1.24 [0.83-1.88],0.2969003463583323
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNPY2,Protein canopy homolog 2,11861,38,0.85 [0.49-1.46],0.5488173345356546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNPY4,Protein canopy homolog 4,12048,37,0.85 [0.57-1.26],0.4147694745502874
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNST,Consortin,12108,41,1.05 [0.81-1.37],0.6863615633874847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTF,Ciliary neurotrophic factor,10235,33,0.70 [0.25-1.95],0.4976761851152433
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN1,Contactin-1,12247,40,1.59 [0.57-4.41],0.373982631702925
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN2,Contactin-2,12195,37,0.65 [0.33-1.28],0.216207293204682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN3,Contactin-3,12112,38,0.80 [0.34-1.86],0.6021477469834392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN4,Contactin-4,12112,38,2.29 [0.69-7.58],0.173731516371544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN5,Contactin-5,12134,37,1.89 [0.92-3.89],0.0830786999655881
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTNAP2,Contactin-associated protein-like 2,12076,37,1.30 [0.64-2.64],0.4639366888723971
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTNAP4,Contactin-associated protein-like 4,10316,33,0.98 [0.71-1.37],0.9253059507108216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COCH,Cochlin,10600,35,1.20 [0.60-2.37],0.607112957171308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL15A1,Collagen alpha-1(XV) chain,10617,36,1.63 [0.51-5.19],0.4116926880899192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL18A1,Collagen alpha-1(XVIII) chain,12159,40,0.43 [0.13-1.42],0.1654565782269826
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL1A1,Collagen alpha-1(I) chain,12247,40,0.75 [0.26-2.18],0.5943786795882446
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL24A1,Collagen alpha-1(XXIV) chain,10538,34,0.92 [0.50-1.67],0.7824805139322607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL28A1,Collagen alpha-1(XXVIII) chain,10316,33,1.28 [0.82-2.00],0.285706062771624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL2A1,Collagen alpha-1(II) chain,10348,34,0.82 [0.54-1.24],0.3478764172680163
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL3A1,Collagen alpha-1(III) chain,10617,36,1.15 [0.29-4.60],0.847869388804463
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL4A1,Collagen alpha-1(IV) chain,12108,41,1.15 [0.58-2.29],0.6942759809963586
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL4A4,Collagen alpha-4(IV) chain,10407,33,0.91 [0.49-1.69],0.7674623729819936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL5A1,Collagen alpha-1(V) chain,10388,35,0.83 [0.36-1.92],0.6674036860940701
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL6A3,Collagen alpha-3(VI) chain,12247,40,0.93 [0.42-2.08],0.8593538262170906
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL9A1,Collagen alpha-1(IX) chain,12076,37,1.17 [0.67-2.05],0.5868205122669936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL9A2,Collagen alpha-2(IX) chain,10425,33,0.93 [0.43-1.99],0.8422641586601824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COLEC12,Collectin-12,12105,40,0.69 [0.23-2.09],0.5079863316968675
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COMMD1,COMM domain-containing protein 1,10348,34,1.27 [0.76-2.14],0.3611190717614128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COMMD9,COMM domain-containing protein 9,10542,34,1.61 [0.90-2.89],0.108571904952364
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COMP,Cartilage oligomeric matrix protein,11980,39,0.56 [0.24-1.30],0.1756346119938743
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COMT,Catechol O-methyltransferase,11742,38,1.15 [0.81-1.63],0.4297942818145862
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COPB2,Coatomer subunit beta',10258,34,0.72 [0.32-1.62],0.4280600890300352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COPE,Coatomer subunit epsilon,11815,37,1.05 [0.57-1.91],0.8824694568462624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",10348,34,0.75 [0.33-1.70],0.485764916552251
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CORO1A,Coronin-1A,11843,40,1.17 [0.89-1.55],0.2641809002803506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CORO6,Coronin-6,10235,33,1.18 [0.50-2.77],0.7006526614873749
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",12048,37,1.09 [0.72-1.63],0.6920812616118208
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COX6B1,Cytochrome c oxidase subunit 6B1,10600,35,1.05 [0.40-2.75],0.9186237038659272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPA1,Carboxypeptidase A1,12247,40,1.21 [0.76-1.94],0.4143240649682628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPA2,Carboxypeptidase A2,12163,37,0.92 [0.58-1.45],0.7055036681141322
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPA4,Carboxypeptidase A4,10181,35,0.89 [0.43-1.87],0.7619598892650494
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPB1,Carboxypeptidase B,12247,40,1.16 [0.72-1.85],0.539362089780844
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPB2,Carboxypeptidase B2,10602,35,0.53 [0.12-2.30],0.3999460394505458
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPE,Carboxypeptidase E,12091,37,0.94 [0.44-2.03],0.88189492328705
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPLX2,Complexin-2,10208,34,0.56 [0.18-1.80],0.3310230851230762
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPM,Carboxypeptidase M,12139,37,0.89 [0.37-2.14],0.8000423782147722
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",10295,36,1.24 [0.40-3.84],0.7034730219161092
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPPED1,Serine/threonine-protein phosphatase CPPED1,12201,37,1.45 [0.96-2.20],0.0778727159114346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPQ,Carboxypeptidase Q,10590,36,1.39 [0.54-3.54],0.4934591957694909
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPTP,Ceramide-1-phosphate transfer protein,10258,34,0.96 [0.41-2.24],0.9164447852294956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPVL,Probable serine carboxypeptidase CPVL,12181,37,1.13 [0.55-2.31],0.737105611253041
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPXM1,Probable carboxypeptidase X1,12159,39,0.75 [0.49-1.13],0.1666559051753005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPXM2,Inactive carboxypeptidase-like protein X2,10600,35,0.35 [0.09-1.35],0.1267332587247376
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CR1,Complement receptor type 1,10562,33,0.55 [0.24-1.30],0.1767274286948233
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CR2,Complement receptor type 2,12165,39,0.86 [0.47-1.57],0.6187129026992066
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,11824,39,1.00 [0.72-1.39],0.9989641104168824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRADD,Death domain-containing protein CRADD,11999,39,1.01 [0.69-1.48],0.9420130111157308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CREB3,Cyclic AMP-responsive element-binding protein 3,10208,34,1.15 [0.67-1.99],0.6067275968827359
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CREBZF,CREB/ATF bZIP transcription factor,10208,34,2.15 [0.87-5.27],0.0957570202244694
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CREG1,Protein CREG1,11964,39,1.60 [0.77-3.29],0.2068911278224893
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRELD1,Protein disulfide isomerase CRELD1,10388,35,0.75 [0.31-1.81],0.5245977872258615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRELD2,Protein disulfide isomerase CRELD2,12139,40,0.70 [0.40-1.21],0.1999020696779447
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRH,Corticoliberin,11803,39,0.86 [0.61-1.21],0.3877089839007001
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRHBP,Corticotropin-releasing factor-binding protein,12105,40,0.47 [0.17-1.29],0.1428364836484504
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRHR1,Corticotropin-releasing factor receptor 1,11861,38,1.00 [0.62-1.59],0.9921535373873246
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRIM1,Cysteine-rich motor neuron 1 protein,12162,40,2.08 [0.56-7.78],0.2752899395250634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRIP2,Cysteine-rich protein 2,12020,39,0.44 [0.19-1.04],0.061155229682084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRISP2,Cysteine-rich secretory protein 2,12195,37,0.75 [0.49-1.15],0.191457004388142
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRISP3,Cysteine-rich secretory protein 3,10513,33,0.70 [0.21-2.41],0.5766446045057902
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRKL,Crk-like protein,12128,40,0.92 [0.71-1.20],0.5532371094843371
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRLF1,Cytokine receptor-like factor 1,12162,40,0.68 [0.22-2.11],0.5100428416998333
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRNN,Cornulin,11769,37,0.98 [0.64-1.51],0.9376403973585604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRTAC1,Cartilage acidic protein 1,12247,40,0.63 [0.25-1.57],0.3195261488638456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRTAM,Cytotoxic and regulatory T-cell molecule,12020,39,0.86 [0.49-1.51],0.5943904527447172
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRTAP,Cartilage-associated protein,10316,33,1.03 [0.53-1.99],0.9363831564830646
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRX,Cone-rod homeobox protein,11861,38,1.11 [0.88-1.38],0.3828576206639735
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYBB1,Beta-crystallin B1,10600,35,0.92 [0.55-1.53],0.7452463728952028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYBB2,Beta-crystallin B2,10586,35,0.90 [0.55-1.47],0.6702062532615508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYGD,Gamma-crystallin D,10586,35,1.18 [0.84-1.65],0.3447838808079122
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYM,Ketimine reductase mu-crystallin,10235,33,1.05 [0.68-1.61],0.8225794732143981
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYZL1,Quinone oxidoreductase-like protein 1,10348,34,1.07 [0.75-1.54],0.7111608875304232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSDE1,Cold shock domain-containing protein E1,10258,34,1.05 [0.81-1.37],0.6984178459296411
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF1,Macrophage colony-stimulating factor 1,12162,40,0.40 [0.13-1.22],0.1069273452368474
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF1R,Macrophage colony-stimulating factor 1 receptor,10602,33,0.83 [0.36-1.95],0.6756061279591343
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF2,Granulocyte-macrophage colony-stimulating factor,10258,34,1.20 [0.48-3.02],0.6956956806621417
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,12020,39,1.11 [0.70-1.74],0.6603673889563542
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF2RB,Cytokine receptor common subunit beta,10295,36,0.97 [0.46-2.01],0.9265079854114184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF3,Granulocyte colony-stimulating factor,11857,37,0.72 [0.38-1.35],0.3051681228595135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF3R,Granulocyte colony-stimulating factor receptor,10295,36,0.61 [0.20-1.91],0.3972599172502233
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSH1,Chorionic somatomammotropin hormone 1,10602,33,0.99 [0.31-3.14],0.982102908696247
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSNK1D,Casein kinase I isoform delta,10295,36,1.20 [0.76-1.89],0.4325520433878639
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSNK2A1,Casein kinase II subunit alpha,10578,34,1.55 [0.77-3.11],0.2223755969671913
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSPG4,Chondroitin sulfate proteoglycan 4,10617,36,0.67 [0.25-1.83],0.4376797052418394
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSPG5,Chondroitin sulfate proteoglycan 5,10235,33,1.13 [0.60-2.13],0.7030872633075478
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSRP3,Cysteine and glycine-rich protein 3,10258,34,0.94 [0.66-1.35],0.7459801956016681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST1,Cystatin-SN,9218,32,0.92 [0.66-1.30],0.6458354277436182
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST3,Cystatin-C,12148,39,0.54 [0.19-1.52],0.2423399639513438
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST5,Cystatin-D,11903,37,0.72 [0.42-1.24],0.2347229212469797
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST6,Cystatin-M,11772,38,1.00 [0.55-1.83],0.997267977660172
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST7,Cystatin-F,12129,40,1.00 [0.74-1.35],0.9972756871163192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSTB,Cystatin-B,11943,40,1.15 [0.59-2.23],0.6896256036929769
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTAG1A_CTAG1B,Cancer/testis antigen 1,10405,33,0.99 [0.50-1.93],0.966147222094316
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTBS,Di-N-acetylchitobiase,10436,33,0.40 [0.18-0.89],0.0244158525076235
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTF1,Cardiotrophin-1,11861,38,1.02 [0.73-1.45],0.8899552960111866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTHRC1,Collagen triple helix repeat-containing protein 1,10617,36,0.55 [0.17-1.77],0.3135556954743144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTLA4,Cytotoxic T-lymphocyte protein 4,10617,36,0.70 [0.23-2.12],0.5288143431089651
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTNNA1,Catenin alpha-1,10235,33,0.87 [0.32-2.39],0.7937890076306766
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTRB1,Chymotrypsinogen B,12112,38,1.05 [0.63-1.78],0.8422862074389006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTRC,Chymotrypsin-C,12109,40,1.35 [0.88-2.07],0.1672183939665485
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTRL,Chymotrypsin-like protease CTRL-1,10586,35,1.60 [1.00-2.57],0.0496883253585586
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSB,Cathepsin B,12130,40,1.06 [0.64-1.76],0.8251202030704621
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSC,Dipeptidyl peptidase 1,12087,40,1.31 [0.70-2.46],0.3955961308855616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSD,Cathepsin D,11353,37,1.05 [0.51-2.17],0.9010998008272044
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSE,Cathepsin E,10388,35,1.61 [0.84-3.06],0.1494638070988358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSF,Cathepsin F,12159,39,0.79 [0.38-1.63],0.5210107783644715
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSH,Pro-cathepsin H,11828,37,0.79 [0.53-1.17],0.234660032813133
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSL,Cathepsin L1,12108,41,1.61 [0.53-4.95],0.4018750660241126
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSO,Cathepsin O,12217,37,0.92 [0.35-2.44],0.8653837708004805
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSS,Cathepsin S,9430,29,0.33 [0.07-1.56],0.1611027931902248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSV,Cathepsin L2,12158,37,0.90 [0.44-1.83],0.772946822964481
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSZ,Cathepsin Z,12136,39,0.74 [0.30-1.84],0.5225895131965408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CUZD1,CUB and zona pellucida-like domain-containing protein 1,10316,33,1.15 [0.52-2.52],0.7329309203358743
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CWC15,Spliceosome-associated protein CWC15 homolog,10472,34,1.49 [1.04-2.13],0.0306554263510941
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CX3CL1,Fractalkine,12020,39,0.60 [0.25-1.42],0.2432322508524242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXADR,Coxsackievirus and adenovirus receptor,12076,37,0.78 [0.44-1.40],0.4067838834918487
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL1,Growth-regulated alpha protein,12093,40,1.03 [0.78-1.37],0.8194428343442653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL10,C-X-C motif chemokine 10,12162,40,1.12 [0.76-1.64],0.5748341844537512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL11,C-X-C motif chemokine 11,12201,37,0.86 [0.58-1.26],0.4355431248584507
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL12,Stromal cell-derived factor 1,11857,37,0.49 [0.23-1.05],0.0662419210327135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL13,C-X-C motif chemokine 13,12201,37,0.80 [0.47-1.37],0.4221951405699907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL14,C-X-C motif chemokine 14,11857,37,1.45 [1.11-1.90],0.006989544353074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL16,C-X-C motif chemokine 16,12231,40,0.32 [0.10-1.02],0.0538536276802857
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL17,C-X-C motif chemokine 17,12217,37,0.57 [0.27-1.19],0.1350145710974551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL3,C-X-C motif chemokine 3,12106,40,0.88 [0.65-1.18],0.3791419427426663
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL5,C-X-C motif chemokine 5,12074,41,0.98 [0.77-1.24],0.8409082191785459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL6,C-X-C motif chemokine 6,12217,37,0.90 [0.61-1.32],0.5866638392303422
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL8,Interleukin-8,12007,36,1.14 [0.77-1.68],0.5059228172770176
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL9,C-X-C motif chemokine 9,12162,40,1.11 [0.75-1.63],0.6150298063618203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYB5A,Cytochrome b5,10208,34,0.78 [0.45-1.34],0.3612990134949572
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYB5R2,NADH-cytochrome b5 reductase 2,10416,33,1.47 [0.87-2.49],0.1533959915690013
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",10258,34,1.32 [1.03-1.70],0.0290385118508949
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYTH3,Cytohesin-3,10208,34,1.06 [0.69-1.64],0.7914005593126396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYTL1,Cytokine-like protein 1,10617,36,0.70 [0.18-2.67],0.6037951089581757
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAAM1,Disheveled-associated activator of morphogenesis 1,10388,35,1.01 [0.69-1.49],0.9552635531447048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAB2,Disabled homolog 2,12195,37,0.86 [0.67-1.12],0.2704339829087706
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAG1,Dystroglycan,12162,40,0.87 [0.47-1.60],0.6507014210408197
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAND5,DAN domain family member 5,10295,36,1.29 [0.81-2.04],0.2844184077348022
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAPK2,Death-associated protein kinase 2,10295,36,1.18 [0.72-1.96],0.5124880024230402
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,12076,37,0.98 [0.77-1.25],0.8736915936656735
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DARS1,"Aspartate--tRNA ligase, cytoplasmic",11999,39,1.05 [0.71-1.56],0.7959221889653414
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBH,Dopamine beta-hydroxylase,10576,33,0.76 [0.60-0.96],0.0238524496888584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBI,Acyl-CoA-binding protein,12058,38,1.01 [0.70-1.48],0.93954301429229
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBN1,Drebrin,10295,36,1.48 [0.85-2.58],0.1631795689733149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBNL,Drebrin-like protein,12162,40,0.96 [0.71-1.30],0.7940288155799389
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",12159,39,0.87 [0.38-1.97],0.7416945739541343
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCC,Netrin receptor DCC,10316,33,1.63 [0.69-3.88],0.2684426120654757
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCDC2C,Doublecortin domain-containing protein 2C,10208,34,0.91 [0.52-1.59],0.7377339273101854
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCLRE1C,Protein artemis,10208,34,1.53 [0.57-4.09],0.4002615544736551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCN,Decorin,11861,38,1.56 [0.45-5.39],0.4828580262695714
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTD,Deoxycytidylate deaminase,10388,35,0.98 [0.69-1.39],0.8976754997906711
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTN1,Dynactin subunit 1,12195,37,1.00 [0.64-1.56],0.987866614271117
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTN2,Dynactin subunit 2,12048,37,1.06 [0.78-1.44],0.6943139840819326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTN6,Dynactin subunit 6,11815,37,1.00 [0.67-1.49],0.9969314896145556
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTPP1,dCTP pyrophosphatase 1,12108,41,2.10 [0.93-4.72],0.0740303581950281
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCUN1D1,DCN1-like protein 1,10235,33,0.95 [0.60-1.50],0.8184338164335185
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCUN1D2,DCN1-like protein 2,10208,34,0.82 [0.51-1.31],0.4026439315432807
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCXR,L-xylulose reductase,12159,39,1.25 [0.74-2.11],0.3953830974845084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDA1,DET1- and DDB1-associated protein 1,10258,34,1.61 [1.02-2.55],0.0414806372705867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",12048,37,1.61 [0.92-2.79],0.0942416052670787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDC,Aromatic-L-amino-acid decarboxylase,12085,41,1.63 [0.94-2.83],0.0798610178416813
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDHD2,Phospholipase DDHD2,10578,34,1.25 [0.76-2.05],0.3875262323239794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDI2,Protein DDI1 homolog 2,10388,35,1.37 [0.93-2.01],0.1134281254090897
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDR1,Epithelial discoidin domain-containing receptor 1,12201,37,0.90 [0.24-3.38],0.8800919282868844
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDT,D-dopachrome decarboxylase,10617,36,,
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX1,ATP-dependent RNA helicase DDX1,10538,34,1.28 [0.75-2.19],0.3600592650857492
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX25,ATP-dependent RNA helicase DDX25,10316,33,1.54 [0.83-2.86],0.1702184691675337
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX39A,ATP-dependent RNA helicase DDX39A,10295,36,1.98 [0.82-4.77],0.1272189139823512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX4,Probable ATP-dependent RNA helicase DDX4,10295,36,0.97 [0.53-1.78],0.9214779712058904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX53,Probable ATP-dependent RNA helicase DDX53,10316,33,1.48 [0.65-3.36],0.3512511834635036
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX58,Antiviral innate immune response receptor RIG-I,11824,39,1.14 [0.73-1.78],0.5636004996814521
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",12076,37,0.97 [0.72-1.32],0.8688381026966205
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFA1_DEFA1B,Neutrophil defensin 1,11875,37,1.40 [0.92-2.15],0.1183800439470995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB103A_DEFB103B,Beta-defensin 103,10211,36,1.22 [0.61-2.43],0.5688652938939105
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB104A_DEFB104B,Beta-defensin 104,10235,33,1.15 [0.68-1.96],0.6051073239374367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB116,Beta-defensin 116,10235,33,0.98 [0.63-1.52],0.9318980899332316
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB118,Beta-defensin 118,10235,33,1.30 [0.88-1.91],0.1878835165007968
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB4A_DEFB4B,Beta-defensin 4A,11944,36,0.92 [0.75-1.13],0.4134184164001551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DENND2B,DENN domain-containing protein 2B,10258,34,1.12 [0.62-2.04],0.7073771313013255
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DENR,Density-regulated protein,10295,36,0.99 [0.55-1.78],0.9748765374137665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DFFA,DNA fragmentation factor subunit alpha,12217,37,0.96 [0.62-1.48],0.8456718432528892
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DGCR6,Protein DGCR6,10235,33,1.40 [0.86-2.27],0.1714031199315731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DGKA,Diacylglycerol kinase alpha,10295,36,1.36 [0.78-2.39],0.2808927311132903
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DGKZ,Diacylglycerol kinase zeta,11857,37,0.95 [0.41-2.24],0.9144885098990344
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DHODH,Dihydroorotate dehydrogenase,10258,34,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DHPS,Deoxyhypusine synthase,10542,34,1.54 [0.98-2.42],0.0592663871394443
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,10586,35,0.90 [0.43-1.88],0.7855941636594804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DIABLO,"Diablo homolog, mitochondrial",12076,41,1.08 [0.84-1.38],0.5680195064122482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DIPK1C,Divergent protein kinase domain 1C,10316,33,1.50 [0.82-2.74],0.1851029540290668
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DIPK2B,Divergent protein kinase domain 2B,10388,35,1.61 [0.49-5.31],0.4307609722421656
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DKK1,Dickkopf-related protein 1,12201,37,0.86 [0.53-1.41],0.5513264913099087
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DKK3,Dickkopf-related protein 3,12247,40,1.06 [0.42-2.71],0.9018914749094458
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DKK4,Dickkopf-related protein 4,12009,39,1.04 [0.58-1.90],0.8857986517130942
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DKKL1,Dickkopf-like protein 1,12048,37,1.16 [0.81-1.65],0.4163486108094324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLG4,Disks large homolog 4,10586,35,0.98 [0.62-1.55],0.9204060307082608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLGAP5,Disks large-associated protein 5,10578,34,1.39 [0.92-2.11],0.121237982827315
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLK1,Protein delta homolog 1,12247,40,0.89 [0.52-1.52],0.6597133267642985
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLL1,Delta-like protein 1,12159,39,0.51 [0.19-1.39],0.1881962325643004
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLL4,Delta-like protein 4,10348,34,0.59 [0.27-1.30],0.1893286495348912
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DMD,Dystrophin,10348,34,1.29 [0.78-2.12],0.3238867839306368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DMP1,Dentin matrix acidic phosphoprotein 1,10348,34,0.86 [0.53-1.40],0.5512042193076042
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJA1,DnaJ homolog subfamily A member 1,10208,34,1.33 [0.75-2.37],0.3262515283753998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJA2,DnaJ homolog subfamily A member 2,12185,37,0.94 [0.66-1.34],0.7337203257622601
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJA4,DnaJ homolog subfamily A member 4,10586,35,1.31 [0.85-2.01],0.2218955016811179
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB1,DnaJ homolog subfamily B member 1,12048,37,0.91 [0.65-1.26],0.5643697230792557
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB14,DnaJ homolog subfamily B member 14,10538,34,1.09 [0.66-1.81],0.7259244020551763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB2,DnaJ homolog subfamily B member 2,10388,35,1.22 [0.68-2.19],0.5044072038820759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB6,DnaJ homolog subfamily B member 6,10291,35,1.02 [0.69-1.51],0.9062101503496232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB8,DnaJ homolog subfamily B member 8,11861,38,1.35 [0.95-1.90],0.0930611285570472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJC21,DnaJ homolog subfamily C member 21,10586,35,0.95 [0.40-2.26],0.9097235131092416
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJC6,Putative tyrosine-protein phosphatase auxilin,10348,34,1.29 [0.88-1.89],0.1954665925672937
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJC9,DnaJ homolog subfamily C member 9,10538,34,1.26 [0.83-1.93],0.2800097232308881
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNER,Delta and Notch-like epidermal growth factor-related receptor,12085,39,0.99 [0.30-3.25],0.9830551623334904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNLZ,DNL-type zinc finger protein,10235,33,0.64 [0.37-1.11],0.112089766580707
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNM1,Dynamin-1,10538,34,0.91 [0.68-1.21],0.5208274706593295
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNM3,Dynamin-3,10578,34,0.87 [0.47-1.63],0.6641917837668554
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNMBP,Dynamin-binding protein,12020,39,1.07 [0.68-1.68],0.7779737080690654
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNPEP,Aspartyl aminopeptidase,10586,35,1.12 [0.63-1.99],0.7112733121117036
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,12151,40,1.17 [0.69-1.98],0.5687419229530719
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOC2B,Double C2-like domain-containing protein beta,10316,33,2.44 [1.57-3.79],7.369523446878664e-05
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOCK9,Dedicator of cytokinesis protein 9,10235,33,0.88 [0.64-1.21],0.4284868882021592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOK1,Docking protein 1,10586,35,1.04 [0.81-1.34],0.7351944775697608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOK2,Docking protein 2,12108,41,0.97 [0.77-1.22],0.7961151873943213
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPEP1,Dipeptidase 1,11999,39,1.94 [1.09-3.45],0.0242862951320642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPEP2,Dipeptidase 2,12048,37,0.92 [0.32-2.71],0.8863463250054839
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPP10,Inactive dipeptidyl peptidase 10,12076,37,1.00 [0.43-2.30],0.9985684679218668
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPP4,Dipeptidyl peptidase 4,11900,38,1.31 [0.46-3.73],0.6074559238004709
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPP6,Dipeptidyl aminopeptidase-like protein 6,12048,37,1.32 [0.55-3.15],0.5392826291131545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPP7,Dipeptidyl peptidase 2,12011,41,1.01 [0.63-1.61],0.9718642959252308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPT,Dermatopontin,12247,40,0.78 [0.27-2.29],0.6514884090762028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPY30,Protein dpy-30 homolog,12146,37,1.08 [0.68-1.72],0.7448012472100501
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DRAXIN,Draxin,12020,39,1.05 [0.55-1.98],0.8919706542234798
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DRG2,Developmentally-regulated GTP-binding protein 2,12048,37,1.00 [0.59-1.68],0.9985309822831338
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSC2,Desmocollin-2,11992,37,0.30 [0.12-0.77],0.0128296256340806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSCAM,Down syndrome cell adhesion molecule,10578,34,0.67 [0.26-1.72],0.4042439040132369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSG2,Desmoglein-2,12112,38,0.99 [0.34-2.90],0.9837551372380466
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSG3,Desmoglein-3,12153,37,0.71 [0.29-1.69],0.4355405038000079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSG4,Desmoglein-4,12018,37,0.91 [0.52-1.61],0.7506389480718297
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTD1,D-aminoacyl-tRNA deacylase 1,10388,35,1.07 [0.73-1.55],0.7364357050165224
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTNB,Dystrobrevin beta,10519,34,1.39 [0.69-2.82],0.3593994806320379
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTX2,Probable E3 ubiquitin-protein ligase DTX2,10316,33,0.96 [0.57-1.64],0.8936947873621482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTX3,Probable E3 ubiquitin-protein ligase DTX3,12048,37,1.29 [0.40-4.10],0.6683778287219024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTYMK,Thymidylate kinase,10600,35,1.23 [0.77-1.95],0.3926107586992168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUOX2,Dual oxidase 2,11861,38,0.67 [0.40-1.14],0.1406456729253261
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUSP13,Dual specificity protein phosphatase 13 isoform A,10542,34,1.27 [0.63-2.59],0.5030051104892326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUSP29,Dual specificity phosphatase 29,10316,33,1.05 [0.65-1.71],0.8395674348440215
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUSP3,Dual specificity protein phosphatase 3,11815,37,0.74 [0.48-1.12],0.1533325489502053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",10538,34,0.89 [0.64-1.23],0.4726948531809123
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DXO,Decapping and exoribonuclease protein,10586,35,2.12 [1.16-3.90],0.0153168244099276
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,10542,34,1.36 [0.81-2.28],0.2495818379050486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DYNLT1,Dynein light chain Tctex-type 1,10316,33,1.59 [1.16-2.20],0.0041987193616345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DYNLT3,Dynein light chain Tctex-type 3,10542,34,1.29 [0.63-2.65],0.4927580368276238
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,12020,39,0.99 [0.73-1.34],0.9663543572596952
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EBI3_IL27,Interleukin-27,12169,37,0.54 [0.20-1.46],0.2262323793980526
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECE1,Endothelin-converting enzyme 1,11815,37,0.85 [0.36-1.98],0.7035949944137603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",10600,35,0.83 [0.51-1.34],0.4436259928288439
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECHS1,"Enoyl-CoA hydratase, mitochondrial",10348,34,0.97 [0.69-1.37],0.8760361698678638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECI2,Enoyl-CoA delta isomerase 2,10258,34,0.79 [0.44-1.42],0.4335167348765667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECM1,Extracellular matrix protein 1,10327,34,0.43 [0.21-0.88],0.0197399496437732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECSCR,Endothelial cell-specific chemotaxis regulator,10235,33,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDA2R,Tumor necrosis factor receptor superfamily member 27,12195,37,0.70 [0.31-1.59],0.3929000047775369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDAR,Tumor necrosis factor receptor superfamily member EDAR,12076,37,0.97 [0.71-1.34],0.860815725446801
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDDM3B,Epididymal secretory protein E3-beta,10542,34,0.51 [0.22-1.16],0.1084889807722707
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,10258,34,1.18 [0.53-2.65],0.688046308324914
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDF1,Endothelial differentiation-related factor 1,10578,34,1.45 [1.06-2.00],0.0207006368395253
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,11861,38,0.64 [0.26-1.57],0.3311952375592117
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDN1,Endothelin-1,10348,34,1.75 [0.58-5.32],0.3207610259953309
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDNRB,Endothelin receptor type B,10295,36,1.40 [0.89-2.22],0.1468427364171031
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EEF1D,Elongation factor 1-delta,10600,35,1.11 [0.79-1.56],0.5543019970016246
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFCAB14,EF-hand calcium-binding domain-containing protein 14,10538,34,0.53 [0.14-1.94],0.3359584575452498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFCAB2,Dynein regulatory complex protein 8,10425,33,1.17 [0.47-2.88],0.7329050497580321
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,12149,39,0.48 [0.18-1.23],0.1247690822420711
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFHD1,EF-hand domain-containing protein D1,10578,34,0.63 [0.22-1.80],0.3911884261247345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFNA1,Ephrin-A1,12097,38,0.42 [0.14-1.25],0.1191388724871383
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFNA4,Ephrin-A4,12005,39,0.91 [0.35-2.37],0.8421480017487308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFNB2,Ephrin-B2,10316,33,1.37 [0.88-2.15],0.1652820182203702
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGF,Pro-epidermal growth factor,12089,40,0.90 [0.69-1.19],0.4708705891201995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGFL7,Epidermal growth factor-like protein 7,11824,39,0.51 [0.24-1.10],0.0855741308116642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGFLAM,Pikachurin,10538,34,1.24 [0.47-3.31],0.6651492361723221
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGFR,Epidermal growth factor receptor,12247,40,2.93 [0.56-15.38],0.2033961692406242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGLN1,Egl nine homolog 1,12076,37,1.38 [0.98-1.95],0.062797635239641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EHBP1,EH domain-binding protein 1,10600,35,0.90 [0.58-1.41],0.6518614699004917
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EHD3,EH domain-containing protein 3,10348,34,1.09 [0.82-1.47],0.5470521065243578
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",10586,35,0.92 [0.49-1.70],0.7811803407084159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",10489,33,1.26 [0.94-1.69],0.1210776206524789
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,10258,34,1.14 [0.71-1.83],0.5738368846864769
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,10348,34,1.64 [0.86-3.10],0.13007396285134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4B,Eukaryotic translation initiation factor 4B,12020,39,0.86 [0.53-1.40],0.5497419920886462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4E,Eukaryotic translation initiation factor 4E,10295,36,1.11 [0.78-1.58],0.5645160387744679
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,12108,41,1.42 [0.96-2.10],0.0818646906807513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,12217,37,0.94 [0.70-1.26],0.6750742105678145
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,10578,34,1.24 [0.78-1.98],0.3637622358005995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF5,Eukaryotic translation initiation factor 5,10258,34,1.56 [0.89-2.74],0.1215400511742192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF5A,Eukaryotic translation initiation factor 5A-1,11857,37,0.83 [0.29-2.37],0.7291810875514051
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELAC1,Zinc phosphodiesterase ELAC protein 1,10578,34,1.04 [0.71-1.54],0.8331456257453465
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELAVL4,ELAV-like protein 4,10235,33,0.69 [0.44-1.09],0.1125188369987968
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELN,Elastin,10600,35,1.00 [0.41-2.46],0.9940803355541888
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELOA,Elongin-A,12048,37,1.52 [1.10-2.10],0.0110026759430799
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELOB,Elongin-B,10258,34,0.98 [0.41-2.36],0.9688550174779168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENAH,Protein enabled homolog,11857,37,0.64 [0.33-1.25],0.1901087137973438
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENDOU,Poly(U)-specific endoribonuclease,9771,30,0.76 [0.36-1.60],0.4729672626436202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENG,Endoglin,12247,40,1.18 [0.23-5.97],0.8396677334917824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENO1,Alpha-enolase,12095,36,1.03 [0.71-1.51],0.8658102707063581
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENO2,Gamma-enolase,12201,37,1.04 [0.66-1.63],0.8718631656304903
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENO3,Beta-enolase,10348,34,0.91 [0.50-1.68],0.7708648818489283
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENOPH1,Enolase-phosphatase E1,10542,34,0.79 [0.39-1.58],0.5040133308814408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,10258,34,1.60 [0.55-4.67],0.3887028248520107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPEP,Glutamyl aminopeptidase,10258,34,1.48 [0.96-2.29],0.0767002765621364
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,12247,40,1.30 [0.51-3.31],0.579654995025755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,12162,40,1.17 [0.56-2.48],0.6757652953539959
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,10348,34,1.00 [0.40-2.49],0.9999324984359116
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,11691,39,1.25 [0.90-1.74],0.1754250505763015
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENSA,Alpha-endosulfine,10542,34,1.03 [0.55-1.92],0.9343576292372436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,11824,39,0.88 [0.46-1.66],0.6860070436750846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,11861,38,2.69 [0.64-11.40],0.1782060712893374
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,11861,38,0.50 [0.22-1.14],0.0992555479959268
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTR1,Endosome-associated-trafficking regulator 1,10348,34,1.82 [1.16-2.85],0.0088225878267094
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EP300,Histone acetyltransferase p300,10295,36,1.88 [1.17-3.04],0.0096321875285787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPB41L5,Band 4.1-like protein 5,10316,33,1.09 [0.65-1.83],0.7545865096762949
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPCAM,Epithelial cell adhesion molecule,12104,40,1.02 [0.78-1.34],0.8906872842624931
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPGN,Epigen,10542,34,1.04 [0.53-2.04],0.9060348182319334
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA1,Ephrin type-A receptor 1,12151,40,0.40 [0.19-0.88],0.0218093897650663
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA10,Ephrin type-A receptor 10,11815,37,1.29 [0.93-1.77],0.1228287292264826
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA2,Ephrin type-A receptor 2,11671,36,0.51 [0.18-1.43],0.1994283962234769
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA4,Ephrin type-A receptor 4,10388,35,0.86 [0.27-2.73],0.8017351079191402
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHB4,Ephrin type-B receptor 4,12247,40,0.57 [0.18-1.83],0.347623322961796
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHB6,Ephrin type-B receptor 6,11999,39,0.39 [0.15-0.96],0.0406593193826058
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHX2,Bifunctional epoxide hydrolase 2,11861,38,0.93 [0.57-1.51],0.7662571486303359
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPN1,Epsin-1,10425,33,0.64 [0.24-1.66],0.3572118537020949
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPO,Erythropoietin,12076,37,1.28 [0.92-1.77],0.1427423277502575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPPK1,Epiplakin,10348,34,1.24 [0.80-1.91],0.3303569545700114
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,12172,37,0.76 [0.28-2.07],0.5892109491736468
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERBB2,Receptor tyrosine-protein kinase erbB-2,12159,39,1.18 [0.35-3.94],0.7938554691671843
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERBB3,Receptor tyrosine-protein kinase erbB-3,12081,40,0.49 [0.10-2.33],0.3663869166543051
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERBB4,Receptor tyrosine-protein kinase erbB-4,12159,39,1.86 [0.64-5.36],0.2515038510471279
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERBIN,Erbin,12048,37,0.95 [0.71-1.26],0.7166243611788451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERC2,ERC protein 2,10316,33,0.67 [0.36-1.24],0.1970994754731424
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERCC1,DNA excision repair protein ERCC-1,10208,34,1.34 [0.54-3.30],0.5275630204098248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EREG,Proepiregulin,11999,39,0.96 [0.67-1.38],0.8105453985399526
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERI1,3'-5' exoribonuclease 1,10425,33,2.29 [1.32-3.98],0.0031325931660987
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERMAP,Erythroid membrane-associated protein,10295,36,0.69 [0.33-1.46],0.3345284443334658
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,10542,34,0.66 [0.27-1.63],0.3662487861341259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERP29,Endoplasmic reticulum resident protein 29,10388,35,0.96 [0.73-1.27],0.779202133817575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERP44,Endoplasmic reticulum resident protein 44,12020,37,0.65 [0.20-2.07],0.4621282427498706
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,10258,34,1.31 [0.68-2.54],0.4236969638577389
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESAM,Endothelial cell-selective adhesion molecule,12247,40,0.80 [0.33-1.95],0.6217174504800639
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESM1,Endothelial cell-specific molecule 1,12105,40,0.82 [0.35-1.88],0.631792808968078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESPL1,Separin,10208,34,0.79 [0.40-1.56],0.503428814472997
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESR1,Estrogen receptor,10295,36,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESYT2,Extended synaptotagmin-2,10586,35,1.07 [0.73-1.58],0.7276399605025866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EVI2B,Protein EVI2B,10208,34,0.96 [0.41-2.27],0.9262661936496108
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EVI5,Ecotropic viral integration site 5 protein homolog,10295,36,1.20 [0.84-1.72],0.3085684892735811
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EVPL,Envoplakin,10425,33,0.62 [0.20-1.88],0.3972086290657353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EXOSC10,Exosome component 10,10258,34,1.30 [0.84-2.00],0.2348280696993859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EXTL1,Exostosin-like 1,10258,34,0.71 [0.31-1.60],0.4095124054791882
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EZR,Ezrin,12201,37,1.06 [0.31-3.57],0.9265210587190972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F10,Coagulation factor X,10602,33,1.38 [0.39-4.91],0.617934722983432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F11,Coagulation factor XI,10467,35,0.49 [0.15-1.59],0.2332547973426026
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F11R,Junctional adhesion molecule A,12112,38,0.92 [0.55-1.55],0.7618870848653156
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F12,Coagulation factor XII,10623,35,1.68 [0.75-3.79],0.2097585020680269
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F13B,Coagulation factor XIII B chain,10558,35,0.60 [0.17-2.14],0.4347980205776998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F2,Prothrombin,10623,35,6.94 [0.83-58.24],0.0744676822888744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F2R,Proteinase-activated receptor 1,12139,40,0.94 [0.57-1.54],0.7923581966402404
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F3,Tissue factor,12125,37,0.67 [0.23-1.96],0.462475172973358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F7,Coagulation factor VII,12148,39,0.89 [0.34-2.34],0.8197888250241324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F9,Coagulation factor IX,12139,39,0.57 [0.11-2.87],0.4956034629750508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP1,"Fatty acid-binding protein, liver",12105,40,0.86 [0.62-1.18],0.3539629625606215
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP2,"Fatty acid-binding protein, intestinal",12108,41,0.90 [0.61-1.31],0.5742941428347902
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP3,"Fatty acid-binding protein, heart",10600,35,0.70 [0.34-1.44],0.3289031901928824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP4,"Fatty acid-binding protein, adipocyte",12247,40,1.03 [0.58-1.80],0.9281964838909604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP5,Fatty acid-binding protein 5,12156,37,0.99 [0.64-1.51],0.9474898330746307
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP6,Gastrotropin,11837,38,0.91 [0.54-1.55],0.7350022402674422
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP9,Fatty acid-binding protein 9,12076,37,0.93 [0.55-1.57],0.7885923886064654
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FADD,FAS-associated death domain protein,12108,41,1.01 [0.70-1.45],0.9568693121650028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM13A,Protein FAM13A,10538,34,1.24 [0.78-1.99],0.3648840233447383
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM171A2,Protein FAM171A2,10578,34,0.91 [0.72-1.14],0.3970818272663576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM171B,Protein FAM171B,10542,34,0.58 [0.14-2.36],0.4454952472951086
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM172A,Cotranscriptional regulator FAM172A,10348,34,1.14 [0.67-1.95],0.6261946910233828
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM20A,Pseudokinase FAM20A,10600,35,2.01 [0.64-6.27],0.2290529916616025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM3B,Protein FAM3B,12048,37,1.08 [0.46-2.53],0.8636318896136699
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM3C,Protein FAM3C,12085,41,0.38 [0.15-0.98],0.0451546760320128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM3D,Protein FAM3D,10538,34,1.01 [0.68-1.50],0.9460048458157496
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAP,Prolyl endopeptidase FAP,12247,40,0.95 [0.34-2.69],0.927556134929354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FARSA,Phenylalanine--tRNA ligase alpha subunit,10316,33,1.13 [0.72-1.77],0.5921652666196727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAS,Tumor necrosis factor receptor superfamily member 6,12214,40,0.60 [0.21-1.73],0.3434962189808083
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FASLG,Tumor necrosis factor ligand superfamily member 6,12217,37,0.69 [0.32-1.50],0.3463995741749774
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FBLN2,Fibulin-2,10617,36,0.92 [0.33-2.62],0.8831491170411938
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FBN2,Fibrillin-2,10316,33,1.08 [0.62-1.88],0.7888137807005305
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FBP1,"Fructose-1,6-bisphosphatase 1",12108,41,1.01 [0.69-1.46],0.9739561671265108
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,10600,35,0.82 [0.52-1.29],0.3876169617652966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCAR,Immunoglobulin alpha Fc receptor,12076,37,1.75 [0.97-3.14],0.0614631720539671
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,10578,34,0.33 [0.10-1.18],0.0877971805437471
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCER2,Low affinity immunoglobulin epsilon Fc receptor,12112,38,0.66 [0.36-1.22],0.1844458513878025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,12064,39,1.09 [0.66-1.79],0.7425271570367789
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,11824,39,1.25 [0.81-1.92],0.3211017275035979
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,12128,39,0.83 [0.48-1.45],0.5100174699270488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCN1,Ficolin-1,10576,33,1.15 [0.61-2.17],0.663780324167053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCN2,Ficolin-2,12059,39,0.95 [0.47-1.93],0.8858477018627471
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL1,Fc receptor-like protein 1,12108,41,0.80 [0.43-1.48],0.4748964422303737
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL2,Fc receptor-like protein 2,12159,37,0.91 [0.51-1.63],0.7583936439873665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL3,Fc receptor-like protein 3,11857,37,1.12 [0.67-1.87],0.6680754017915377
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL5,Fc receptor-like protein 5,12112,38,1.73 [1.10-2.72],0.0180110646833946
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL6,Fc receptor-like protein 6,12076,37,0.76 [0.51-1.15],0.1955911153725902
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRLB,Fc receptor-like B,11824,39,1.38 [1.00-1.92],0.0511831294013773
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FDX1,"Adrenodoxin, mitochondrial",10258,34,1.27 [0.79-2.02],0.3217104925974455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FDX2,"Ferredoxin-2, mitochondrial",10258,34,0.84 [0.45-1.59],0.5953501078208228
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FEN1,Flap endonuclease 1,11824,39,1.41 [1.10-1.82],0.0074809591191445
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FES,Tyrosine-protein kinase Fes/Fps,11824,39,1.33 [0.78-2.25],0.2963797096378755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FETUB,Fetuin-B,12139,39,0.55 [0.27-1.13],0.1037905067867059
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGA,Fibrinogen alpha chain,10370,35,1.13 [0.39-3.32],0.8210694998878908
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",10578,34,1.38 [0.92-2.08],0.1152748849489437
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF12,Fibroblast growth factor 12,10295,36,0.96 [0.47-1.99],0.9195945356523272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF16,Fibroblast growth factor 16,10295,36,0.95 [0.47-1.90],0.8752426046351821
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF19,Fibroblast growth factor 19,12162,40,1.02 [0.71-1.47],0.9141066423589812
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF2,Fibroblast growth factor 2,12076,37,0.97 [0.63-1.50],0.8984742051025629
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF20,Fibroblast growth factor 20,10295,36,1.31 [0.74-2.33],0.3531365772114521
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF21,Fibroblast growth factor 21,12169,37,0.98 [0.76-1.25],0.8474940265978277
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF23,Fibroblast growth factor 23,12177,37,1.22 [0.76-1.96],0.4126063740395714
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF3,Fibroblast growth factor 3,10295,36,0.49 [0.12-1.93],0.3055063398069843
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF5,Fibroblast growth factor 5,11857,37,1.63 [0.75-3.51],0.2141305517323146
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF6,Fibroblast growth factor 6,10295,36,1.55 [1.01-2.38],0.0435862046838866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF7,Fibroblast growth factor 7,10208,34,1.11 [0.77-1.60],0.5806068671530524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF9,Fibroblast growth factor 9,10190,34,0.65 [0.31-1.40],0.273140789096855
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFBP1,Fibroblast growth factor-binding protein 1,12159,39,0.91 [0.37-2.23],0.837315816279832
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFBP2,Fibroblast growth factor-binding protein 2,10617,36,1.35 [0.73-2.52],0.3419892642221663
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFBP3,Fibroblast growth factor-binding protein 3,10586,35,0.91 [0.37-2.21],0.8291216874944976
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFR2,Fibroblast growth factor receptor 2,12159,39,1.73 [0.49-6.06],0.3944189155292049
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFR4,Fibroblast growth factor receptor 4,10388,35,1.42 [0.78-2.58],0.2468681996061759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGL1,Fibrinogen-like protein 1,10602,33,0.78 [0.48-1.27],0.3118924592797549
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGR,Tyrosine-protein kinase Fgr,11815,37,1.30 [0.91-1.87],0.1536647208051705
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FH,"Fumarate hydratase, mitochondrial",10235,33,0.98 [0.65-1.48],0.932341865017644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FHIP2A,FHF complex subunit HOOK interacting protein 2A,10258,34,0.93 [0.45-1.92],0.8496320798642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FHIT,Bis(5'-adenosyl)-triphosphatase,11815,37,1.01 [0.68-1.50],0.9660630360162326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FIS1,Mitochondrial fission 1 protein,12118,40,0.95 [0.66-1.38],0.8009197346997738
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,10578,34,1.10 [0.79-1.54],0.5743790068324888
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,12124,37,1.03 [0.79-1.34],0.818431332887188
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,12020,39,0.97 [0.51-1.85],0.9256313906090764
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,12020,39,0.92 [0.68-1.24],0.5716071907112877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,11794,37,1.12 [0.65-1.93],0.683234522055304
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBPL,FK506-binding protein-like,10538,34,1.17 [0.67-2.05],0.5791803041881921
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLI1,Friend leukemia integration 1 transcription factor,11824,39,0.96 [0.74-1.25],0.7562436532355526
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,12020,39,1.06 [0.39-2.90],0.912468853563601
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLT1,Vascular endothelial growth factor receptor 1,12034,36,0.79 [0.18-3.42],0.7529656155979005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLT3,Receptor-type tyrosine-protein kinase FLT3,11824,39,0.66 [0.24-1.80],0.4149917622246252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLT3LG,Fms-related tyrosine kinase 3 ligand,12217,37,1.06 [0.44-2.56],0.9039923086615588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLT4,Vascular endothelial growth factor receptor 3,12159,39,0.51 [0.23-1.14],0.1000830777258127
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FMNL1,Formin-like protein 1,11815,37,1.40 [1.07-1.83],0.0130608092928346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FMR1,Synaptic functional regulator FMR1,11824,39,1.08 [0.47-2.44],0.859278563744793
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FN1,Fibronectin,10623,35,1.58 [0.48-5.23],0.4534952646193159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FNDC1,Fibronectin type III domain-containing protein 1,10586,35,0.50 [0.25-0.99],0.0479312741601822
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,10542,34,1.61 [0.81-3.21],0.1769631749560118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOLH1,Glutamate carboxypeptidase 2,10295,36,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOLR1,Folate receptor alpha,12106,39,0.92 [0.34-2.49],0.8714338550054015
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOLR2,Folate receptor beta,12201,37,0.55 [0.20-1.46],0.2300310102814229
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOLR3,Folate receptor gamma,12120,39,0.97 [0.82-1.14],0.7208174638211096
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOS,Proto-oncogene c-Fos,10190,34,1.01 [0.41-2.52],0.9817688296875268
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOSB,Protein fosB,11815,37,1.07 [0.54-2.15],0.8417549865850926
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOXJ3,Forkhead box protein J3,10295,36,1.35 [0.73-2.48],0.3363017285511351
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOXO1,Forkhead box protein O1,12076,37,1.25 [0.89-1.77],0.1959480555837159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOXO3,Forkhead box protein O3,11824,39,1.06 [0.79-1.42],0.7132775575860136
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FRMD4B,FERM domain-containing protein 4B,10258,34,1.01 [0.63-1.61],0.9801918197333516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FRMD7,FERM domain-containing protein 7,10316,33,0.92 [0.33-2.53],0.8690053331499623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FRZB,Secreted frizzled-related protein 3,11984,39,1.15 [0.37-3.60],0.8069602392090501
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FSHB,Follitropin subunit beta,10348,34,0.83 [0.48-1.41],0.4852815130271292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FST,Follistatin,12139,40,0.90 [0.51-1.58],0.7152353074948208
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FSTL1,Follistatin-related protein 1,10348,34,0.70 [0.15-3.19],0.6432825546423089
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FSTL3,Follistatin-related protein 3,12086,40,0.53 [0.21-1.36],0.1869311217489564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FTCD,Formimidoyltransferase-cyclodeaminase,10563,35,0.79 [0.52-1.20],0.2705076621804361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUCA1,Tissue alpha-L-fucosidase,12187,39,1.24 [0.85-1.81],0.2668262480872468
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUOM,Fucose mutarotase,10388,35,1.22 [0.74-2.00],0.4432945360460166
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FURIN,Furin,12159,39,0.98 [0.42-2.29],0.9586445067572849
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUS,RNA-binding protein FUS,11807,39,1.23 [0.62-2.42],0.5579522862817279
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",10400,33,0.82 [0.44-1.52],0.5245572462717848
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,12201,37,1.07 [0.57-2.01],0.8326927479947575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUT8,"Alpha-(1,6)-fucosyltransferase",12020,39,1.12 [0.69-1.81],0.6561370634590508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FXN,"Frataxin, mitochondrial",12195,37,0.95 [0.64-1.42],0.8166460928803796
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FXYD5,FXYD domain-containing ion transport regulator 5,11857,37,0.80 [0.50-1.29],0.3631971736834736
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FYB1,FYN-binding protein 1,12094,38,0.99 [0.73-1.36],0.9663557973899763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FZD10,Frizzled-10,10316,33,1.21 [0.77-1.88],0.408589289428811
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FZD8,Frizzled-8,10235,33,0.75 [0.31-1.83],0.5338607689718438
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GABARAP,Gamma-aminobutyric acid receptor-associated protein,10542,34,0.69 [0.33-1.48],0.3422613072544462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,10425,33,0.60 [0.29-1.24],0.1706042743585607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,10235,33,1.04 [0.62-1.76],0.8687710356625429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAD1,Glutamate decarboxylase 1,10208,34,0.90 [0.25-3.26],0.8767044043143039
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAD2,Glutamate decarboxylase 2,10295,36,0.98 [0.49-1.97],0.9538785972726228
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,10425,33,1.09 [0.58-2.02],0.796693405922384
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,10348,34,1.08 [0.58-2.00],0.8086814074284686
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAGE2A,G antigen 2A,10208,34,0.67 [0.33-1.35],0.2614339038139086
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAL,Galanin peptides,12162,40,0.90 [0.57-1.42],0.6575461276239121
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,12048,37,2.14 [0.77-5.93],0.144461337089635
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,12195,37,0.90 [0.29-2.77],0.85190234323441
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,11857,37,0.95 [0.47-1.90],0.8781512558822265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,10600,35,0.86 [0.26-2.83],0.799708266915605
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT7,N-acetylgalactosaminyltransferase 7,12048,37,1.04 [0.26-4.13],0.9523174289075708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAMT,Guanidinoacetate N-methyltransferase,10258,34,0.97 [0.40-2.32],0.93918956621504
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,10160,35,0.80 [0.31-2.04],0.6363222775913154
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GART,Trifunctional purine biosynthetic protein adenosine-3,10578,34,0.90 [0.26-3.14],0.8694108063148037
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAS2,Growth arrest-specific protein 2,10425,33,1.04 [0.55-1.95],0.9127257995481716
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAS6,Growth arrest-specific protein 6,12173,40,2.34 [0.79-6.94],0.1248186248613929
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GASK1A,Golgi-associated kinase 1A,10258,34,1.32 [0.62-2.81],0.4706470981532432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAST,Gastrin,10586,35,0.98 [0.77-1.24],0.8468424717937089
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,10208,34,2.03 [0.65-6.38],0.2243734774961654
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",10348,34,1.05 [0.69-1.60],0.830170573105118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBA,Lysosomal acid glucosylceramidase,10316,33,0.75 [0.41-1.40],0.3734534972196304
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBP1,Guanylate-binding protein 1,10570,35,1.33 [0.85-2.10],0.2109498826757232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBP2,Guanylate-binding protein 2,11857,37,0.89 [0.54-1.50],0.6705391720598783
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBP4,Guanylate-binding protein 4,11815,37,1.11 [0.63-1.94],0.7203720645978109
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBP6,Guanylate-binding protein 6,10258,34,1.06 [0.53-2.10],0.8729827709172239
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GC,Vitamin D-binding protein,10623,35,0.58 [0.16-2.08],0.4048935868608497
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCC1,GRIP and coiled-coil domain-containing protein 1,10586,35,1.03 [0.76-1.40],0.8477007854672659
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCG,Pro-glucagon,11824,39,1.16 [0.93-1.45],0.2013327108199477
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,10147,34,1.38 [0.78-2.44],0.2688720409955867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCLM,Glutamate--cysteine ligase regulatory subunit,10258,34,0.94 [0.45-1.93],0.8605785973791384
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",12048,37,0.96 [0.42-2.23],0.9332446563912056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GDF15,Growth/differentiation factor 15,12247,40,0.86 [0.43-1.73],0.6762677189664213
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GDF2,Growth/differentiation factor 2,12108,41,0.59 [0.27-1.29],0.186072922041898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GDNF,Glial cell line-derived neurotrophic factor,11815,37,0.62 [0.28-1.40],0.2520408833764556
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GET3,ATPase GET3,10600,35,1.21 [0.71-2.07],0.4813829260133517
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFAP,Glial fibrillary acidic protein,11801,38,0.48 [0.26-0.90],0.0218350205574726
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFER,FAD-linked sulfhydryl oxidase ALR,11824,39,0.95 [0.60-1.51],0.8416131923626448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,11824,39,0.84 [0.63-1.14],0.2677731336347804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFRA1,GDNF family receptor alpha-1,12169,37,0.89 [0.31-2.51],0.8256992921839909
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFRA2,GDNF family receptor alpha-2,12048,37,1.31 [0.33-5.22],0.6997327050722415
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFRA3,GDNF family receptor alpha-3,11981,39,0.53 [0.19-1.49],0.2300912915966353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFRAL,GDNF family receptor alpha-like,10258,33,1.22 [0.72-2.07],0.4544578315164871
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGA1,ADP-ribosylation factor-binding protein GGA1,11815,37,1.23 [0.86-1.77],0.2514761799977907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGACT,Gamma-glutamylaminecyclotransferase,10600,35,1.09 [0.69-1.72],0.7073493548028201
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGCT,Gamma-glutamylcyclotransferase,10573,35,1.13 [0.58-2.18],0.7176213464482751
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGH,Gamma-glutamyl hydrolase,11922,38,1.15 [0.50-2.64],0.7376885484521736
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGT1,Glutathione hydrolase 1 proenzyme,12097,38,1.02 [0.57-1.83],0.9440952152836576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGT5,Glutathione hydrolase 5 proenzyme,12020,39,1.94 [0.59-6.40],0.2740416794095101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GH1,Somatotropin,12085,41,1.00 [0.85-1.18],0.9951185443809843
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GH2,Growth hormone variant,11824,39,0.87 [0.71-1.06],0.1681866458692732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GHR,Growth hormone receptor,10388,35,0.47 [0.15-1.47],0.192955628712432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GHRHR,Growth hormone-releasing hormone receptor,11815,37,1.08 [0.67-1.73],0.756768675645123
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GHRL,Appetite-regulating hormone,12108,41,0.74 [0.53-1.03],0.0738749314290336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GID8,Glucose-induced degradation protein 8 homolog,10578,34,1.48 [0.77-2.84],0.2432122241155392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIGYF2,GRB10-interacting GYF protein 2,10578,34,0.98 [0.63-1.52],0.9336976506509403
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIMAP7,GTPase IMAP family member 7,10388,35,1.79 [0.95-3.37],0.0699710365509886
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIMAP8,GTPase IMAP family member 8,10208,34,0.90 [0.46-1.74],0.7518652022140665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIP,Gastric inhibitory polypeptide,10348,34,1.39 [0.83-2.33],0.2054362794370918
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIPC2,PDZ domain-containing protein GIPC2,10586,35,1.44 [0.50-4.17],0.4970658335084152
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIPC3,PDZ domain-containing protein GIPC3,10538,34,1.03 [0.73-1.45],0.8595285054288804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIPR,Gastric inhibitory polypeptide receptor,10295,36,0.28 [0.11-0.67],0.0046086442868762
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIT1,ARF GTPase-activating protein GIT1,10295,36,0.98 [0.70-1.37],0.913437073117106
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GJA8,Gap junction alpha-8 protein,10208,34,0.87 [0.48-1.57],0.6352896341243985
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GKN1,Gastrokine-1,11581,37,1.21 [0.41-3.52],0.7312923955649336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLA,Alpha-galactosidase A,10372,35,1.69 [0.73-3.88],0.2201228568145714
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLB1,Beta-galactosidase,12020,39,1.56 [0.80-3.02],0.1915939593527367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLI2,Zinc finger protein GLI2,10295,36,2.10 [1.27-3.48],0.0040851391769657
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLO1,Lactoylglutathione lyase,11861,38,0.97 [0.59-1.59],0.9081974813113106
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLOD4,Glyoxalase domain-containing protein 4,12095,40,0.97 [0.44-2.12],0.9340101351912736
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLP1R,Glucagon-like peptide 1 receptor,10235,33,1.20 [0.54-2.63],0.6545832253197116
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLRX,Glutaredoxin-1,12017,41,1.45 [0.92-2.29],0.1117919035927551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",10388,35,0.99 [0.68-1.43],0.9460335418715232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,11815,37,0.60 [0.26-1.36],0.2172380278928535
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLYR1,Putative oxidoreductase GLYR1,10542,34,1.49 [1.05-2.12],0.0244766201295857
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GM2A,Ganglioside GM2 activator,10333,35,0.79 [0.31-2.00],0.6222531506554045
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GMFG,Glia maturation factor gamma,10600,35,1.03 [0.65-1.61],0.910657570989556
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GMPR,GMP reductase 1,12217,37,1.04 [0.58-1.84],0.9043607199519954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GMPR2,GMP reductase 2,10388,35,1.12 [0.84-1.50],0.4507066899633998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNAS,Neuroendocrine secretory protein 55,10578,34,1.38 [1.03-1.85],0.0290083169613763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,11824,39,1.16 [0.75-1.79],0.5144708936752889
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,10316,33,1.05 [0.57-1.91],0.8809046414746967
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNLY,Granulysin,12112,38,0.83 [0.47-1.46],0.5202038010055616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNPDA1,Glucosamine-6-phosphate isomerase 1,10348,34,1.07 [0.41-2.78],0.8945183095020248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNPDA2,Glucosamine-6-phosphate isomerase 2,10388,35,0.67 [0.26-1.67],0.3860763783847873
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GOLGA3,Golgin subfamily A member 3,10578,34,0.98 [0.64-1.50],0.9337163594640744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GOLM2,Protein GOLM2,12201,37,1.32 [0.36-4.82],0.6718589150513099
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,12076,37,1.02 [0.76-1.37],0.9011122853522804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GORASP2,Golgi reassembly-stacking protein 2,10538,34,0.96 [0.47-1.95],0.9157863466860796
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GOT1,"Aspartate aminotransferase, cytoplasmic",10617,36,1.53 [0.79-2.95],0.2100182706703761
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP1BA,Platelet glycoprotein Ib alpha chain,12053,39,0.84 [0.34-2.06],0.7027693601393586
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP1BB,Platelet glycoprotein Ib beta chain,10258,34,1.08 [0.66-1.76],0.7674946743678419
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,11713,38,1.02 [0.74-1.42],0.8948031882757314
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP5,Platelet glycoprotein V,10388,35,0.79 [0.32-1.96],0.6143070951876612
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP6,Platelet glycoprotein VI,12094,38,0.93 [0.66-1.29],0.6489015476192853
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPA33,Cell surface A33 antigen,12048,37,1.03 [0.84-1.27],0.7837469046469661
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPC1,Glypican-1,12195,37,0.53 [0.20-1.43],0.2123858906504682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPC5,Glypican-5,12020,39,1.08 [0.65-1.79],0.7803160278710335
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPD1,Glycerol-3-phosphate dehydrogenase,10542,34,0.74 [0.37-1.48],0.3911436276363499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPHA2,Glycoprotein hormone alpha-2,10538,34,0.73 [0.31-1.72],0.4742325441247739
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPI,Glucose-6-phosphate isomerase,10602,33,1.43 [0.74-2.74],0.2830736497463222
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,10538,34,0.70 [0.48-1.02],0.0629396692825772
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPKOW,G-patch domain and KOW motifs-containing protein,11815,37,1.98 [1.17-3.35],0.0112470422422276
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPNMB,Transmembrane glycoprotein NMB,11775,41,1.27 [0.47-3.41],0.6322281399121936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPR101,Probable G-protein coupled receptor 101,10235,33,1.37 [0.95-1.99],0.0937173909832713
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPR158,Probable G-protein coupled receptor 158,10578,34,0.74 [0.27-2.03],0.5601197845795778
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPR15L,Protein GPR15L,10538,34,0.86 [0.49-1.50],0.5873837039831462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPR37,Prosaposin receptor GPR37,11861,38,0.92 [0.61-1.41],0.7174455997643188
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPRC5C,G-protein coupled receptor family C group 5 member C,10542,34,1.07 [0.61-1.85],0.8225826975516328
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRAP2,GRB2-related adapter protein 2,12108,41,0.99 [0.80-1.24],0.949243668152364
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,10600,35,1.09 [0.65-1.81],0.7471886123079718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRIK2,"Glutamate receptor ionotropic, kainate 2",10578,34,1.04 [0.50-2.17],0.9228202299831226
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",10235,33,1.29 [0.88-1.90],0.1937370465439905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRK5,G protein-coupled receptor kinase 5,11861,38,0.98 [0.55-1.74],0.9324135798616178
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRN,Progranulin,12063,37,0.69 [0.20-2.37],0.5500321068338417
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRP,Gastrin-releasing peptide,10348,34,1.22 [0.70-2.13],0.4733603752834545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRPEL1,"GrpE protein homolog 1, mitochondrial",12048,37,0.97 [0.59-1.59],0.9099353614449214
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRSF1,G-rich sequence factor 1,10153,34,0.92 [0.60-1.41],0.7127761351042801
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSAP,Gamma-secretase-activating protein,11824,39,1.36 [1.12-1.64],0.0020464629906352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSN,Gelsolin,10572,33,0.57 [0.18-1.82],0.3391698684008922
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSR,"Glutathione reductase, mitochondrial",10538,33,4.02 [1.05-15.35],0.0419310182917539
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTA1,Glutathione S-transferase A1,12087,41,0.94 [0.67-1.32],0.710555435502187
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTA3,Glutathione S-transferase A3,11824,39,0.92 [0.63-1.34],0.6571901190428258
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTM4,Glutathione S-transferase Mu 4,10258,34,0.83 [0.49-1.43],0.5087487211860222
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTP1,Glutathione S-transferase P,11739,37,1.21 [0.82-1.78],0.3338009557248165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTT2B,Glutathione S-transferase theta-2B,10586,35,1.09 [0.94-1.25],0.2481710740637628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,10425,33,0.58 [0.27-1.23],0.1531325859309281
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GTPBP2,GTP-binding protein 2,10316,33,1.30 [0.86-1.96],0.2161885198027432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GUCA2A,Guanylin,12058,38,1.47 [0.64-3.37],0.3646516283762817
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GUCY2C,Heat-stable enterotoxin receptor,10425,33,0.80 [0.49-1.30],0.3725306264289275
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GUK1,Guanylate kinase,10258,34,1.02 [0.44-2.37],0.9706439328049408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GUSB,Beta-glucuronidase,12170,39,1.02 [0.64-1.62],0.9385218374280112
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GYS1,"Glycogen [starch] synthase, muscle",11861,38,1.12 [0.82-1.54],0.4646592091013607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GZMA,Granzyme A,12217,37,1.19 [0.54-2.62],0.6646076733484483
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GZMB,Granzyme B,12076,37,0.86 [0.53-1.42],0.56101255224409
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GZMH,Granzyme H,11861,38,1.42 [1.13-1.80],0.0031415960573512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",H2AP,Huntingtin-interacting protein M,10208,34,0.84 [0.40-1.75],0.639214094501771
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",10258,34,1.27 [0.95-1.71],0.1096125696946246
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",12148,37,1.20 [0.82-1.76],0.3486730356347712
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HAO1,Hydroxyacid oxidase 1,12195,37,0.93 [0.74-1.18],0.5603222806595494
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HARS1,"Histidine--tRNA ligase, cytoplasmic",12112,38,1.09 [0.75-1.59],0.6554503737088351
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HAVCR1,Hepatitis A virus cellular receptor 1,12174,37,1.11 [0.71-1.75],0.6418183593194668
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HAVCR2,Hepatitis A virus cellular receptor 2,12112,38,0.60 [0.26-1.42],0.2457452342903675
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HBEGF,Proheparin-binding EGF-like growth factor,12148,37,0.96 [0.64-1.43],0.8341659119352893
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HBQ1,Hemoglobin subunit theta-1,12195,37,1.17 [0.73-1.87],0.5100511678582693
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HBZ,Hemoglobin subunit zeta,10600,35,1.23 [0.91-1.65],0.1825366188095808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HCG22,Protein PBMUCL2,10258,34,0.81 [0.36-1.81],0.607153342188984
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HCLS1,Hematopoietic lineage cell-specific protein,12217,37,0.87 [0.52-1.48],0.6121387497637012
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDAC8,Histone deacetylase 8,10295,36,1.20 [0.78-1.84],0.4169739468345463
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDAC9,Histone deacetylase 9,10235,33,0.96 [0.55-1.68],0.8872316248204066
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDDC2,5'-deoxynucleotidase HDDC2,10538,34,1.02 [0.48-2.16],0.964366142584018
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDGF,Hepatoma-derived growth factor,12178,37,1.22 [0.91-1.65],0.1871810192641358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDGFL2,Hepatoma-derived growth factor-related protein 2,10586,35,1.54 [1.01-2.35],0.0466839728513866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEBP1,Heme-binding protein 1,11861,38,0.61 [0.33-1.14],0.120034833211595
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEG1,Protein HEG homolog 1,10388,35,0.55 [0.15-1.93],0.3462724109008831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEPACAM2,HEPACAM family member 2,10586,35,1.05 [0.47-2.33],0.9106323326142816
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEPH,Hephaestin,10600,35,0.82 [0.22-3.00],0.7594161058608535
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEXIM1,Protein HEXIM1,12076,37,1.13 [0.79-1.62],0.5056793476497572
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HGF,Hepatocyte growth factor,12217,37,0.84 [0.36-1.98],0.6960841300523104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HGFAC,Hepatocyte growth factor activator,10494,33,0.72 [0.38-1.37],0.3175082415961284
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,11824,39,0.91 [0.62-1.32],0.6047715783395498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HHEX,Hematopoietically-expressed homeobox protein HHEX,10586,35,1.28 [0.84-1.96],0.2471210095529418
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HIF1A,Hypoxia-inducible factor 1-alpha,10295,36,0.99 [0.60-1.62],0.9633729810878076
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HIP1,Huntingtin-interacting protein 1,10258,34,1.27 [0.54-3.00],0.5886585670170086
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HIP1R,Huntingtin-interacting protein 1-related protein,10561,35,1.46 [0.91-2.34],0.1161163037877536
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HJV,Hemojuvelin,10578,34,0.86 [0.39-1.89],0.7022314597368686
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HK2,Hexokinase-2,11861,38,1.36 [0.52-3.59],0.5324481942370098
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",10578,34,0.88 [0.32-2.38],0.7952252893699409
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",12046,37,1.34 [0.62-2.92],0.4537770696754887
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",12076,37,0.67 [0.24-1.88],0.4426709159168562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMBS,Porphobilinogen deaminase,12195,37,1.40 [0.74-2.68],0.3040930538713012
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMCN2,Hemicentin-2,10371,35,1.02 [0.58-1.81],0.946802357366656
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",10348,34,1.21 [0.64-2.29],0.5595809720244733
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",10258,34,0.93 [0.42-2.08],0.8621865666680752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMMR,Hyaluronan mediated motility receptor,10186,34,1.40 [0.87-2.25],0.1606541178426104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMOX1,Heme oxygenase 1,11966,41,0.85 [0.46-1.55],0.5901863780331615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMOX2,Heme oxygenase 2,11815,37,1.27 [0.74-2.18],0.3769674704066085
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNF1A,Hepatocyte nuclear factor 1-alpha,10316,33,0.79 [0.43-1.45],0.4503166596859455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNMT,Histamine N-methyltransferase,11966,39,0.71 [0.39-1.28],0.2534381387922894
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,11830,38,0.97 [0.66-1.42],0.8634344652148167
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,10578,34,1.89 [1.24-2.88],0.0028878303363006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HPCAL1,Hippocalcin-like protein 1,12217,37,0.95 [0.64-1.42],0.7990936837675007
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HPGDS,Hematopoietic prostaglandin D synthase,11824,39,1.54 [0.82-2.89],0.1821240213620101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HPSE,Heparanase,10467,36,0.98 [0.70-1.39],0.9285161043822048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HRAS,GTPase Hras,10396,32,1.00 [0.72-1.39],0.9973103691109444
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,10348,34,0.87 [0.33-2.32],0.7873572102807609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HRG,Histidine-rich glycoprotein,10558,35,1.99 [0.72-5.52],0.1874623626649647
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HS1BP3,HCLS1-binding protein 3,10348,34,1.07 [0.74-1.56],0.7127034011530379
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,12048,37,1.35 [0.63-2.92],0.4405509750730976
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,12195,37,0.83 [0.35-1.94],0.6667809313184796
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,10295,36,0.93 [0.33-2.67],0.8949810522512632
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSBP1,Heat shock factor-binding protein 1,10348,34,0.99 [0.70-1.40],0.9507949815583604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,12076,37,1.16 [0.55-2.44],0.6878404152023366
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,10586,35,1.04 [0.62-1.73],0.891441756175435
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSD17B3,Testosterone 17-beta-dehydrogenase 3,10258,34,0.89 [0.44-1.79],0.7374211314801845
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,10348,34,1.40 [0.73-2.69],0.3133391524734245
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSP90B1,Endoplasmin,11757,37,1.10 [0.76-1.60],0.6003660336156462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPA1A,Heat shock 70 kDa protein 1A,12151,40,1.05 [0.72-1.55],0.7956783545164462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPA2,Heat shock-related 70 kDa protein 2,10542,34,1.61 [0.83-3.15],0.1600471790092872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPB1,Heat shock protein beta-1,11917,41,1.11 [0.72-1.72],0.6359822729043292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPB6,Heat shock protein beta-6,12195,37,0.79 [0.35-1.79],0.5678669864775081
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,12029,39,0.65 [0.21-2.04],0.4584935602248962
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HTR1A,5-hydroxytryptamine receptor 1A,10235,33,0.91 [0.57-1.46],0.7055031648745766
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HTR1B,5-hydroxytryptamine receptor 1B,10235,33,1.11 [0.55-2.24],0.7742477551336859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HTRA2,"Serine protease HTRA2, mitochondrial",12159,39,0.87 [0.55-1.39],0.5684498185625415
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HYAL1,Hyaluronidase-1,12047,39,1.98 [0.62-6.30],0.2500948518710837
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HYOU1,Hypoxia up-regulated protein 1,12247,40,0.36 [0.10-1.27],0.1124330070267746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICA1,Islet cell autoantigen 1,11857,37,0.83 [0.56-1.21],0.3313219478989134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM1,Intercellular adhesion molecule 1,12056,39,0.90 [0.33-2.46],0.8419944004890892
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM2,Intercellular adhesion molecule 2,12247,40,0.53 [0.23-1.24],0.1449535658433932
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM3,Intercellular adhesion molecule 3,12247,40,0.94 [0.31-2.81],0.909823771568601
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM4,Intercellular adhesion molecule 4,12076,37,0.90 [0.52-1.55],0.6964608445618674
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM5,Intercellular adhesion molecule 5,12108,41,0.96 [0.52-1.79],0.9061836525150504
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICOSLG,ICOS ligand,12048,37,0.39 [0.09-1.77],0.22128931348624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ID4,DNA-binding protein inhibitor ID-4,10425,33,0.77 [0.31-1.90],0.5684635827187824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IDI2,Isopentenyl-diphosphate delta-isomerase 2,11815,37,0.80 [0.41-1.57],0.5154899942849163
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IDO1,"Indoleamine 2,3-dioxygenase 1",10348,34,1.12 [0.69-1.82],0.6537332599244788
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IDS,Iduronate 2-sulfatase,12217,37,4.81 [0.14-166.95],0.3853127719947981
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IDUA,Alpha-L-iduronidase,12195,37,0.89 [0.47-1.66],0.7125963490297786
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,10271,32,1.14 [0.49-2.66],0.7597637222715193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,10425,33,0.75 [0.39-1.43],0.3780885051513103
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,10425,33,1.98 [1.07-3.66],0.0284314483073477
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNAR1,Interferon alpha/beta receptor 1,10538,34,0.48 [0.12-1.95],0.3032285760192561
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNG,Interferon gamma,11857,37,1.13 [0.87-1.46],0.3661791872920611
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNGR1,Interferon gamma receptor 1,12162,40,0.69 [0.17-2.77],0.6037022057593278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNGR2,Interferon gamma receptor 2,12020,39,1.14 [0.66-1.94],0.6420212772658449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNL1,Interferon lambda-1,11815,37,0.93 [0.48-1.78],0.8212186803874616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNL2,Interferon lambda-2,10235,33,1.10 [0.68-1.77],0.6941434700762315
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNLR1,Interferon lambda receptor 1,12076,37,0.71 [0.29-1.72],0.4484437848933591
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNW1,Interferon omega-1,10258,34,1.32 [0.66-2.64],0.4362165822481831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFT20,Intraflagellar transport protein 20 homolog,10316,33,1.49 [0.77-2.87],0.2378003273719114
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGBP1,Immunoglobulin-binding protein 1,10578,34,1.38 [0.83-2.30],0.2152121266535026
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,10235,33,0.88 [0.41-1.91],0.7510199720969021
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,10617,36,1.62 [0.48-5.49],0.4369121836689253
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGF1R,Insulin-like growth factor 1 receptor,12048,37,1.14 [0.29-4.53],0.8479195003436104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,10258,34,1.70 [1.12-2.58],0.0121225418372905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGF2R,Cation-independent mannose-6-phosphate receptor,12112,38,0.68 [0.19-2.37],0.5407981197555216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP1,Insulin-like growth factor-binding protein 1,12225,40,0.97 [0.77-1.23],0.813753850046256
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP2,Insulin-like growth factor-binding protein 2,12233,40,1.15 [0.74-1.79],0.5423613229214093
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP3,Insulin-like growth factor-binding protein 3,12165,39,0.94 [0.35-2.53],0.8955948408164449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP4,Insulin-like growth factor-binding protein 4,11953,38,0.64 [0.31-1.31],0.2225003859568115
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP6,Insulin-like growth factor-binding protein 6,12058,38,0.54 [0.19-1.54],0.247587783889959
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP7,Insulin-like growth factor-binding protein 7,12247,40,0.97 [0.38-2.50],0.9517855399769272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBPL1,Insulin-like growth factor-binding protein-like 1,12108,41,0.79 [0.34-1.83],0.5848742262167431
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFL4,Insulin growth factor-like family member 4,10295,36,1.10 [0.76-1.60],0.623014748941191
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGHMBP2,DNA-binding protein SMUBP-2,10258,34,1.40 [0.87-2.25],0.1662919937663782
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGLC2,Immunoglobulin lambda constant 2,10596,35,1.76 [0.84-3.70],0.1360799449350137
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGLON5,IgLON family member 5,10208,34,1.22 [0.94-1.58],0.1290208899050823
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGSF21,Immunoglobulin superfamily member 21,10348,34,1.16 [0.52-2.60],0.7242174433156445
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGSF3,Immunoglobulin superfamily member 3,12048,37,1.66 [0.86-3.18],0.1278753901528336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGSF8,Immunoglobulin superfamily member 8,12108,41,0.67 [0.26-1.73],0.4052651975531153
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGSF9,Protein turtle homolog A,10600,35,0.87 [0.58-1.31],0.5084778551290976
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IKBKG,NF-kappa-B essential modulator,12076,37,1.08 [0.78-1.50],0.6328068275180032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IKZF2,Zinc finger protein Helios,11824,39,1.13 [0.86-1.48],0.3765167344347689
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL10,Interleukin-10,11857,37,1.09 [0.79-1.49],0.6114888548508068
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL10RA,Interleukin-10 receptor subunit alpha,11857,37,1.05 [0.65-1.68],0.8412744201907181
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL10RB,Interleukin-10 receptor subunit beta,12162,40,0.28 [0.10-0.78],0.0148008452339652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL11,Interleukin-11,11857,37,0.77 [0.45-1.33],0.352569909481225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL12A_IL12B,Interleukin-12,12048,37,0.85 [0.59-1.23],0.3945547331470841
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL12B,Interleukin-12 subunit beta,12217,37,0.85 [0.50-1.45],0.5563030190041192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL12RB1,Interleukin-12 receptor subunit beta-1,11857,37,1.11 [0.53-2.33],0.7885616951355346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL12RB2,Interleukin-12 receptor subunit beta-2,10295,36,0.91 [0.73-1.12],0.3615785758621715
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL13,Interleukin-13,11857,37,1.23 [0.77-1.95],0.3858077127813208
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL13RA1,Interleukin-13 receptor subunit alpha-1,11970,38,0.17 [0.04-0.72],0.0161122564160922
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL13RA2,Interleukin-13 receptor subunit alpha-2,10235,33,1.43 [0.44-4.73],0.5527739681832575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL15,Interleukin-15,12076,37,1.80 [0.78-4.16],0.1663459964595345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL15RA,Interleukin-15 receptor subunit alpha,11857,37,0.65 [0.28-1.48],0.3002701224650345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL16,Pro-interleukin-16,12217,37,0.94 [0.46-1.93],0.8649939758219855
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17A,Interleukin-17A,11842,37,1.33 [0.76-2.30],0.3162068475600849
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17C,Interleukin-17C,11857,37,1.03 [0.69-1.53],0.8836938381021138
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17D,Interleukin-17D,11857,37,0.56 [0.19-1.62],0.2810078792463009
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17F,Interleukin-17F,11857,37,1.02 [0.71-1.48],0.9068647286198026
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17RA,Interleukin-17 receptor A,12112,38,0.88 [0.46-1.69],0.7015316354298162
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17RB,Interleukin-17 receptor B,11932,37,0.68 [0.39-1.20],0.1839481948783934
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL18,Interleukin-18,12071,40,0.65 [0.35-1.22],0.1809680088281718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL18BP,Interleukin-18-binding protein,12165,39,0.67 [0.26-1.76],0.4208678474420854
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL18R1,Interleukin-18 receptor 1,12217,37,1.20 [0.51-2.82],0.6807779745194245
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL18RAP,Interleukin-18 receptor accessory protein,11951,39,1.02 [0.87-1.20],0.7730728448627421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL19,Interleukin-19,11808,41,0.89 [0.59-1.35],0.5881815037484739
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1A,Interleukin-1 alpha,11857,37,1.08 [0.67-1.74],0.7588573397064204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1B,Interleukin-1 beta,11802,37,0.64 [0.35-1.17],0.1451631980493376
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1R1,Interleukin-1 receptor type 1,12097,38,0.56 [0.16-2.04],0.3805409979297545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1R2,Interleukin-1 receptor type 2,12088,40,0.92 [0.22-3.94],0.9140335221665588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1RAP,Interleukin-1 receptor accessory protein,12112,38,0.68 [0.35-1.34],0.2683470203895423
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1RL1,Interleukin-1 receptor-like 1,12214,40,1.06 [0.56-1.98],0.8671872210982772
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1RL2,Interleukin-1 receptor-like 2,11857,37,1.02 [0.47-2.21],0.9633599608249666
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1RN,Interleukin-1 receptor antagonist protein,12094,39,1.08 [0.67-1.74],0.7635451357919292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2,Interleukin-2,11857,37,1.56 [0.61-3.99],0.3483937528770079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL20,Interleukin-20,11857,37,0.89 [0.49-1.65],0.7186500639894683
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL20RA,Interleukin-20 receptor subunit alpha,11857,37,0.69 [0.31-1.54],0.3611515535130134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL20RB,Interleukin-20 receptor subunit beta,10295,36,0.56 [0.25-1.27],0.1640005207244512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL21R,Interleukin-21 receptor,10295,36,0.54 [0.22-1.28],0.1611279172143452
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL22,Interleukin-22,10542,34,1.15 [0.72-1.81],0.5609896353919218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL22RA1,Interleukin-22 receptor subunit alpha-1,11857,37,0.55 [0.23-1.28],0.1640052926739216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL24,Interleukin-24,11857,37,1.04 [0.59-1.83],0.892208789633198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL25,Interleukin-25,10173,34,0.49 [0.19-1.22],0.1251914043234837
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2RA,Interleukin-2 receptor subunit alpha,12002,40,0.48 [0.23-1.02],0.0553424699190236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2RB,Interleukin-2 receptor subunit beta,11857,37,0.87 [0.39-1.95],0.7300316064736998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2RG,Cytokine receptor common subunit gamma,10542,34,0.22 [0.07-0.74],0.0146518775530376
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL3,Interleukin-3,10208,34,1.26 [0.69-2.29],0.4576298697180095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL31,Interleukin-31,10295,36,0.92 [0.50-1.69],0.7926180861713541
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL31RA,Interleukin-31 receptor subunit alpha,10248,36,0.65 [0.29-1.48],0.3065684625061859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL32,Interleukin-32,12076,37,1.53 [0.83-2.84],0.1742189981276838
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL33,Interleukin-33,11857,37,0.72 [0.34-1.52],0.391195664432695
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL34,Interleukin-34,11799,37,0.52 [0.25-1.09],0.0847759791177646
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL36A,Interleukin-36 alpha,10295,36,1.01 [0.57-1.77],0.978068575941012
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL36G,Interleukin-36 gamma,10245,35,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL3RA,Interleukin-3 receptor subunit alpha,11857,37,1.16 [0.48-2.79],0.7450912040795346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL4,Interleukin-4,11857,37,1.18 [0.81-1.71],0.3976744414890938
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL4R,Interleukin-4 receptor subunit alpha,12076,37,0.69 [0.29-1.62],0.3899360889100508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL5,Interleukin-5,11857,37,0.76 [0.60-0.98],0.0338726102822097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL5RA,Interleukin-5 receptor subunit alpha,12076,37,1.23 [0.74-2.05],0.4304661676145386
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL6,Interleukin-6,12048,37,1.01 [0.68-1.50],0.9606949319867044
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL6R,Interleukin-6 receptor subunit alpha,12039,39,0.98 [0.42-2.28],0.9678594042791692
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL6ST,Interleukin-6 receptor subunit beta,12108,41,1.04 [0.21-5.23],0.9623946747640472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL7,Interleukin-7,12076,37,0.82 [0.51-1.30],0.3945399725593358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL7R,Interleukin-7 receptor subunit alpha,12112,38,0.92 [0.53-1.58],0.760002527845131
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL9,Interleukin-9,10425,33,0.65 [0.29-1.43],0.2815864936524936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,11795,37,1.21 [0.75-1.96],0.4422368545726204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMMT,MICOS complex subunit MIC60,10542,34,1.73 [1.06-2.82],0.0277156726477865
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMPA1,Inositol monophosphatase 1,12020,39,1.01 [0.63-1.61],0.9823150384791828
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMPACT,Protein IMPACT,10586,35,1.45 [0.82-2.55],0.1976405579110568
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMPG1,Interphotoreceptor matrix proteoglycan 1,10235,33,0.90 [0.28-2.88],0.8567685773222731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ING1,Inhibitor of growth protein 1,11794,37,1.74 [1.21-2.51],0.0028803710004032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INHBB,Inhibin beta B chain,10388,35,1.16 [0.64-2.11],0.6292617385533823
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INHBC,Inhibin beta C chain,12112,38,0.55 [0.30-1.03],0.0606500880415109
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPP1,Inositol polyphosphate 1-phosphatase,12048,37,1.37 [0.82-2.28],0.2322006649453958
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",10348,34,1.47 [0.85-2.54],0.165433006996323
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",10578,34,1.83 [1.24-2.71],0.0024237235338259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",12048,37,0.93 [0.68-1.26],0.6407770071902308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INSL3,Insulin-like 3,10586,35,0.82 [0.50-1.33],0.4142093515994579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INSL4,Early placenta insulin-like peptide,10542,34,0.97 [0.49-1.93],0.9290575626329256
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INSL5,Insulin-like peptide INSL5,10538,34,0.92 [0.64-1.31],0.6349846696791972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INSR,Insulin receptor,10295,36,0.55 [0.08-3.86],0.5489467966018703
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IPCEF1,Interactor protein for cytohesin exchange factors 1,12005,39,1.02 [0.74-1.41],0.9081045081267162
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IQGAP2,Ras GTPase-activating-like protein IQGAP2,12048,37,1.21 [0.73-2.01],0.4681100254064556
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",11861,38,1.24 [0.93-1.65],0.1405958690940583
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IRAK1,Interleukin-1 receptor-associated kinase 1,11857,37,0.82 [0.52-1.29],0.3864961696277653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IRAK4,Interleukin-1 receptor-associated kinase 4,12076,37,1.05 [0.79-1.40],0.7260994240502618
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,11660,37,0.78 [0.35-1.75],0.5503331128384474
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ISM1,Isthmin-1,12076,37,0.92 [0.43-1.96],0.8295583352150376
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ISM2,Isthmin-2,10617,36,1.05 [0.52-2.15],0.8893159798574511
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IST1,IST1 homolog,10458,33,0.97 [0.69-1.35],0.8402000852724018
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGA11,Integrin alpha-11,12076,37,1.26 [0.53-2.98],0.5992891916959413
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGA2,Integrin alpha-2,10388,35,0.65 [0.25-1.69],0.3791899980699966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGA5,Integrin alpha-5,12112,38,0.96 [0.30-3.06],0.94933065022664
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGA6,Integrin alpha-6,12076,37,0.80 [0.44-1.43],0.4510526855694604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGAL,Integrin alpha-L,10295,36,0.55 [0.30-1.00],0.0514869241998475
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGAM,Integrin alpha-M,12112,38,1.04 [0.42-2.59],0.931853044361616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGAV,Integrin alpha-V,12195,37,0.26 [0.05-1.41],0.1174627043661653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGAX,Integrin alpha-X,10425,33,0.69 [0.33-1.46],0.3341477221991439
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB1,Integrin beta-1,12105,39,0.83 [0.21-3.20],0.7812688512654771
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB1BP1,Integrin beta-1-binding protein 1,11824,39,0.80 [0.41-1.55],0.5117587070208369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB1BP2,Integrin beta-1-binding protein 2,11861,38,0.95 [0.73-1.23],0.6800467095952343
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB2,Integrin beta-2,12034,39,0.80 [0.29-2.22],0.6690198642028558
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB5,Integrin beta-5,12159,39,0.99 [0.46-2.10],0.9722817931164048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB6,Integrin beta-6,11857,37,0.95 [0.36-2.51],0.9117204467963366
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB7,Integrin beta-7,12195,37,0.98 [0.52-1.86],0.9560839967378671
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGBL1,Integrin beta-like protein 1,10617,36,0.61 [0.24-1.59],0.3142002381195924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,10623,35,2.34 [0.56-9.74],0.2437014516048078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,12165,39,0.78 [0.37-1.63],0.5022341829184154
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,10623,35,0.80 [0.23-2.76],0.7198817081441959
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,10542,34,1.37 [0.77-2.43],0.2799554829529203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITM2A,Integral membrane protein 2A,12076,37,0.82 [0.50-1.35],0.4422221525121782
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITPA,Inosine triphosphate pyrophosphatase,10258,34,1.17 [0.73-1.90],0.5154652206675585
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",10348,34,0.74 [0.43-1.29],0.2925974627079422
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",10235,33,1.28 [0.69-2.39],0.4351993593281426
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",11815,37,0.72 [0.38-1.37],0.3207149273277264
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IZUMO1,Izumo sperm-egg fusion protein 1,10208,34,0.91 [0.43-1.94],0.8129017207540993
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JAM2,Junctional adhesion molecule B,12201,37,0.42 [0.13-1.37],0.1492453325945164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JAM3,Junctional adhesion molecule C,10388,35,0.78 [0.39-1.54],0.4685791117678528
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JCHAIN,Immunoglobulin J chain,11857,37,0.94 [0.59-1.50],0.7872745747312939
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,10208,34,1.32 [0.84-2.06],0.2320513538051641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JPT2,Jupiter microtubule associated homolog 2,10538,34,1.10 [0.75-1.62],0.6292393141029566
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JUN,Transcription factor AP-1,11857,37,1.29 [0.84-1.99],0.2454164635284584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,12048,37,0.83 [0.45-1.51],0.5399619061194134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KAZN,Kazrin,10538,34,1.07 [0.77-1.47],0.6972540869368202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCNC4,Potassium voltage-gated channel subfamily C member 4,10235,33,0.54 [0.23-1.27],0.1559660946664475
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCNH2,Potassium voltage-gated channel subfamily H member 2,10316,33,1.09 [0.73-1.62],0.6739909949793379
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCNIP4,Kv channel-interacting protein 4,11815,37,0.86 [0.45-1.66],0.6605431892262954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCTD5,BTB/POZ domain-containing protein KCTD5,10389,35,1.81 [1.10-3.00],0.0202211154022509
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KDM3A,Lysine-specific demethylase 3A,10295,36,1.16 [0.87-1.54],0.3076321400067084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KDR,Vascular endothelial growth factor receptor 2,12159,39,0.43 [0.14-1.30],0.1324687240463722
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KEL,Kell blood group glycoprotein,11815,37,1.01 [0.44-2.29],0.9825514007024884
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KHDC3L,KH domain-containing protein 3,10208,34,1.31 [0.94-1.83],0.1049031306741101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KHK,Ketohexokinase,10348,34,1.15 [0.68-1.94],0.608738939239619
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIAA0319,Dyslexia-associated protein KIAA0319,10586,35,0.89 [0.31-2.59],0.831469814455123
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIAA1549,UPF0606 protein KIAA1549,10425,33,0.90 [0.56-1.46],0.6751271441846387
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIAA1549L,UPF0606 protein KIAA1549L,10425,33,0.62 [0.18-2.10],0.4440062718761176
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIAA2013,Uncharacterized protein KIAA2013,10542,34,1.05 [0.60-1.82],0.8753619575545124
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIF1C,Kinesin-like protein KIF1C,10258,34,1.18 [0.51-2.74],0.6970968317387318
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIF20B,Kinesin-like protein KIF20B,10235,33,1.14 [0.78-1.67],0.506617148696076
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIF22,Kinesin-like protein KIF22,10258,34,1.11 [0.83-1.46],0.4848191215789135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIFBP,KIF-binding protein,12048,37,0.87 [0.61-1.23],0.4230739518938181
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,10542,34,0.87 [0.60-1.27],0.4856143668439872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,11824,39,1.16 [0.81-1.66],0.4131648612419911
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,10538,34,0.84 [0.68-1.04],0.1038193297165754
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,11824,39,0.99 [0.79-1.24],0.9118269844926576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,10208,34,0.34 [0.15-0.80],0.0127817093961606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIRREL1,Kin of IRRE-like protein 1,10235,33,0.73 [0.35-1.55],0.4122654174914382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIRREL2,Kin of IRRE-like protein 2,11815,37,0.74 [0.34-1.58],0.4327656217849517
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIT,Mast/stem cell growth factor receptor Kit,12139,39,0.98 [0.38-2.52],0.964020687625673
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KITLG,Kit ligand,12108,41,0.79 [0.38-1.67],0.5383834785310502
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLB,Beta-klotho,11815,37,0.89 [0.59-1.33],0.5601050555515428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLF4,Krueppel-like factor 4,10235,33,1.37 [0.63-2.99],0.4290503932348227
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLHL41,Kelch-like protein 41,10578,34,1.53 [0.92-2.54],0.10415558347659
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK1,Kallikrein-1,11988,39,1.23 [1.01-1.51],0.0438193883686743
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK10,Kallikrein-10,12114,39,0.87 [0.42-1.78],0.7037165102430654
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK11,Kallikrein-11,12049,39,1.30 [0.56-3.00],0.5383941398371441
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK12,Kallikrein-12,11824,39,1.01 [0.82-1.23],0.9473351464255758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK13,Kallikrein-13,11838,35,1.32 [0.68-2.56],0.414185068549936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK14,Kallikrein-14,12195,37,1.16 [0.63-2.16],0.6360682254456703
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK15,Kallikrein-15,10521,34,1.34 [0.74-2.43],0.3332099546830515
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK3,Prostate-specific antigen,10617,36,0.83 [0.47-1.45],0.5075432670344744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK4,Kallikrein-4,12195,37,0.75 [0.44-1.27],0.2868324284783051
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK6,Kallikrein-6,12135,39,0.78 [0.31-1.92],0.584122753354426
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK7,Kallikrein-7,10123,33,1.39 [0.60-3.21],0.4392140310982386
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK8,Kallikrein-8,11707,39,0.98 [0.44-2.19],0.9698795581687216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLKB1,Plasma kallikrein,10401,35,0.88 [0.24-3.22],0.8453320229972543
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRB1,Killer cell lectin-like receptor subfamily B member 1,12217,37,0.69 [0.32-1.51],0.3523107863422987
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,10235,33,1.10 [0.68-1.78],0.708727570836948
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRD1,Natural killer cells antigen CD94,12217,37,0.79 [0.42-1.51],0.4783337981763904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRF1,Killer cell lectin-like receptor subfamily F member 1,10295,36,1.03 [0.50-2.11],0.9381836056493748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRK1,NKG2-D type II integral membrane protein,10586,35,0.54 [0.29-1.02],0.0562307925094865
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT14,"Keratin, type I cytoskeletal 14",11432,37,0.62 [0.19-2.01],0.4297672394867942
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT17,"Keratin, type I cytoskeletal 17",10258,34,0.88 [0.35-2.21],0.7779354375103695
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT18,"Keratin, type I cytoskeletal 18",12048,37,0.99 [0.68-1.44],0.9569904431319765
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT19,"Keratin, type I cytoskeletal 19",12054,37,1.01 [0.66-1.55],0.9607307025563306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT5,"Keratin, type II cytoskeletal 5",11815,37,0.77 [0.41-1.46],0.4261734946277701
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT6C,"Keratin, type II cytoskeletal 6C",10258,34,1.21 [0.58-2.49],0.6137278344900954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT8,"Keratin, type II cytoskeletal 8",10235,33,1.18 [0.82-1.70],0.3846038558648073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KYAT1,Kynurenine--oxoglutarate transaminase 1,12092,41,1.34 [0.85-2.11],0.2127391645732708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KYNU,Kynureninase,12217,37,0.96 [0.50-1.83],0.894240422329729
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",L1CAM,Neural cell adhesion molecule L1,12159,39,0.80 [0.29-2.18],0.66366071347515
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,10600,35,0.99 [0.70-1.41],0.961336237353158
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LACRT,Extracellular glycoprotein lacritin,10518,34,0.57 [0.25-1.27],0.1655728235188106
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LACTB2,Endoribonuclease LACTB2,12108,41,1.02 [0.67-1.55],0.918346047157396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAG3,Lymphocyte activation gene 3 protein,12048,37,0.99 [0.49-2.03],0.9830779644360448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,12105,40,0.89 [0.40-1.94],0.7616625689491996
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,12020,39,0.99 [0.76-1.30],0.9625658815677208
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMA1,Laminin subunit alpha-1,10258,34,1.08 [0.62-1.88],0.7853287862632143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMA4,Laminin subunit alpha-4,12162,40,0.51 [0.20-1.25],0.1390109947055229
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMB1,Laminin subunit beta-1,10348,34,2.87 [0.94-8.79],0.0643936853489022
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMP1,Lysosome-associated membrane glycoprotein 1,10299,35,1.14 [0.41-3.18],0.8023829743234487
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMP2,Lysosome-associated membrane glycoprotein 2,11740,35,2.13 [0.40-11.45],0.3790445242582934
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMP3,Lysosome-associated membrane glycoprotein 3,12201,37,0.63 [0.35-1.12],0.1153461867209244
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMTOR5,Ragulator complex protein LAMTOR5,10542,34,1.88 [1.22-2.89],0.004004115617372
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAP3,Cytosol aminopeptidase,11857,37,0.69 [0.36-1.33],0.2732046985567342
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LARP1,La-related protein 1,10542,34,1.15 [0.72-1.85],0.5592403085042248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAT,Linker for activation of T-cells family member 1,12217,37,0.81 [0.56-1.16],0.2499667035592422
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAT2,Linker for activation of T-cells family member 2,12048,37,0.95 [0.75-1.21],0.6826544771437537
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LATS1,Serine/threonine-protein kinase LATS1,10295,36,0.99 [0.68-1.46],0.9793603401416962
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAYN,Layilin,11999,39,0.76 [0.32-1.79],0.5296491972483804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LBP,Lipopolysaccharide-binding protein,12165,39,1.15 [0.70-1.87],0.583154379048417
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LBR,Delta(14)-sterol reductase LBR,12201,37,1.37 [0.99-1.90],0.056661903088993
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LCAT,Phosphatidylcholine-sterol acyltransferase,10602,33,0.61 [0.18-2.10],0.4315240886702736
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LCN15,Lipocalin-15,10578,34,1.30 [0.86-1.97],0.2082629718550803
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LCN2,Neutrophil gelatinase-associated lipocalin,11781,38,1.06 [0.51-2.21],0.8666535367374293
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LCP1,Plastin-2,10617,36,0.98 [0.49-1.93],0.9427820504184872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LDLR,Low-density lipoprotein receptor,12124,40,0.62 [0.35-1.09],0.0954283752103092
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LDLRAP1,Low density lipoprotein receptor adapter protein 1,10578,34,1.00 [0.71-1.41],0.9852721272174344
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LECT2,Leukocyte cell-derived chemotaxin-2,10600,35,0.67 [0.41-1.11],0.1205266355972756
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEFTY2,Left-right determination factor 2,12169,37,1.23 [0.66-2.29],0.5144379456652217
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEG1,Protein LEG1 homolog,10028,34,0.77 [0.46-1.29],0.3212342784042081
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LELP1,Late cornified envelope-like proline-rich protein 1,10235,33,0.67 [0.38-1.17],0.1553576131330951
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEO1,RNA polymerase-associated protein LEO1,10578,34,0.99 [0.36-2.73],0.9863510755488358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEP,Leptin,12108,41,0.89 [0.58-1.38],0.6158754413176842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEPR,Leptin receptor,12108,41,1.46 [0.63-3.42],0.3784253871117208
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LETM1,Mitochondrial proton/calcium exchanger protein,10578,34,1.01 [0.54-1.87],0.984281517784033
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS1,Galectin-1,12108,41,1.71 [0.81-3.61],0.1561724207782074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS3,Galectin-3,12124,40,2.20 [0.93-5.20],0.0725863953202251
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS3BP,Galectin-3-binding protein,10623,35,0.79 [0.25-2.46],0.6819300495752537
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS4,Galectin-4,12105,40,0.74 [0.43-1.28],0.2803588791382089
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS7_LGALS7B,Galectin-7,12047,37,0.99 [0.48-2.04],0.9745268493069028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS8,Galectin-8,12201,37,0.96 [0.59-1.57],0.8834030052140247
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS9,Galectin-9,12106,40,0.83 [0.35-2.01],0.6847281980012003
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGMN,Legumain,12162,40,0.75 [0.34-1.67],0.4819117956004786
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LHB,Lutropin subunit beta,11824,39,1.14 [0.83-1.55],0.4276406110974622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,12127,39,1.19 [0.76-1.89],0.4460342834373194
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LIF,Leukemia inhibitory factor,11815,37,0.89 [0.48-1.66],0.7215307547688445
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LIFR,Leukemia inhibitory factor receptor,12076,37,1.27 [0.38-4.26],0.7036618980979725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,12112,38,1.27 [0.54-2.96],0.5859694393034609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,10617,36,1.23 [0.86-1.76],0.2606908933115763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,10258,34,1.34 [0.80-2.24],0.265931274513563
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,12085,41,1.43 [0.60-3.40],0.4188685166117796
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,10600,35,0.88 [0.57-1.37],0.5716674208497806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,12247,40,1.17 [0.42-3.27],0.7646500661029336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,12200,40,0.90 [0.40-2.00],0.7891145761117302
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,11857,37,1.20 [0.63-2.30],0.5754254559013174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,12247,40,1.02 [0.69-1.51],0.9204105278873168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LIPF,Gastric triacylglycerol lipase,10348,34,1.46 [0.89-2.37],0.1314062928678382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LMNB1,Lamin-B1,10517,34,1.44 [0.97-2.12],0.0710319047862756
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LMNB2,Lamin-B2,10586,35,1.90 [0.71-5.06],0.2022338920443165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LMOD1,Leiomodin-1,10578,34,0.70 [0.25-1.95],0.4911244175616899
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LMOD2,Leiomodin-2,10235,33,1.13 [0.69-1.84],0.6247106928419682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LONP1,"Lon protease homolog, mitochondrial",10348,34,1.05 [0.72-1.53],0.8171325087376997
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPA,Apolipoprotein(a),10370,34,0.94 [0.78-1.13],0.4844992352087548
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPCAT2,Lysophosphatidylcholine acyltransferase 2,12048,37,1.70 [1.24-2.31],0.0008616453779628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPL,Lipoprotein lipase,12108,41,1.34 [0.71-2.51],0.3639023849086004
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPO,Lactoperoxidase,11726,36,0.92 [0.56-1.51],0.7370127084623808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPP,Lipoma-preferred partner,10258,34,1.15 [0.70-1.90],0.5758928811026356
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,10258,34,1.13 [0.84-1.52],0.425080909467134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,10316,33,1.20 [0.67-2.15],0.5426836464017806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRG1,Leucine-rich alpha-2-glycoprotein,10623,35,0.37 [0.12-1.14],0.0828685259846174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,12148,37,0.96 [0.41-2.27],0.9229015504551668
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,10253,35,0.59 [0.15-2.31],0.4520863143322893
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRP1,Prolow-density lipoprotein receptor-related protein 1,12048,37,1.51 [0.52-4.38],0.4452427768999353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRP11,Low-density lipoprotein receptor-related protein 11,12108,41,0.52 [0.23-1.16],0.1079737393782895
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRP2,Low-density lipoprotein receptor-related protein 2,10316,33,1.23 [0.56-2.68],0.6101334529937732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRP2BP,LRP2-binding protein,10316,33,0.86 [0.55-1.35],0.5186515224935171
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,12201,37,1.38 [0.94-2.03],0.0976535920208607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRC25,Leucine-rich repeat-containing protein 25,12048,37,1.17 [0.55-2.45],0.6852262877308025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRC37A2,Leucine-rich repeat-containing protein 37A2,10538,34,0.50 [0.23-1.11],0.08738307107365
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRC38,Leucine-rich repeat-containing protein 38,10316,33,1.46 [0.84-2.54],0.1754206344935867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRC59,Leucine-rich repeat-containing protein 59,10600,35,1.25 [0.68-2.28],0.477033015404406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,10542,34,1.23 [0.65-2.33],0.529657045919203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRN1,Leucine-rich repeat neuronal protein 1,11857,37,0.55 [0.26-1.18],0.1258622003905074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,10316,33,1.54 [0.85-2.80],0.1569241034912861
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,10578,34,1.93 [0.81-4.63],0.1382395046549858
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LSM1,U6 snRNA-associated Sm-like protein LSm1,11824,39,1.02 [0.62-1.66],0.9402919030906592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LSM8,U6 snRNA-associated Sm-like protein LSm8,10425,33,1.09 [0.79-1.51],0.5912302125856986
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LSP1,Lymphocyte-specific protein 1,12076,37,1.07 [0.52-2.21],0.8583458849778303
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTA,Lymphotoxin-alpha,12076,37,0.66 [0.32-1.37],0.2671253526429537
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTA4H,Leukotriene A-4 hydrolase,12195,37,1.33 [0.81-2.18],0.2538894288830812
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTB,Lymphotoxin-beta,10542,34,1.00 [0.40-2.51],0.9935968583094628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTBP2,Latent-transforming growth factor beta-binding protein 2,12247,40,1.06 [0.45-2.53],0.8874518678694134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTBP3,Latent-transforming growth factor beta-binding protein 3,11824,39,1.06 [0.64-1.75],0.8288000355769223
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTBR,Tumor necrosis factor receptor superfamily member 3,12061,40,0.54 [0.19-1.54],0.2474720801491728
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTO1,Protein LTO1 homolog,11857,37,1.27 [0.71-2.27],0.423771980202792
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LUZP2,Leucine zipper protein 2,10542,34,0.52 [0.22-1.22],0.1324163625351033
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LXN,Latexin,11971,38,1.12 [0.73-1.71],0.6113429290901873
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY6D,Lymphocyte antigen 6D,12061,39,0.84 [0.39-1.82],0.6569023528999536
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY75,Lymphocyte antigen 75,12076,37,1.34 [0.62-2.91],0.4524290859911749
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY9,T-lymphocyte surface antigen Ly-9,11967,37,0.83 [0.31-2.24],0.7152607256376915
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY96,Lymphocyte antigen 96,12020,39,2.26 [1.19-4.27],0.0122365545190672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYAR,Cell growth-regulating nucleolar protein,11824,39,1.62 [1.27-2.06],0.0001078593120439
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYN,Tyrosine-protein kinase Lyn,12048,37,0.84 [0.60-1.19],0.3375485560509058
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYPD1,Ly6/PLAUR domain-containing protein 1,11815,37,1.15 [0.79-1.69],0.4697602633132713
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYPD3,Ly6/PLAUR domain-containing protein 3,12053,39,0.59 [0.25-1.40],0.2337221577136193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYPD8,Ly6/PLAUR domain-containing protein 8,11824,39,0.59 [0.32-1.06],0.0782575001004592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYPLA2,Acyl-protein thioesterase 2,10235,33,0.75 [0.49-1.14],0.172410362040594
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,10316,33,1.18 [0.91-1.54],0.2131819178990732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,10623,35,0.40 [0.08-2.04],0.2712523720984598
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYZL2,Lysozyme-like protein 2,10208,34,1.29 [0.57-2.93],0.5412872852716841
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LZTFL1,Leucine zipper transcription factor-like protein 1,10388,35,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",M6PR,Cation-dependent mannose-6-phosphate receptor,10348,34,0.75 [0.29-1.97],0.558837105042498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,11976,39,1.45 [1.00-2.12],0.0512919214760721
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAEA,E3 ubiquitin-protein transferase MAEA,11824,39,1.00 [0.49-2.04],0.9961252809169534
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAG,Myelin-associated glycoprotein,10316,33,1.91 [1.05-3.46],0.033670277438975
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAGEA3,Melanoma-associated antigen 3,10425,33,0.96 [0.65-1.42],0.8344818791207452
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAGED1,Melanoma-associated antigen D1,11824,39,0.69 [0.36-1.31],0.2562346789195359
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAMDC2,MAM domain-containing protein 2,10600,35,0.70 [0.27-1.80],0.461159162175073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAMDC4,Apical endosomal glycoprotein,10542,34,1.20 [0.66-2.18],0.5567311086523302
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",10348,34,0.98 [0.26-3.69],0.9819175150406982
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAN2B2,Epididymis-specific alpha-mannosidase,10600,35,0.85 [0.50-1.45],0.5447316823395498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",10208,34,0.83 [0.42-1.62],0.5821249140932807
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MANF,Mesencephalic astrocyte-derived neurotrophic factor,12162,40,0.92 [0.73-1.16],0.4891442880859576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MANSC1,MANSC domain-containing protein 1,12159,39,0.53 [0.18-1.55],0.2473200427564533
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MANSC4,MANSC domain-containing protein 4,10258,34,0.77 [0.46-1.28],0.3084839470647648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,10235,33,1.10 [0.37-3.26],0.8575157316057197
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,10258,34,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP2,Microtubule-associated protein 2,10586,35,0.94 [0.46-1.92],0.8715473425469159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,10538,34,1.00 [0.60-1.68],0.9876612916111998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,12076,37,0.91 [0.68-1.22],0.5178700783493236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,11824,39,1.06 [0.80-1.41],0.6869004295809482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,11999,39,1.00 [0.77-1.30],0.9915112678147056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPK13,Mitogen-activated protein kinase 13,10208,34,1.64 [1.04-2.59],0.0323375397943623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPK9,Mitogen-activated protein kinase 9,12076,37,1.14 [0.58-2.26],0.7039615345636614
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPKAPK2,MAP kinase-activated protein kinase 2,10425,33,1.08 [0.69-1.70],0.7345281153711251
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPRE3,Microtubule-associated protein RP/EB family member 3,10208,34,0.91 [0.70-1.19],0.498788427157944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPT,Microtubule-associated protein tau,11815,37,1.05 [0.61-1.81],0.8693401481539333
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MARCO,Macrophage receptor MARCO,12108,41,0.88 [0.31-2.52],0.8085611860328247
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MARS1,"Methionine--tRNA ligase, cytoplasmic",10372,35,1.16 [0.79-1.70],0.4421383580511575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MASP1,Mannan-binding lectin serine protease 1,11999,39,1.44 [0.42-4.98],0.560482142834684
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MATN2,Matrilin-2,12125,40,1.11 [0.43-2.89],0.8282059641780806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MATN3,Matrilin-3,12005,39,1.04 [0.41-2.61],0.941180652694011
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAVS,Mitochondrial antiviral-signaling protein,11824,39,0.97 [0.70-1.32],0.8252447513251349
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAX,Protein max,11815,37,1.05 [0.79-1.40],0.7144619825937997
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MB,Myoglobin,12247,40,0.82 [0.45-1.48],0.5111643708987772
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MBL2,Mannose-binding protein C,10468,35,1.10 [0.80-1.50],0.5591035702487436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCAM,Cell surface glycoprotein MUC18,12165,39,1.29 [0.57-2.91],0.5402237782560706
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",10578,34,1.15 [0.57-2.32],0.7049673577437141
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCEMP1,Mast cell-expressed membrane protein 1,10295,36,1.22 [0.89-1.68],0.2215289268741583
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCFD2,Multiple coagulation factor deficiency protein 2,12048,41,0.96 [0.50-1.84],0.9073456319332088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCTS1,Malignant T-cell-amplified sequence 1,10538,34,1.19 [0.42-3.37],0.7396895989667633
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,12020,39,1.02 [0.68-1.54],0.9232988142228662
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDH1,"Malate dehydrogenase, cytoplasmic",10539,33,1.72 [0.82-3.60],0.1491546318060892
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDK,Midkine,12129,39,0.89 [0.51-1.56],0.6836894707706329
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDM1,Nuclear protein MDM1,10316,33,3.06 [1.29-7.25],0.010962479235486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",10348,34,1.05 [0.73-1.51],0.7848883420736386
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MED18,Mediator of RNA polymerase II transcription subunit 18,11824,39,0.83 [0.57-1.22],0.3376236954325602
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MED21,Mediator of RNA polymerase II transcription subunit 21,10258,34,1.08 [0.57-2.06],0.8141963839943682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEGF10,Multiple epidermal growth factor-like domains protein 10,12105,40,0.65 [0.30-1.41],0.2735294816587598
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEGF11,Multiple epidermal growth factor-like domains protein 11,10258,34,0.60 [0.18-1.99],0.4031605057738398
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEGF9,Multiple epidermal growth factor-like domains protein 9,12214,40,0.91 [0.22-3.86],0.9035698986373936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MELTF,Melanotransferrin,10600,35,1.26 [0.42-3.83],0.6789977537778551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MENT,Protein MENT,10388,35,0.65 [0.15-2.86],0.5686019189576084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEP1A,Meprin A subunit alpha,10538,34,1.12 [0.70-1.79],0.644971174340062
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEP1B,Meprin A subunit beta,12108,41,0.97 [0.77-1.21],0.7609251632055922
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEPE,Matrix extracellular phosphoglycoprotein,12105,40,0.94 [0.34-2.63],0.9039434537031762
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MERTK,Tyrosine-protein kinase Mer,12217,37,1.44 [0.47-4.46],0.5252180483079091
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MESD,LRP chaperone MESD,12112,38,0.95 [0.75-1.21],0.6863598156207324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MET,Hepatocyte growth factor receptor,12128,39,0.92 [0.22-3.79],0.9103644916516392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",METAP1,Methionine aminopeptidase 1,11815,37,1.05 [0.39-2.80],0.9204863075017906
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",12076,37,1.05 [0.74-1.50],0.7808288223217948
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",METAP2,Methionine aminopeptidase 2,12169,37,0.84 [0.51-1.37],0.4803391433319226
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP3,Microfibril-associated glycoprotein 3,11861,38,1.59 [1.07-2.36],0.0213225523177593
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP3L,Microfibrillar-associated protein 3-like,10316,33,1.08 [0.69-1.71],0.7287965173900806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP4,Microfibril-associated glycoprotein 4,10388,35,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP5,Microfibrillar-associated protein 5,12247,40,0.69 [0.35-1.36],0.2857066817895797
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFGE8,Lactadherin,12112,38,1.17 [0.60-2.31],0.6448910200280276
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MGLL,Monoglyceride lipase,12139,40,0.90 [0.65-1.24],0.5269212387958218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MGMT,Methylated-DNA--protein-cysteine methyltransferase,12076,37,0.83 [0.66-1.04],0.1086162018646702
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MIA,Melanoma-derived growth regulatory protein,12159,39,0.80 [0.36-1.75],0.5722798516829695
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MICALL2,MICAL-like protein 2,10316,33,1.31 [0.86-1.99],0.2049893109230799
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,12076,37,1.05 [0.85-1.29],0.6725650355633735
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MIF,Macrophage migration inhibitory factor,12097,38,1.10 [0.71-1.68],0.6741553149892838
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MILR1,Allergin-1,11857,37,1.16 [0.66-2.03],0.6112490351577577
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,10542,34,1.01 [0.74-1.38],0.9496781808321972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MINK1,Misshapen-like kinase 1,10586,35,1.03 [0.72-1.46],0.887856317427695
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MITD1,MIT domain-containing protein 1,12020,39,1.01 [0.75-1.36],0.9695239581123494
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MKI67,Proliferation marker protein Ki-67,10295,36,2.03 [1.39-2.98],0.0002766909658908
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MLLT1,Protein ENL,10208,34,1.14 [0.73-1.79],0.5569927624380648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MLN,Promotilin,12076,37,1.03 [0.74-1.43],0.8664639805452949
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MME,Neprilysin,12048,37,1.07 [0.76-1.51],0.6997103685006134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP1,Interstitial collagenase,11628,34,0.85 [0.61-1.17],0.3162666584134791
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP10,Stromelysin-2,12075,40,1.10 [0.68-1.78],0.6860033699786885
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP12,Macrophage metalloelastase,12090,37,0.67 [0.38-1.18],0.1649894684071479
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP13,Collagenase 3,11815,37,0.92 [0.38-2.22],0.8462488458016119
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP15,Matrix metalloproteinase-15,10600,35,0.68 [0.27-1.69],0.4030378022558696
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP3,Stromelysin-1,12112,38,1.26 [0.72-2.20],0.4180880583059058
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP7,Matrilysin,11841,38,0.87 [0.47-1.58],0.6385443682166905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP8,Neutrophil collagenase,12175,37,0.96 [0.65-1.42],0.8339403167472161
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP9,Matrix metalloproteinase-9,12086,38,0.66 [0.41-1.07],0.0955968643040628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",10258,34,1.23 [0.66-2.29],0.5143019535389254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MN1,Transcriptional activator MN1,10316,33,0.94 [0.52-1.69],0.8370119355473337
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MNAT1,CDK-activating kinase assembly factor MAT1,10425,33,1.93 [1.22-3.04],0.005044212633681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MNDA,Myeloid cell nuclear differentiation antigen,12087,41,1.29 [1.05-1.58],0.0159215475759486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MOCS2,Molybdopterin synthase catalytic subunit,10388,35,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MOG,Myelin-oligodendrocyte glycoprotein,12195,37,0.65 [0.27-1.57],0.3386840744172528
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORC3,MORC family CW-type zinc finger protein 3,10586,35,2.41 [1.35-4.31],0.0029754560485437
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORF4L1,Mortality factor 4-like protein 1,10425,33,1.39 [0.77-2.52],0.2743600615044786
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORF4L2,Mortality factor 4-like protein 2,10208,34,1.02 [0.43-2.44],0.9674067163414568
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORN4,MORN repeat-containing protein 4,10208,34,0.75 [0.44-1.30],0.3101412109025531
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPHOSPH8,M-phase phosphoprotein 8,11861,38,1.16 [0.80-1.67],0.427632773972798
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPI,Mannose-6-phosphate isomerase,12048,37,0.97 [0.69-1.37],0.8734869540883239
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,12139,40,0.85 [0.59-1.22],0.372347741078827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPO,Myeloperoxidase,12112,38,1.28 [0.74-2.24],0.3757522958202632
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPRIP,Myosin phosphatase Rho-interacting protein,10517,34,1.08 [0.50-2.34],0.8395707165825225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRC1,Macrophage mannose receptor 1,10602,33,0.68 [0.21-2.14],0.5071887345492858
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRI1,Methylthioribose-1-phosphate isomerase,10316,33,1.49 [0.91-2.46],0.1167655765740497
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL24,"39S ribosomal protein L24, mitochondrial",10258,34,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL28,"39S ribosomal protein L28, mitochondrial",10578,34,1.57 [0.98-2.51],0.0603034219077342
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL46,"39S ribosomal protein L46, mitochondrial",11815,37,0.89 [0.30-2.66],0.8367650133627347
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL52,"39S ribosomal protein L52, mitochondrial",10186,34,1.43 [0.41-5.03],0.574551196157669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",10578,34,0.80 [0.47-1.36],0.4117787295798406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPS16,"28S ribosomal protein S16, mitochondrial",10295,36,0.97 [0.31-3.00],0.95586975572001
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSLN,Mesothelin,12023,37,0.93 [0.55-1.57],0.7901270108564973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSLNL,Mesothelin-like protein,10316,33,1.04 [0.45-2.42],0.9231858446112996
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSMB,Beta-microseminoprotein,12056,40,0.82 [0.56-1.20],0.3056059839850243
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSR1,Macrophage scavenger receptor types I and II,12201,37,1.48 [0.76-2.87],0.2485516654381449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSRA,Mitochondrial peptide methionine sulfoxide reductase,12159,39,1.02 [0.69-1.51],0.935832401318146
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MST1,Hepatocyte growth factor-like protein,10435,33,1.08 [0.60-1.92],0.8046582434053887
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSTN,Growth/differentiation factor 8,11861,38,0.73 [0.41-1.30],0.2845227516380367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTDH,Protein LYRIC,10295,36,1.18 [0.84-1.67],0.3402827572182871
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",10586,35,1.64 [0.83-3.27],0.1556622189833713
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,10425,33,1.15 [0.85-1.55],0.3584525798794142
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTIF3,"Translation initiation factor IF-3, mitochondrial",10538,34,1.01 [0.70-1.47],0.9557512163388516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTPN,Myotrophin,11861,38,0.94 [0.38-2.32],0.8960345459687811
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTR,Methionine synthase,10258,34,1.18 [0.78-1.77],0.4407016595810744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTSS1,Protein MTSS 1,10538,34,0.92 [0.68-1.25],0.6020335357435854
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTSS2,Protein MTSS 2,10542,34,1.04 [0.74-1.46],0.8268219807840069
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTUS1,Microtubule-associated tumor suppressor 1,10425,33,0.80 [0.42-1.55],0.5092952504677954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MUC13,Mucin-13,11815,37,1.06 [0.59-1.91],0.8450721617586602
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MUC16,Mucin-16,12048,37,0.98 [0.85-1.14],0.821410116749976
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MUC2,Mucin-2,10617,36,1.33 [0.95-1.86],0.0915212176945529
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MUCL3,Mucin-like protein 3,10208,34,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MVK,Mevalonate kinase,11857,37,0.97 [0.66-1.41],0.8612546501975831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MXRA8,Matrix remodeling-associated protein 8,10388,35,0.72 [0.31-1.66],0.4415564124825321
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYBPC1,"Myosin-binding protein C, slow-type",10600,35,1.19 [0.75-1.88],0.4634009318572751
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYBPC2,"Myosin-binding protein C, fast-type",10348,34,1.22 [0.91-1.63],0.194145989874476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,10578,34,1.20 [0.77-1.86],0.4200669157170249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYDGF,Myeloid-derived growth factor,10600,35,0.93 [0.67-1.29],0.6589038115409298
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYH4,Myosin-4,10258,34,1.15 [0.61-2.18],0.6676608860899942
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYH7B,Myosin-7B,10208,34,0.79 [0.34-1.84],0.5926049478954973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYH9,Myosin-9,10617,36,1.03 [0.78-1.37],0.8106216080197985
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",10258,34,1.03 [0.49-2.18],0.9415175095524618
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYL3,Myosin light chain 3,10348,34,1.11 [0.69-1.78],0.6661124157838116
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYL4,Myosin light chain 4,10348,34,1.45 [0.87-2.40],0.1531445588647318
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYL6B,Myosin light chain 6B,10316,33,0.94 [0.64-1.38],0.7555830278277211
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",10316,33,1.71 [1.12-2.59],0.0122142486400498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYO6,Unconventional myosin-VI,10578,34,1.26 [0.56-2.85],0.5804127465707651
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYO9B,Unconventional myosin-IXb,11857,37,1.03 [0.67-1.58],0.90375190332933
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYOC,Myocilin,12112,38,0.85 [0.45-1.61],0.6156864153645867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYOM1,Myomesin-1,10235,33,1.53 [0.98-2.38],0.0587403937210376
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYOM2,Myomesin-2,10258,34,1.28 [0.67-2.44],0.4532987729058665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYOM3,Myomesin-3,10388,35,1.12 [0.78-1.60],0.5424974906440581
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MZB1,Marginal zone B- and B1-cell-specific protein,12148,40,0.76 [0.44-1.31],0.3201974541394171
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MZT1,Mitotic-spindle organizing protein 1,11824,39,0.80 [0.44-1.45],0.4541627211376108
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAA10,N-alpha-acetyltransferase 10,10258,34,1.44 [0.76-2.72],0.2649182500636212
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAA80,N-alpha-acetyltransferase 80,10316,33,1.09 [0.82-1.45],0.5327129338927469
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAAA,N-acylethanolamine-hydrolyzing acid amidase,11965,38,1.20 [0.75-1.94],0.4515533518732849
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NACC1,Nucleus accumbens-associated protein 1,10542,34,1.34 [0.81-2.20],0.2491377885273445
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NADK,NAD kinase,12108,41,1.50 [1.06-2.11],0.0207046841548499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAGA,Alpha-N-acetylgalactosaminidase,10267,36,1.42 [0.99-2.04],0.0584969285660423
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAGK,N-acetyl-D-glucosamine kinase,10329,34,1.67 [0.98-2.84],0.0569137094605903
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,10388,35,2.99 [0.69-12.93],0.1429885783218932
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAMPT,Nicotinamide phosphoribosyltransferase,11824,39,1.34 [0.94-1.93],0.1099851857089642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAP1L4,Nucleosome assembly protein 1-like 4,10515,34,1.47 [0.64-3.39],0.3658873571838046
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAPRT,Nicotinate phosphoribosyltransferase,10586,35,1.86 [0.92-3.78],0.0838418137440506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NARS1,"Asparagine--tRNA ligase, cytoplasmic",10578,34,1.24 [0.61-2.52],0.549430561389043
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NBL1,Neuroblastoma suppressor of tumorigenicity 1,12159,39,0.61 [0.20-1.83],0.3811593407326936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NBN,Nibrin,11857,37,1.42 [1.02-1.98],0.037063352729254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCAM1,Neural cell adhesion molecule 1,12165,39,1.73 [0.67-4.49],0.2563304257419005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCAM2,Neural cell adhesion molecule 2,12112,38,1.34 [0.46-3.87],0.5927776074883735
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCAN,Neurocan core protein,12201,37,1.13 [0.52-2.47],0.754449072115824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCF2,Neutrophil cytosol factor 2,12062,37,1.06 [0.76-1.47],0.7493862455215129
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCK2,Cytoplasmic protein NCK2,12162,40,0.92 [0.70-1.20],0.5248137579915975
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCLN,Nicalin,11857,37,1.37 [0.94-1.99],0.1024477596034227
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCR1,Natural cytotoxicity triggering receptor 1,12058,37,0.63 [0.28-1.39],0.2524724593443712
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,10538,34,0.42 [0.16-1.06],0.0664423041337364
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCS1,Neuronal calcium sensor 1,12195,37,1.98 [0.72-5.43],0.1858966793432814
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDRG1,Protein NDRG1,11815,37,1.28 [0.95-1.72],0.1019408985517688
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,10542,34,1.19 [0.81-1.76],0.3696896835873454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,10279,36,0.81 [0.32-2.03],0.6460355588907771
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,10538,34,1.09 [0.75-1.57],0.6554831398230885
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",11824,39,0.52 [0.32-0.85],0.008329848113026
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEB,Nebulin,10258,34,1.37 [0.70-2.67],0.3574721387057714
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECAP2,Adaptin ear-binding coat-associated protein 2,10258,34,0.99 [0.60-1.61],0.9548703591448032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECTIN1,Nectin-1,10295,36,0.39 [0.13-1.21],0.1032270143448265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECTIN2,Nectin-2,12085,41,0.32 [0.12-0.89],0.0280620106219649
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECTIN4,Nectin-4,12159,39,0.56 [0.21-1.50],0.2479822529549471
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,10295,36,1.18 [0.60-2.33],0.6375555019150605
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEDD9,Enhancer of filamentation 1,10295,36,0.82 [0.29-2.28],0.698727152739975
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEFL,Neurofilament light polypeptide,11776,36,1.16 [0.58-2.31],0.6727833990183819
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEK7,Serine/threonine-protein kinase Nek7,10425,33,0.91 [0.56-1.46],0.6883531220563051
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NELL1,Protein kinase C-binding protein NELL1,12159,39,1.37 [0.71-2.63],0.3431044007400746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NELL2,Protein kinase C-binding protein NELL2,12162,40,0.67 [0.24-1.84],0.4372375001663554
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NENF,Neudesin,10542,34,0.76 [0.51-1.13],0.174952639844873
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEO1,Neogenin,10578,34,0.30 [0.06-1.45],0.1336584110155979
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEXN,Nexilin,10602,33,0.87 [0.53-1.43],0.5857291520756485
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFASC,Neurofascin,12217,37,1.36 [0.49-3.81],0.5595207730448754
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFAT5,Nuclear factor of activated T-cells 5,10295,36,1.17 [0.83-1.64],0.3710832502983361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",12076,37,1.03 [0.75-1.41],0.8680852779948727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",11857,37,0.75 [0.43-1.30],0.3001264103040247
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFE2,Transcription factor NF-E2 45 kDa subunit,10348,34,1.20 [0.78-1.85],0.4158105181379262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFIC,Nuclear factor 1 C-type,10578,34,0.58 [0.19-1.74],0.3325642631327224
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFKB1,Nuclear factor NF-kappa-B p105 subunit,10258,34,1.11 [0.71-1.74],0.6513126304429727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFKB2,Nuclear factor NF-kappa-B p100 subunit,10425,33,0.44 [0.15-1.30],0.1364419353543569
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFKBIE,NF-kappa-B inhibitor epsilon,11824,39,1.24 [0.72-2.12],0.4416286826699978
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",10538,34,0.99 [0.72-1.37],0.968703622672662
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFX1,Transcriptional repressor NF-X1,10258,34,1.18 [0.73-1.89],0.4986804332910347
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFYA,Nuclear transcription factor Y subunit alpha,10258,34,1.52 [0.85-2.72],0.1549612981546539
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NGF,Beta-nerve growth factor,12020,39,0.48 [0.04-5.57],0.5555747607524515
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NGFR,Tumor necrosis factor receptor superfamily member 16,10600,35,0.60 [0.17-2.09],0.4184073869560041
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NGRN,Neugrin,10586,35,2.22 [0.93-5.26],0.0709668159568907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NHLRC3,NHL repeat-containing protein 3,10133,35,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NID1,Nidogen-1,12116,39,0.84 [0.41-1.71],0.6239912566089116
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NID2,Nidogen-2,12112,38,0.91 [0.62-1.34],0.6422427610874749
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NINJ1,Ninjurin-1,11824,39,1.27 [0.85-1.90],0.2488327887645334
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NIT1,Deaminated glutathione amidase,10348,34,1.40 [0.68-2.88],0.3654438163263442
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NIT2,Omega-amidase NIT2,10557,34,0.94 [0.60-1.47],0.7869803578566539
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NLGN1,Neuroligin-1,10316,33,1.43 [1.06-1.94],0.0193099289400617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NLGN2,Neuroligin-2,10235,33,1.02 [0.52-2.02],0.9536839966919636
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NME1,Nucleoside diphosphate kinase A,10295,36,2.07 [0.63-6.79],0.2316310963541927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NME3,Nucleoside diphosphate kinase 3,12125,40,0.63 [0.18-2.29],0.4866846905369932
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMI,N-myc-interactor,10508,34,1.14 [0.74-1.77],0.5553646047059138
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,12020,39,1.34 [1.02-1.75],0.0364401392018742
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMRK2,Nicotinamide riboside kinase 2,10208,34,1.02 [0.48-2.19],0.9521382847621852
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,10578,34,1.03 [0.64-1.68],0.8920602700759612
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOMO1,Nodal modulator 1,12112,38,0.93 [0.27-3.21],0.907086947341412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOP56,Nucleolar protein 56,10258,34,0.67 [0.61-0.74],2.5070145189813315e-16
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOS1,"Nitric oxide synthase, brain",11815,37,1.35 [0.76-2.39],0.3095527190725424
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOS2,"Nitric oxide synthase, inducible",10258,34,1.46 [0.71-2.98],0.3003956015089284
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOS3,"Nitric oxide synthase, endothelial",11815,37,0.77 [0.42-1.41],0.3937335427052324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOTCH1,Neurogenic locus notch homolog protein 1,12247,40,1.11 [0.18-6.78],0.9092811110122088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOTCH2,Neurogenic locus notch homolog protein 2,10617,36,4.75 [1.24-18.23],0.0230240582526197
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOTCH3,Neurogenic locus notch homolog protein 3,12247,40,0.95 [0.42-2.17],0.9097691366897626
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPC2,NPC intracellular cholesterol transporter 2,10423,36,0.93 [0.34-2.57],0.8890417282338501
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPDC1,Neural proliferation differentiation and control protein 1,12108,41,0.74 [0.29-1.86],0.5230914740183246
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPHS1,Nephrin,10295,36,1.06 [0.41-2.70],0.906808146623312
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPHS2,Podocin,10295,36,0.95 [0.69-1.30],0.7339232149793624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPL,N-acetylneuraminate lyase,10600,35,1.23 [0.60-2.53],0.5658921629834368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPPB,Natriuretic peptides B,11861,38,1.02 [0.81-1.27],0.8800323272993206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPPC,C-type natriuretic peptide,12076,37,0.68 [0.33-1.39],0.2943583437154176
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPR1,Atrial natriuretic peptide receptor 1,10258,34,1.53 [0.82-2.88],0.1844241157601178
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPTN,Neuroplastin,11824,39,0.83 [0.54-1.28],0.4031678804971288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPTX1,Neuronal pentraxin-1,12112,38,0.80 [0.37-1.71],0.563992397948801
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPTX2,Neuronal pentraxin-2,10617,36,1.38 [0.50-3.82],0.5296509357433627
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPTXR,Neuronal pentraxin receptor,12108,41,0.95 [0.41-2.19],0.90203492500616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPY,Pro-neuropeptide Y,12195,37,1.00 [0.64-1.58],0.9839891822987052
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRCAM,Neuronal cell adhesion molecule,12108,41,1.21 [0.47-3.17],0.6916548742571034
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRGN,Neurogranin,10602,33,0.95 [0.66-1.38],0.8042331296526932
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRN1,Neuritin,10578,34,1.32 [0.67-2.61],0.4176384938911692
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRP1,Neuropilin-1,12181,39,1.38 [0.51-3.75],0.5231366460429816
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRP2,Neuropilin-2,12112,38,1.39 [0.54-3.59],0.4987580925056407
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRTN,Neurturin,11857,37,1.03 [0.59-1.81],0.9126169406984764
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRXN3,Neurexin-3,10316,33,1.00 [0.39-2.55],0.9939175011862836
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NSFL1C,NSFL1 cofactor p47,12201,37,1.08 [0.70-1.67],0.7292058759108435
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",10600,35,1.23 [0.79-1.91],0.3593237122296576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NT5C1A,Cytosolic 5'-nucleotidase 1A,10586,35,1.08 [0.41-2.82],0.8714834830583873
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NT5C3A,Cytosolic 5'-nucleotidase 3A,12063,37,1.11 [0.79-1.57],0.5348275191988363
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NT5E,5'-nucleotidase,12159,39,0.89 [0.54-1.46],0.6372756555468815
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTF3,Neurotrophin-3,12076,37,1.00 [0.44-2.24],0.9908639226175068
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTF4,Neurotrophin-4,11824,39,0.56 [0.21-1.51],0.2518544273855909
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTRK2,BDNF/NT-3 growth factors receptor,12108,41,1.16 [0.39-3.47],0.7949260068573833
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTRK3,NT-3 growth factor receptor,12201,37,0.79 [0.21-3.05],0.7368331767281697
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTproBNP,N-terminal prohormone of brain natriuretic peptide,12108,41,0.96 [0.73-1.26],0.7606911835417379
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUB1,NEDD8 ultimate buster 1,12076,37,1.18 [0.85-1.65],0.3266102602805498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,10542,34,0.87 [0.60-1.26],0.4579418192116381
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUCB2,Nucleobindin-2,12173,36,0.90 [0.40-2.02],0.798303772568228
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDC,Nuclear migration protein nudC,12217,37,0.95 [0.59-1.52],0.8152185004347784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,10348,34,1.56 [0.59-4.12],0.3670677033871584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,10258,34,0.95 [0.49-1.85],0.8840108011312882
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT16,U8 snoRNA-decapping enzyme,10519,34,1.22 [0.84-1.76],0.2953173472151221
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],12048,37,1.28 [0.81-2.02],0.297402531268185
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT5,ADP-sugar pyrophosphatase,12112,38,0.98 [0.56-1.72],0.9416620576897902
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUMB,Protein numb homolog,10295,36,1.07 [0.72-1.59],0.7283085010143169
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUP50,Nuclear pore complex protein Nup50,10258,34,1.42 [0.71-2.86],0.3261066134206563
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NXPE4,NXPE family member 4,10258,34,0.59 [0.18-1.91],0.3798665690436789
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NXPH1,Neurexophilin-1,11815,37,0.66 [0.29-1.50],0.3212748507726986
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NXPH3,Neurexophilin-3,10295,36,0.47 [0.17-1.31],0.1486594349387028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OBP2B,Odorant-binding protein 2b,11988,39,1.08 [0.69-1.70],0.7387306581742459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OCLN,Occludin,10578,34,1.05 [0.50-2.20],0.8962141893145991
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ODAM,Odontogenic ameloblast-associated protein,11799,37,0.97 [0.58-1.62],0.906048837007462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OFD1,Oral-facial-digital syndrome 1 protein,10425,33,1.28 [0.86-1.91],0.2318981603767098
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OGA,Protein O-GlcNAcase,10538,34,1.19 [0.75-1.90],0.4658820823716444
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OGFR,Opioid growth factor receptor,12048,37,1.63 [0.70-3.76],0.2540511066094522
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OGN,Mimecan,12112,38,0.59 [0.28-1.24],0.1660171989104987
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,10425,33,0.70 [0.36-1.37],0.3003866194709584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OLFM4,Olfactomedin-4,10001,34,1.17 [0.89-1.54],0.2591767997998587
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OLR1,Oxidized low-density lipoprotein receptor 1,12000,41,1.20 [0.78-1.83],0.4122789900082438
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OMD,Osteomodulin,12162,40,0.67 [0.37-1.22],0.1931692960781479
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OMG,Oligodendrocyte-myelin glycoprotein,12048,37,1.05 [0.67-1.66],0.8289998957306575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OMP,Olfactory marker protein,10235,33,1.07 [0.57-2.01],0.8327025077486936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OPHN1,Oligophrenin-1,10586,35,1.06 [0.78-1.44],0.6973440391153121
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OPLAH,5-oxoprolinase,10348,34,1.27 [0.80-2.03],0.3147486310542143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OPTC,Opticin,12048,37,1.09 [0.59-2.03],0.7870445133362632
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ORM1,Alpha-1-acid glycoprotein 1,10587,34,1.10 [0.21-5.67],0.9070123260239076
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSBPL2,Oxysterol-binding protein-related protein 2,10586,35,1.15 [0.57-2.29],0.6970067012581909
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSCAR,Osteoclast-associated immunoglobulin-like receptor,12125,40,0.98 [0.43-2.24],0.9620817427735796
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSM,Oncostatin-M,12028,37,0.78 [0.51-1.17],0.2294951660779823
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSMR,Oncostatin-M-specific receptor subunit beta,12181,39,0.55 [0.14-2.19],0.3996802451899501
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSTN,Osteocrin,10316,33,1.01 [0.44-2.29],0.9859758892447028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OTOA,Otoancorin,10235,33,1.09 [0.61-1.94],0.7736988936427525
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OTUD6B,Deubiquitinase OTUD6B,10538,34,1.16 [0.67-2.02],0.5940604209842458
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OTUD7B,OTU domain-containing protein 7B,10578,34,0.97 [0.57-1.65],0.9184259465316716
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",10348,34,1.17 [0.73-1.89],0.5070979953472861
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OXT,Oxytocin-neurophysin 1,12201,37,1.01 [0.81-1.26],0.9391606056037748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",P4HB,Protein disulfide-isomerase,12060,39,0.66 [0.31-1.41],0.280546642745747
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PACS2,Phosphofurin acidic cluster sorting protein 2,10258,34,1.44 [0.87-2.37],0.1578608876782062
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PADI2,Protein-arginine deiminase type-2,11857,37,1.53 [1.15-2.05],0.0035200491247513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PADI4,Protein-arginine deiminase type-4,11799,37,1.29 [0.97-1.72],0.0849664256283997
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAEP,Glycodelin,12020,39,0.99 [0.67-1.47],0.9670305355829998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,10578,34,0.77 [0.53-1.14],0.193306652392226
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",10425,33,1.33 [0.71-2.52],0.3756611396801722
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,11861,38,0.95 [0.57-1.60],0.8558373606283924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAGR1,PAXIP1-associated glutamate-rich protein 1,10348,34,1.35 [0.70-2.58],0.3712968319848841
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,10190,34,1.01 [0.53-1.92],0.9764103058984532
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAK4,Serine/threonine-protein kinase PAK 4,11815,37,0.86 [0.51-1.43],0.5535579477731583
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PALLD,Palladin,10295,36,1.57 [0.95-2.57],0.0754684731848477
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PALM,Paralemmin-1,10477,34,0.65 [0.22-1.88],0.4249585635685505
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PALM2,Paralemmin-2,10586,35,0.66 [0.26-1.65],0.3703805183745273
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PALM3,Paralemmin-3,10258,34,1.14 [0.79-1.65],0.4941946162887827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAM,Peptidyl-glycine alpha-amidating monooxygenase,12182,40,0.69 [0.28-1.75],0.4380927967460227
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAMR1,Inactive serine protease PAMR1,12112,38,0.76 [0.26-2.17],0.6051136077566122
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAPPA,Pappalysin-1,11857,37,1.01 [0.53-1.94],0.972589949253442
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PARD3,Partitioning defective 3 homolog,10425,33,0.96 [0.60-1.54],0.8563367807376242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PARK7,Parkinson disease protein 7,12112,38,1.16 [0.68-1.99],0.5829023217926957
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PARP1,Poly [ADP-ribose] polymerase 1,12076,37,1.43 [1.07-1.93],0.0173243773088586
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAXX,Protein PAXX,10388,35,1.54 [0.81-2.92],0.1865597054603752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PBK,Lymphokine-activated killer T-cell-originated protein kinase,10208,34,1.17 [0.39-3.53],0.7739507895866538
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PBLD,Phenazine biosynthesis-like domain-containing protein,11815,37,0.58 [0.31-1.09],0.0914709520380274
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,10538,34,0.85 [0.26-2.80],0.7917908573777634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCARE,Photoreceptor cilium actin regulator,10235,33,0.81 [0.49-1.33],0.4025913800788676
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,10374,35,1.32 [0.68-2.54],0.4143348873506164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCBP2,Poly(rC)-binding protein 2,10578,34,1.11 [0.70-1.76],0.6576401081413039
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH1,Protocadherin-1,12178,37,0.69 [0.16-2.87],0.6056371634899262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH12,Protocadherin-12,10578,34,1.19 [0.33-4.24],0.7871603542254073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH17,Protocadherin-17,12108,41,1.20 [0.56-2.59],0.6345855512390333
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH7,Protocadherin-7,10538,34,0.71 [0.24-2.10],0.5400322326400246
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH9,Protocadherin-9,10538,34,1.13 [0.42-3.03],0.8125782211769437
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDHB15,Protocadherin beta-15,10542,34,0.69 [0.29-1.64],0.4021708088360803
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCNA,Proliferating cell nuclear antigen,10208,34,1.26 [0.85-1.87],0.2534408523283077
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCSK7,Proprotein convertase subtilisin/kexin type 7,10542,34,1.37 [0.75-2.50],0.3131267536894275
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCSK9,Proprotein convertase subtilisin/kexin type 9,12247,40,0.78 [0.38-1.61],0.5094502342555287
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCYT2,Ethanolamine-phosphate cytidylyltransferase,10538,34,0.94 [0.61-1.46],0.7963521795077616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDAP1,28 kDa heat- and acid-stable phosphoprotein,10600,35,0.91 [0.65-1.27],0.5807363602690823
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD1,Programmed cell death protein 1,12176,37,0.45 [0.21-0.93],0.0321776058610973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD1LG2,Programmed cell death 1 ligand 2,12048,37,0.50 [0.19-1.27],0.1455430217015107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD5,Programmed cell death protein 5,12201,37,1.02 [0.62-1.67],0.9429990943489184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD6,Programmed cell death protein 6,12108,41,1.30 [0.80-2.13],0.2896363766246151
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCL2,Phosducin-like protein 2,10208,34,0.65 [0.29-1.44],0.2886858594169507
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",10208,34,0.83 [0.40-1.70],0.6060000556615195
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",10258,34,1.40 [0.96-2.02],0.0773523144236891
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",10388,35,1.07 [0.77-1.48],0.6868327227521605
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFA,Platelet-derived growth factor subunit A,12247,40,0.80 [0.54-1.17],0.2454649919814975
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFB,Platelet-derived growth factor subunit B,12162,40,0.83 [0.60-1.14],0.2450748156922932
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFC,Platelet-derived growth factor C,11824,39,0.75 [0.28-2.01],0.5702771564999632
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFRA,Platelet-derived growth factor receptor alpha,12108,41,1.55 [0.60-3.98],0.3672521905322761
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFRB,Platelet-derived growth factor receptor beta,12247,40,0.84 [0.38-1.86],0.6607723665081449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDIA2,Protein disulfide-isomerase A2,10208,34,0.66 [0.26-1.67],0.3787290962647279
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDIA3,Protein disulfide-isomerase A3,10388,35,0.92 [0.25-3.42],0.9004910485144475
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDIA4,Protein disulfide-isomerase A4,10617,36,0.94 [0.55-1.60],0.8061036174303564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDIA5,Protein disulfide-isomerase A5,10208,34,0.82 [0.44-1.51],0.5237905388450085
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDLIM5,PDZ and LIM domain protein 5,10578,34,1.04 [0.78-1.38],0.7967690828500602
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDLIM7,PDZ and LIM domain protein 7,12162,40,0.95 [0.76-1.19],0.6754311294907791
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",11824,39,1.44 [0.98-2.11],0.0614012375627596
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDRG1,p53 and DNA damage-regulated protein 1,10316,33,1.00 [0.54-1.86],0.9976524492146958
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,10208,34,0.94 [0.50-1.79],0.859799406341678
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDZD2,PDZ domain-containing protein 2,10258,34,0.90 [0.51-1.58],0.7057162357920949
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,10295,36,1.50 [0.83-2.71],0.1800138061238928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PEAR1,Platelet endothelial aggregation receptor 1,12247,40,1.37 [0.40-4.72],0.6179756651010642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PEBP1,Phosphatidylethanolamine-binding protein 1,12112,38,1.06 [0.65-1.73],0.8268648195558174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PECAM1,Platelet endothelial cell adhesion molecule,12112,38,0.83 [0.32-2.16],0.697947027116671
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PECR,Peroxisomal trans-2-enoyl-CoA reductase,10348,34,2.90 [1.86-4.53],2.6907677881814846e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PENK,Proenkephalin-A,10388,35,0.55 [0.18-1.66],0.2897639582646362
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PEPD,Xaa-Pro dipeptidase,10602,33,0.39 [0.12-1.28],0.1195054317176667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PER3,Period circadian protein homolog 3,10295,36,0.84 [0.63-1.11],0.2218616798462847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PF4,Platelet factor 4,10544,33,0.77 [0.55-1.08],0.1346649367235314
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PFDN2,Prefoldin subunit 2,11815,37,1.16 [0.71-1.91],0.5474426033248492
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PFDN4,Prefoldin subunit 4,10208,34,0.88 [0.44-1.73],0.7077262926391985
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PFDN6,Prefoldin subunit 6,10316,33,1.17 [0.79-1.75],0.4366213317764825
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",12020,37,1.20 [0.82-1.74],0.3427502049455553
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGA4,Pepsin A-4,10602,33,1.07 [0.68-1.69],0.7693869116237618
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",10600,35,1.16 [0.64-2.08],0.6238657915530619
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGF,Placenta growth factor,12217,37,0.98 [0.30-3.22],0.9742325442975652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGLYRP1,Peptidoglycan recognition protein 1,12200,40,0.93 [0.48-1.80],0.8212116808180995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,10489,35,0.95 [0.33-2.74],0.9233515914184048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGLYRP4,Peptidoglycan recognition protein 4,10258,34,1.00 [0.60-1.67],0.9990518163346638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGM2,Phosphoglucomutase-2,10316,33,1.15 [0.70-1.90],0.573894918865947
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGR,Progesterone receptor,10295,36,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHACTR2,Phosphatase and actin regulator 2,10578,34,0.95 [0.71-1.27],0.7345185443251709
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHLDB1,Pleckstrin homology-like domain family B member 1,10538,34,0.84 [0.44-1.59],0.5897718575679992
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHLDB2,Pleckstrin homology-like domain family B member 2,10208,34,1.24 [0.96-1.61],0.1047241548702061
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,12020,39,0.69 [0.28-1.73],0.4285095366140139
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,10388,35,1.07 [0.48-2.40],0.8658322992413944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PI16,Peptidase inhibitor 16,10602,33,0.58 [0.16-2.12],0.4092417423528423
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PI3,Elafin,11951,39,1.03 [0.61-1.73],0.9128382881650752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",10578,34,1.24 [0.82-1.87],0.3142320868457966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIGR,Polymeric immunoglobulin receptor,11950,38,1.02 [0.45-2.33],0.9607069415521268
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,12076,37,1.38 [0.88-2.16],0.156666734331405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,12112,38,0.46 [0.14-1.44],0.1799179721583174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,10295,36,1.19 [0.71-2.00],0.5169150849139121
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PILRA,Paired immunoglobulin-like type 2 receptor alpha,12112,38,1.09 [0.55-2.17],0.8095028596451407
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PILRB,Paired immunoglobulin-like type 2 receptor beta,12108,41,1.28 [0.77-2.12],0.3407495112478219
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,10388,35,1.32 [0.80-2.17],0.2803653550364039
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PITHD1,PITH domain-containing protein 1,10190,34,0.87 [0.54-1.38],0.5524845395142808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PKD1,Polycystin-1,10600,35,1.05 [0.30-3.69],0.9338273252437688
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PKD2,Polycystin-2,10258,34,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PKLR,Pyruvate kinase PKLR,12128,40,1.17 [0.78-1.74],0.4420190666124051
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PKN3,Serine/threonine-protein kinase N3,10425,33,0.71 [0.44-1.15],0.165737798650168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G10,Group 10 secretory phospholipase A2,12020,39,1.09 [0.68-1.76],0.7221140876595353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G15,Phospholipase A2 group XV,12159,39,1.60 [0.56-4.60],0.3841897229161279
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G1B,Phospholipase A2,12229,40,1.57 [0.83-2.95],0.1643975307830427
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G2A,"Phospholipase A2, membrane associated",12057,40,1.21 [0.80-1.83],0.3769883891178008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G4A,Cytosolic phospholipase A2,12162,40,0.96 [0.69-1.32],0.7891353798553551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G7,Platelet-activating factor acetylhydrolase,12112,38,0.68 [0.29-1.60],0.3729414342956688
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLAT,Tissue-type plasminogen activator,12214,40,1.11 [0.63-1.96],0.7068938401611292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLAU,Urokinase-type plasminogen activator,12112,38,1.06 [0.39-2.88],0.9081355104740892
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLAUR,Urokinase plasminogen activator surface receptor,12029,40,1.17 [0.42-3.30],0.7625061842190128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLB1,"Phospholipase B1, membrane-associated",10586,35,1.08 [0.62-1.86],0.7944861066620849
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",10295,36,1.00 [0.48-2.10],0.9971242201459204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",10586,35,1.17 [0.83-1.65],0.3633940783107121
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLEKHO1,Pleckstrin homology domain-containing family O member 1,10586,35,1.10 [0.69-1.74],0.6941995268776483
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLG,Plasminogen,10353,34,1.43 [0.31-6.50],0.6426244881373215
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLIN1,Perilipin-1,11815,37,0.92 [0.39-2.16],0.8463544703433867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLIN3,Perilipin-3,12108,41,1.42 [0.78-2.57],0.2550902404862414
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLPBP,Pyridoxal phosphate homeostasis protein,12108,41,1.16 [0.77-1.74],0.4742911046880389
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLSCR3,Phospholipid scramblase 3,10566,35,1.25 [0.73-2.12],0.4169524345547257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLTP,Phospholipid transfer protein,12212,40,1.27 [0.56-2.90],0.5658523604565331
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXDC1,Plexin domain-containing protein 1,11824,39,1.29 [0.64-2.61],0.4775041577726421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXDC2,Plexin domain-containing protein 2,10586,35,1.23 [0.40-3.84],0.716254507597308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXNA4,Plexin-A4,12076,37,0.92 [0.64-1.31],0.6275701960742948
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXNB2,Plexin-B2,12189,40,1.22 [0.38-3.97],0.7365365651540451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXNB3,Plexin-B3,12073,41,1.17 [0.66-2.09],0.5868822904067423
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,12037,41,1.08 [0.92-1.28],0.3401213109739038
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PMCH,Pro-MCH,10258,34,1.15 [0.85-1.55],0.3778986062203787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PMM2,Phosphomannomutase 2,10258,34,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PMS1,PMS1 protein homolog 1,10316,33,1.47 [0.87-2.47],0.1500609051239598
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PMVK,Phosphomevalonate kinase,11793,37,0.94 [0.72-1.22],0.6418138922723431
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNLIP,Pancreatic triacylglycerol lipase,10602,33,1.69 [1.03-2.78],0.0386627762380482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNLIPRP1,Inactive pancreatic lipase-related protein 1,10586,35,1.22 [0.81-1.84],0.3414122463268892
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNLIPRP2,Pancreatic lipase-related protein 2,12105,40,1.02 [0.92-1.13],0.6973038232330051
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNMA1,Paraneoplastic antigen Ma1,10348,34,1.02 [0.57-1.83],0.9402018782023746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNMA2,Paraneoplastic antigen Ma2,10235,33,1.09 [0.52-2.27],0.8196985050287424
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",11857,37,1.14 [0.92-1.41],0.235907412286711
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PODXL,Podocalyxin,12048,37,0.90 [0.13-6.09],0.9138968042057192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PODXL2,Podocalyxin-like protein 2,12159,39,0.78 [0.28-2.21],0.6399644699049603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POF1B,Protein POF1B,10295,36,1.06 [0.54-2.09],0.8631387613683308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POLR2A,DNA-directed RNA polymerase II subunit RPB1,10295,36,0.92 [0.30-2.81],0.8829881440209405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",12048,37,1.88 [1.15-3.05],0.0113693616241923
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POMC,Pro-opiomelanocortin,10348,34,0.89 [0.55-1.45],0.6468850739103308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PON1,Serum paraoxonase/arylesterase 1,10602,33,1.65 [0.42-6.43],0.4733593225745732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PON2,Serum paraoxonase/arylesterase 2,11861,38,0.65 [0.29-1.48],0.3043643836311931
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PON3,Serum paraoxonase/lactonase 3,12162,40,1.78 [0.57-5.57],0.3201595248383528
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POSTN,Periostin,10617,36,1.42 [0.64-3.17],0.3893985509987331
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPBP,Platelet basic protein,10552,34,0.82 [0.56-1.21],0.3299280465409723
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPCDC,Phosphopantothenoylcysteine decarboxylase,12201,37,1.39 [0.76-2.54],0.2870030123022643
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPIB,Peptidyl-prolyl cis-trans isomerase B,12126,40,0.93 [0.69-1.25],0.6118613135594002
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPIE,Peptidyl-prolyl cis-trans isomerase E,10425,33,0.88 [0.49-1.59],0.6833929334285006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",10617,36,1.13 [0.71-1.80],0.6057096041563079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPL,Periplakin,10295,36,0.59 [0.20-1.74],0.3421423362739447
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPM1A,Protein phosphatase 1A,11824,39,0.59 [0.21-1.64],0.3096875844050821
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPM1B,Protein phosphatase 1B,10295,36,1.26 [0.86-1.86],0.2325126972943917
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPM1F,Protein phosphatase 1F,10600,35,0.91 [0.49-1.71],0.7803807687782758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPME1,Protein phosphatase methylesterase 1,12048,37,1.13 [0.70-1.83],0.6067329805069633
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,10542,34,1.02 [0.68-1.52],0.9234750021298446
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,12159,39,0.89 [0.66-1.21],0.4622431824439874
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,10425,33,0.97 [0.61-1.56],0.9074715985646848
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,10578,34,0.84 [0.54-1.31],0.4450600505911966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,10578,34,0.51 [0.18-1.43],0.1987119362552452
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R2,Protein phosphatase inhibitor 2,12108,41,1.01 [0.71-1.43],0.9458459891994664
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R9B,Neurabin-2,12217,37,0.92 [0.68-1.25],0.5979299069388948
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,10538,34,1.11 [0.84-1.47],0.4476756334600584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP3R1,Calcineurin subunit B type 1,12020,39,1.17 [0.59-2.33],0.6527744859230096
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPT1,Palmitoyl-protein thioesterase 1,10316,33,1.04 [0.68-1.59],0.8596014602222588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPY,Pancreatic prohormone,12114,38,1.08 [0.82-1.42],0.6025065839527102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PQBP1,Polyglutamine-binding protein 1,11824,39,1.16 [0.76-1.76],0.4962313524954271
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRAME,Melanoma antigen preferentially expressed in tumors,10208,34,1.05 [0.29-3.80],0.9389746591186718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRAP1,Proline-rich acidic protein 1,10617,36,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRC1,Protein regulator of cytokinesis 1,10542,34,1.03 [0.53-2.00],0.9299440549656508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRCP,Lysosomal Pro-X carboxypeptidase,12185,39,1.12 [0.45-2.76],0.8092964894160082
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX1,Peroxiredoxin-1,11783,38,1.01 [0.72-1.42],0.9494031275707004
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX2,Peroxiredoxin-2,10424,33,1.20 [0.72-1.98],0.4814006497861598
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",11857,37,0.92 [0.60-1.39],0.6822494984067512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX5,"Peroxiredoxin-5, mitochondrial",12217,37,0.96 [0.62-1.49],0.8623003589007971
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX6,Peroxiredoxin-6,12195,37,1.16 [0.72-1.85],0.5490407587043842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PREB,Prolactin regulatory element-binding protein,11857,37,0.21 [0.07-0.64],0.0063922695053744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRELP,Prolargin,12105,40,0.66 [0.21-2.03],0.4629979365494833
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRG2,Bone marrow proteoglycan,10617,36,0.60 [0.32-1.13],0.1113491172656872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRG3,Proteoglycan 3,10617,36,0.55 [0.31-0.97],0.0386440877517692
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,11857,37,0.95 [0.54-1.67],0.8582480920475557
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,10316,33,0.94 [0.32-2.76],0.9141172476600782
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,12108,41,1.08 [0.78-1.50],0.6551080405740024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,10568,35,1.14 [0.77-1.69],0.5120094724754486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKCQ,Protein kinase C theta type,11857,37,0.96 [0.49-1.88],0.89593677450276
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKD2,Serine/threonine-protein kinase D2,10258,34,1.28 [0.75-2.19],0.3725801560283088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKG1,cGMP-dependent protein kinase 1,10388,35,0.98 [0.76-1.27],0.8889923083113358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,11824,39,1.04 [0.68-1.60],0.8499092270444797
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRL,Prolactin,12201,37,1.34 [0.93-1.91],0.1121374809122833
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRND,Prion-like protein doppel,10586,35,0.95 [0.52-1.73],0.8725436345247526
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PROC,Vitamin K-dependent protein C,12139,39,1.03 [0.31-3.35],0.9657652519670304
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PROCR,Endothelial protein C receptor,10258,34,0.73 [0.25-2.18],0.5748762347708758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PROK1,Prokineticin-1,12076,37,0.95 [0.57-1.58],0.8459458839840839
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PROS1,Vitamin K-dependent protein S,10623,35,0.76 [0.20-2.91],0.6906193227653613
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRR4,Proline-rich protein 4,10300,35,0.81 [0.49-1.33],0.40319166447953
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRR5,Proline-rich protein 5,10295,36,1.82 [1.23-2.70],0.002948502306254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRRT3,Proline-rich transmembrane protein 3,10348,34,0.75 [0.32-1.77],0.5052598143919346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS2,Trypsin-2,12165,39,1.19 [0.70-2.03],0.5144701114617543
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS22,Brain-specific serine protease 4,10295,36,0.90 [0.36-2.28],0.8287592550843806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS27,Serine protease 27,12076,41,1.45 [0.74-2.82],0.2795548498711636
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS53,Serine protease 53,10586,35,1.81 [0.78-4.21],0.1656566085736963
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS8,Prostasin,12068,39,0.86 [0.43-1.74],0.6749592343517001
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,11815,37,0.91 [0.70-1.19],0.5058891850022728
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRTG,Protogenin,12195,37,1.09 [0.34-3.45],0.889437406990436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRTN3,Myeloblastin,11796,38,1.40 [0.87-2.24],0.1626503756063262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRUNE2,Protein prune homolog 2,10425,33,0.97 [0.32-3.00],0.9630529933533414
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSAP,Prosaposin,10506,36,1.34 [0.53-3.40],0.536294250267811
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSAPL1,Proactivator polypeptide-like 1,10538,34,1.09 [0.57-2.07],0.8037730009297053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSCA,Prostate stem cell antigen,10538,34,0.96 [0.85-1.09],0.5440898276711508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSG1,Pregnancy-specific beta-1-glycoprotein 1,12020,39,1.09 [0.84-1.40],0.5194268265265215
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSIP1,PC4 and SFRS1-interacting protein,12076,37,1.28 [0.90-1.82],0.1766073802972567
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMA1,Proteasome subunit alpha type-1,11824,39,1.14 [0.63-2.04],0.6629426269695409
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMC3,26S proteasome regulatory subunit 6A,10208,34,0.65 [0.21-1.96],0.4397652528647249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMD1,26S proteasome non-ATPase regulatory subunit 1,10578,34,1.59 [0.96-2.65],0.0735312651143085
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMD5,26S proteasome non-ATPase regulatory subunit 5,10316,33,1.09 [0.63-1.89],0.7650677047651497
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMD9,26S proteasome non-ATPase regulatory subunit 9,12048,37,1.30 [0.80-2.10],0.2860723288069915
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSME1,Proteasome activator complex subunit 1,12002,39,1.01 [0.47-2.15],0.9864877779418024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSME2,Proteasome activator complex subunit 2,11961,39,1.54 [0.72-3.29],0.2629155075524901
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMG3,Proteasome assembly chaperone 3,12076,37,1.44 [0.84-2.44],0.1825133383862863
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMG4,Proteasome assembly chaperone 4,10295,36,1.41 [0.86-2.31],0.1767484449694398
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSPN,Persephin,12076,37,0.90 [0.66-1.22],0.491472578745306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSRC1,Proline/serine-rich coiled-coil protein 1,11824,39,1.13 [0.71-1.80],0.6097392470484095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,10022,34,0.98 [0.72-1.35],0.910221475535816
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",11815,37,0.72 [0.27-1.92],0.5162967970101305
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTGDS,Prostaglandin-H2 D-isomerase,12014,39,0.53 [0.19-1.48],0.2287320559815955
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTGES2,Prostaglandin E synthase 2,10207,36,1.22 [0.69-2.14],0.4955624563322411
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTGR1,Prostaglandin reductase 1,10600,35,1.22 [0.83-1.80],0.3040022053727369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTH,Parathyroid hormone,10316,33,1.11 [0.73-1.70],0.6117482817094961
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,12076,37,1.00 [0.47-2.12],0.9995733523804186
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTK7,Inactive tyrosine-protein kinase 7,11815,37,0.69 [0.31-1.50],0.3482233151591283
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTN,Pleiotrophin,11861,38,0.73 [0.40-1.34],0.3098132698546674
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTP4A3,Protein tyrosine phosphatase type IVA 3,10295,36,0.64 [0.31-1.34],0.238625686281209
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,12020,39,1.07 [0.75-1.54],0.6963445913834524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,12139,40,0.89 [0.66-1.21],0.4635967425398598
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,10277,36,1.22 [0.54-2.77],0.630235789824082
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRB,Receptor-type tyrosine-protein phosphatase beta,10600,35,0.65 [0.21-2.08],0.4708958689706293
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRC,Receptor-type tyrosine-protein phosphatase C,10617,36,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRF,Receptor-type tyrosine-protein phosphatase F,12247,40,0.50 [0.19-1.32],0.1608477486026454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRH,Receptor-type tyrosine-protein phosphatase H,10538,34,1.24 [0.64-2.44],0.5233616536837733
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,10538,34,0.43 [0.07-2.51],0.3464195853170492
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRM,Receptor-type tyrosine-protein phosphatase mu,12063,37,1.17 [0.35-3.89],0.7988865718367305
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,11988,39,0.51 [0.21-1.24],0.1393118286585687
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRR,Receptor-type tyrosine-protein phosphatase R,10586,35,0.72 [0.29-1.80],0.4827181623537061
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRS,Receptor-type tyrosine-protein phosphatase S,12247,40,0.69 [0.22-2.19],0.5302357169600793
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,10600,35,0.48 [0.17-1.33],0.1576627596848842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,10388,35,1.30 [0.76-2.22],0.3422259331015
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTS,6-pyruvoyl tetrahydrobiopterin synthase,11761,37,0.94 [0.55-1.60],0.8104220129480479
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTTG1,Securin,10425,33,1.40 [0.71-2.76],0.3271752551373589
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTX3,Pentraxin-related protein PTX3,12076,37,1.27 [0.66-2.44],0.4655903619564738
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PVALB,Parvalbumin alpha,12124,37,1.04 [0.80-1.36],0.7682789941161476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PVR,Poliovirus receptor,12201,37,1.73 [0.82-3.64],0.1514955905683057
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PXDNL,Peroxidasin-like protein,10542,34,0.92 [0.49-1.75],0.8045254935899584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PXN,Paxillin,11815,37,1.48 [0.97-2.26],0.072279311325077
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PYDC1,Pyrin domain-containing protein 1,10348,34,1.20 [0.58-2.48],0.6188067411973366
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PYY,Peptide YY,10258,34,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PZP,Pregnancy zone protein,10623,35,0.63 [0.36-1.10],0.1038992114776781
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",QDPR,Dihydropteridine reductase,12046,41,1.05 [0.56-1.99],0.8694420914586446
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",QPCT,Glutaminyl-peptide cyclotransferase,12136,39,0.84 [0.29-2.45],0.7511413736163319
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",QSOX1,Sulfhydryl oxidase 1,10415,35,0.90 [0.36-2.23],0.8212560204018797
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB10,Ras-related protein Rab-10,10600,35,1.04 [0.58-1.88],0.8928120443789466
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB11FIP3,Rab11 family-interacting protein 3,10600,35,0.96 [0.71-1.30],0.7938915602301865
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB27B,Ras-related protein Rab-27B,10600,35,0.95 [0.64-1.42],0.8119929357780885
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB2B,Ras-related protein Rab-2B,10542,34,1.13 [0.67-1.92],0.6381373832199436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB33A,Ras-related protein Rab-33A,10258,34,1.14 [0.69-1.86],0.6109110758125447
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB37,Ras-related protein Rab-37,11857,37,1.17 [0.86-1.59],0.3252127304289708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB39B,Ras-related protein Rab-39B,10258,34,1.17 [0.88-1.55],0.2682572976366001
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,10235,33,1.04 [0.58-1.86],0.8858899206939859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB44,Ras-related protein Rab-44,10542,34,1.52 [1.01-2.30],0.0444571571893718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB6A,Ras-related protein Rab-6A,12076,37,1.41 [0.83-2.39],0.1981786407225265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB6B,Ras-related protein Rab-6B,11815,37,1.03 [0.57-1.87],0.923366737827088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RABEP1,Rab GTPase-binding effector protein 1,10388,35,1.06 [0.70-1.61],0.7685142896067547
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RABEPK,Rab9 effector protein with kelch motifs,11824,39,1.37 [0.92-2.04],0.1218780301225442
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RABGAP1L,Rab GTPase-activating protein 1-like,11857,37,1.29 [0.82-2.02],0.2672146359910132
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAC3,Ras-related C3 botulinum toxin substrate 3,10316,33,0.76 [0.40-1.42],0.3893546089802976
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAD23B,UV excision repair protein RAD23 homolog B,11824,39,0.69 [0.36-1.32],0.2633426964937377
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAD51,DNA repair protein RAD51 homolog 1,10425,33,1.13 [0.67-1.91],0.6587845286293725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RALB,Ras-related protein Ral-B,10295,36,1.41 [0.54-3.65],0.4836619496684564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RALY,RNA-binding protein Raly,10542,34,1.39 [0.85-2.27],0.1850412990966774
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RANBP1,Ran-specific GTPase-activating protein,10348,34,1.53 [0.84-2.80],0.1615948292370341
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RANBP2,E3 SUMO-protein ligase RanBP2,10235,33,2.14 [0.95-4.82],0.0652091085300429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RANGAP1,Ran GTPase-activating protein 1,11824,39,1.29 [0.80-2.08],0.2960114205659974
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAP1A,Ras-related protein Rap-1A,10295,36,0.56 [0.28-1.12],0.1018345036593027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAPGEF2,Rap guanine nucleotide exchange factor 2,10425,33,1.38 [0.80-2.38],0.2444082103326581
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RARRES1,Retinoic acid receptor responder protein 1,11824,39,0.80 [0.31-2.05],0.6437000289936345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RARRES2,Retinoic acid receptor responder protein 2,12181,39,0.98 [0.53-1.82],0.950335120460444
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RASA1,Ras GTPase-activating protein 1,11815,37,0.62 [0.25-1.56],0.3072306323454348
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,10208,34,0.94 [0.45-1.94],0.8603169956883857
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RASSF2,Ras association domain-containing protein 2,11824,39,1.38 [0.97-1.96],0.0712207932339388
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBFOX3,RNA binding protein fox-1 homolog 3,10578,34,0.59 [0.22-1.57],0.2937691555595872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBKS,Ribokinase,11836,38,1.31 [0.75-2.28],0.3462304779963696
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBM17,Splicing factor 45,10578,34,0.89 [0.57-1.38],0.5951892870230939
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBM19,Probable RNA-binding protein 19,10258,34,1.17 [0.64-2.16],0.6084972206990332
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBM25,RNA-binding protein 25,10208,34,0.67 [0.31-1.43],0.2987647128797979
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBP1,Retinol-binding protein 1,10316,33,0.73 [0.38-1.40],0.3474521129894629
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBP2,Retinol-binding protein 2,12048,37,0.73 [0.48-1.11],0.1382370279430889
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBP5,Retinol-binding protein 5,12048,37,1.31 [0.80-2.15],0.2852180154748112
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBP7,Retinoid-binding protein 7,10538,34,1.16 [0.70-1.91],0.56607383689974
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBPMS,RNA-binding protein with multiple splicing,10295,36,1.03 [0.65-1.63],0.9047901273200628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBPMS2,RNA-binding protein with multiple splicing 2,10348,34,1.07 [0.78-1.47],0.6854284639221389
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RCC1,Regulator of chromosome condensation,10542,34,1.14 [0.68-1.93],0.6164518126847548
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RCOR1,REST corepressor 1,11861,38,1.31 [0.86-2.00],0.2059979143256912
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,10348,34,2.23 [0.43-11.59],0.341574446354295
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REEP4,Receptor expression-enhancing protein 4,10578,34,1.13 [0.68-1.89],0.6308388216566608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG1A,Lithostathine-1-alpha,12030,38,0.95 [0.53-1.71],0.8673648173712787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG1B,Lithostathine-1-beta,12247,40,1.01 [0.62-1.65],0.9536362613257144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG3A,Regenerating islet-derived protein 3-alpha,12247,40,0.83 [0.52-1.32],0.4210665148444368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG3G,Regenerating islet-derived protein 3-gamma,10542,34,1.74 [0.91-3.32],0.0913821580756085
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG4,Regenerating islet-derived protein 4,12125,40,0.90 [0.50-1.62],0.7309770841803547
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RELB,Transcription factor RelB,10295,36,1.34 [0.82-2.20],0.2390031985558258
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RELT,Tumor necrosis factor receptor superfamily member 19L,12112,38,0.51 [0.17-1.54],0.233910262019818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REN,Renin,12108,41,1.32 [0.97-1.80],0.0790001876094079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REPS1,RalBP1-associated Eps domain-containing protein 1,10295,36,1.16 [0.53-2.51],0.7112471335930779
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REST,RE1-silencing transcription factor,10208,34,1.10 [0.44-2.75],0.8456483522865432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,12048,37,0.56 [0.27-1.16],0.1206421025958931
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RETN,Resistin,12089,39,0.93 [0.47-1.85],0.8370672014956042
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REXO2,"Oligoribonuclease, mitochondrial",10258,34,1.20 [0.70-2.06],0.4994037683893854
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RFC4,Replication factor C subunit 4,10542,34,3.95 [1.45-10.80],0.0073813489426048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGCC,Regulator of cell cycle RGCC,10578,34,0.88 [0.57-1.36],0.5588142564275552
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,10425,33,1.31 [0.89-1.93],0.1648323007867689
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGMA,Repulsive guidance molecule A,12201,37,0.79 [0.31-2.02],0.6210899182892953
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGMB,RGM domain family member B,12201,37,0.70 [0.23-2.17],0.536240035994114
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGS10,Regulator of G-protein signaling 10,10578,34,1.03 [0.60-1.77],0.920122449654169
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGS8,Regulator of G-protein signaling 8,11857,37,0.89 [0.53-1.49],0.6545965675353749
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RHOC,Rho-related GTP-binding protein RhoC,11946,38,0.97 [0.75-1.24],0.789803923100108
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RICTOR,Rapamycin-insensitive companion of mTOR,10295,36,0.67 [0.36-1.22],0.1872433637018008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,10388,35,1.00 [0.52-1.94],0.9977539521485428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RILP,Rab-interacting lysosomal protein,12148,37,1.20 [0.74-1.94],0.4679371663000853
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RILPL2,RILP-like protein 2,10600,35,0.98 [0.70-1.37],0.904767722492363
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,10258,34,1.21 [0.83-1.76],0.3305564828055914
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RLN1,Prorelaxin H1,10578,34,0.49 [0.14-1.74],0.2729429703682581
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RLN2,Prorelaxin H2,10364,34,1.07 [0.54-2.15],0.8388137204747946
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE1,Ribonuclease pancreatic,10602,33,0.54 [0.13-2.19],0.390046040956204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE10,Inactive ribonuclease-like protein 10,10348,34,0.72 [0.35-1.47],0.3647638213131199
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE3,Eosinophil cationic protein,12055,41,1.16 [0.94-1.43],0.1772786828144315
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE4,Ribonuclease 4,10236,33,0.77 [0.23-2.53],0.6637265000574515
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE6,Ribonuclease K6,10520,33,0.65 [0.20-2.12],0.4738291390207066
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASEH2A,Ribonuclease H2 subunit A,10578,34,1.12 [0.61-2.08],0.7139919399337825
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASET2,Ribonuclease T2,12199,39,1.52 [0.58-3.98],0.3957676989834768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF149,E3 ubiquitin-protein ligase RNF149,10348,34,0.55 [0.18-1.61],0.2739561068447883
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF168,E3 ubiquitin-protein ligase RNF168,10295,36,1.72 [1.06-2.79],0.0281595504187322
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF31,E3 ubiquitin-protein ligase RNF31,10295,36,1.31 [0.63-2.72],0.4722989352765464
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF4,E3 ubiquitin-protein ligase RNF4,10425,33,0.40 [0.19-0.86],0.0186286301155611
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF41,E3 ubiquitin-protein ligase NRDP1,11824,39,1.22 [0.81-1.83],0.3452987287264969
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF43,E3 ubiquitin-protein ligase RNF43,10425,33,1.00 [0.56-1.78],0.9980556331451876
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF5,E3 ubiquitin-protein ligase RNF5,10348,34,1.06 [0.66-1.70],0.8012324176574377
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ROBO1,Roundabout homolog 1,12125,40,0.56 [0.17-1.82],0.3328866227008568
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ROBO2,Roundabout homolog 2,12201,37,0.97 [0.27-3.41],0.9558616350688036
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ROBO4,Roundabout homolog 4,10348,34,0.57 [0.09-3.70],0.5582801791991546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,12108,41,0.47 [0.19-1.14],0.0942775306460137
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RP2,Protein XRP2,12048,37,1.50 [0.79-2.83],0.2160071813513575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPA2,Replication protein A 32 kDa subunit,10295,36,1.02 [0.36-2.92],0.9644155889220088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPE,Ribulose-phosphate 3-epimerase,10425,33,0.86 [0.52-1.43],0.5663730617497394
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPGR,X-linked retinitis pigmentosa GTPase regulator,10316,33,1.23 [0.64-2.38],0.5361580509171515
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPL14,60S ribosomal protein L14,10348,34,1.98 [1.17-3.35],0.0107461710271029
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPS10,40S ribosomal protein S10,10258,34,1.44 [0.77-2.68],0.2528246351561598
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RRAS,Ras-related protein R-Ras,10316,33,1.04 [0.80-1.34],0.7776076220689929
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RRM2,Ribonucleoside-diphosphate reductase subunit M2,11824,39,0.66 [0.32-1.33],0.2422037764182577
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,11824,39,0.93 [0.61-1.44],0.7601056825697168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RRP15,RRP15-like protein,10235,33,1.02 [0.71-1.47],0.9088832210539808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RSPO1,R-spondin-1,12020,39,0.72 [0.30-1.70],0.452765491622309
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RSPO3,R-spondin-3,12195,37,0.81 [0.29-2.29],0.6902815162668929
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RTBDN,Retbindin,12048,37,0.72 [0.26-2.02],0.5307371372491253
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RTKN2,Rhotekin-2,10258,34,1.31 [0.80-2.14],0.2856476219724133
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",10578,34,1.04 [0.73-1.49],0.8189527712729667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RTN4R,Reticulon-4 receptor,12195,37,0.48 [0.20-1.14],0.0963711419785454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RUVBL1,RuvB-like 1,11824,39,1.06 [0.82-1.35],0.6709191742366667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RWDD1,RWD domain-containing protein 1,12201,37,1.02 [0.65-1.62],0.9229932335537988
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RYR1,Ryanodine receptor 1,10258,34,1.28 [0.61-2.69],0.51704268538929
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A11,Protein S100-A11,12016,41,1.38 [0.90-2.13],0.1433984016663649
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A12,Protein S100-A12,11932,37,1.24 [0.86-1.78],0.2557092579620074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A13,Protein S100-A13,10295,36,0.99 [0.40-2.43],0.9743887793231528
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A14,Protein S100-A14,10578,34,1.09 [0.61-1.94],0.776589869784527
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A16,Protein S100-A16,11799,37,0.78 [0.47-1.31],0.3491781899020291
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A3,Protein S100-A3,10542,34,0.37 [0.10-1.34],0.1292528174975599
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A4,Protein S100-A4,12159,39,0.86 [0.53-1.42],0.5645704725921181
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100G,Protein S100-G,10578,34,0.71 [0.32-1.61],0.4168980542318964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100P,Protein S100-P,11861,38,1.31 [0.87-1.98],0.2023980876340151
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAA4,Serum amyloid A-4 protein,10623,35,0.88 [0.24-3.23],0.8459653497748352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAFB2,Scaffold attachment factor B2,10578,34,2.48 [1.41-4.38],0.0016840443656915
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAG,S-arrestin,10235,33,0.81 [0.40-1.63],0.5512092732019942
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAMD9L,Sterile alpha motif domain-containing protein 9-like,12076,37,1.04 [0.70-1.55],0.8472356810155123
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAP18,Histone deacetylase complex subunit SAP18,10425,33,0.76 [0.44-1.31],0.3181707003223804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SARG,Specifically androgen-regulated gene protein,10551,35,1.07 [0.79-1.46],0.6426440192198963
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SART1,U4/U6.U5 tri-snRNP-associated protein 1,10258,34,1.30 [0.67-2.51],0.4344026323221475
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAT1,Diamine acetyltransferase 1,10258,34,1.39 [0.87-2.24],0.1708678144936409
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAT2,Thialysine N-epsilon-acetyltransferase,10425,33,0.97 [0.59-1.60],0.9132494749684874
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SATB1,DNA-binding protein SATB1,10578,34,1.60 [0.69-3.72],0.2732351133090466
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SBSN,Suprabasin,10597,36,0.74 [0.29-1.94],0.5446398007433421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCAMP3,Secretory carrier-associated membrane protein 3,12048,37,1.06 [0.76-1.48],0.7426181987473842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARA5,Scavenger receptor class A member 5,12201,37,0.68 [0.24-1.89],0.4595571545482816
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARB1,Scavenger receptor class B member 1,11815,37,1.31 [0.93-1.84],0.1247053005413403
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARB2,Lysosome membrane protein 2,11805,38,0.76 [0.29-1.96],0.5637173592414664
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARF1,Scavenger receptor class F member 1,12247,40,1.00 [0.51-1.95],0.9962821703994692
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARF2,Scavenger receptor class F member 2,12201,37,0.68 [0.27-1.75],0.4281686352690532
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCG2,Secretogranin-2,12126,36,0.75 [0.30-1.88],0.5407432750534753
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCG3,Secretogranin-3,12125,40,0.87 [0.38-1.96],0.7303877326527096
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGB1A1,Uteroglobin,12112,40,1.26 [0.75-2.12],0.3860982039476972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGB2A2,Mammaglobin-A,10258,34,1.38 [0.60-3.20],0.4523942563709654
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGB3A1,Secretoglobin family 3A member 1,10388,35,0.63 [0.18-2.19],0.4707227858059712
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGB3A2,Secretoglobin family 3A member 2,12139,40,0.86 [0.61-1.23],0.4171797029287395
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGN,Secretagogin,11857,37,0.88 [0.45-1.72],0.7024837817758218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCIN,Adseverin,10235,33,0.84 [0.51-1.40],0.5054477176299482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCLY,Selenocysteine lyase,12148,37,1.12 [0.61-2.05],0.7131617895670119
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN2A,Sodium channel protein type 2 subunit alpha,10235,33,1.07 [0.56-2.07],0.8291795462679952
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN2B,Sodium channel subunit beta-2,10316,33,1.48 [0.61-3.56],0.3823047575248114
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN3A,Sodium channel protein type 3 subunit alpha,10316,33,1.45 [0.71-2.94],0.3073297595251848
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN3B,Sodium channel subunit beta-3,10235,33,1.02 [0.50-2.08],0.9658980095581556
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN4B,Sodium channel subunit beta-4,10348,34,0.95 [0.43-2.10],0.9041647616622266
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCP2,Non-specific lipid-transfer protein,11824,39,1.14 [0.82-1.59],0.4417752992110446
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCPEP1,Retinoid-inducible serine carboxypeptidase,10302,34,0.92 [0.46-1.83],0.8097222419861488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCRG1,Scrapie-responsive protein 1,10600,35,0.36 [0.11-1.24],0.1061259258177893
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCRIB,Protein scribble homolog,10348,34,1.18 [0.87-1.61],0.2841086296055948
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCRN1,Secernin-1,12076,37,1.03 [0.61-1.74],0.9028348496829628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCT,Secretin,10316,33,1.23 [0.62-2.44],0.5463984710821652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDC1,Syndecan-1,12108,41,0.92 [0.45-1.91],0.8317499318028516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDC4,Syndecan-4,12108,41,0.94 [0.51-1.71],0.8272407163035861
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDCCAG8,Serologically defined colon cancer antigen 8,10542,34,1.13 [0.84-1.51],0.4152669525248575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDHB,Succinate dehydrogenase,10538,34,0.73 [0.42-1.28],0.2716517510361771
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDK2,Protein sidekick-2,10388,35,0.79 [0.32-1.94],0.6120883621879796
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEC31A,Protein transport protein Sec31A,10348,34,0.99 [0.64-1.53],0.963398881528234
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEL1L,Protein sel-1 homolog 1,10348,34,1.01 [0.37-2.72],0.9849774414666846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELE,E-selectin,12247,40,0.57 [0.34-0.98],0.0403606441214563
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELENOP,Selenoprotein P,10623,35,1.39 [0.36-5.36],0.6342512385687415
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELL,L-selectin,10623,35,0.25 [0.08-0.83],0.0237202118783463
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELP,P-selectin,12165,39,0.87 [0.53-1.43],0.5722191513962053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELPLG,P-selectin glycoprotein ligand 1,12076,37,1.23 [0.39-3.85],0.7220628107590756
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA3F,Semaphorin-3F,12108,41,0.50 [0.17-1.48],0.2091654895933472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA3G,Semaphorin-3G,10388,35,1.11 [0.52-2.33],0.7923435950810613
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA4C,Semaphorin-4C,12048,37,1.58 [0.72-3.46],0.2551789526722849
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA4D,Semaphorin-4D,12201,37,0.55 [0.21-1.45],0.2275051582606767
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA6C,Semaphorin-6C,10295,36,1.45 [0.48-4.40],0.5086683408831529
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA7A,Semaphorin-7A,12214,40,1.41 [0.55-3.60],0.4724633947672352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEPTIN3,Neuronal-specific septin-3,10578,34,0.70 [0.43-1.14],0.1523167506259503
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEPTIN7,Septin-7,10425,33,1.08 [0.63-1.84],0.7897921120633358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEPTIN8,Septin-8,10572,35,1.64 [0.79-3.40],0.1846263638294458
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEPTIN9,Septin-9,12048,37,1.98 [0.94-4.17],0.0715990379225394
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA1,Alpha-1-antitrypsin,10411,35,5.48 [0.11-281.48],0.3970166952166643
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA11,Serpin A11,12247,40,1.24 [0.62-2.50],0.5469196339396152
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA12,Serpin A12,11730,40,1.16 [0.92-1.46],0.1980512073317745
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA3,Alpha-1-antichymotrypsin,10570,35,1.63 [0.20-13.15],0.645749188707867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA4,Kallistatin,10428,35,0.99 [0.26-3.80],0.9837228236422612
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA5,Plasma serine protease inhibitor,10469,35,0.39 [0.12-1.23],0.1079459962659573
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA6,Corticosteroid-binding globulin,10623,35,0.62 [0.08-4.74],0.6446840165108016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA7,Thyroxine-binding globulin,10623,35,0.24 [0.04-1.40],0.1134657402301384
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA9,Serpin A9,11986,36,0.64 [0.41-1.00],0.0504530619452322
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB1,Leukocyte elastase inhibitor,12071,38,1.09 [0.79-1.49],0.6097095263632841
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB5,Serpin B5,11861,38,1.16 [0.65-2.10],0.6147348264931596
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB6,Serpin B6,12165,37,1.13 [0.69-1.85],0.6311220880011733
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB8,Serpin B8,12217,37,1.41 [1.01-1.97],0.0453717439907545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB9,Serpin B9,12020,39,1.40 [0.61-3.19],0.4249899931895703
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINC1,Antithrombin-III,10602,35,0.33 [0.04-2.81],0.3124219187839371
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPIND1,Heparin cofactor 2,10602,35,1.52 [0.45-5.09],0.4980339435557994
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINE1,Plasminogen activator inhibitor 1,12247,40,0.89 [0.59-1.35],0.5781271357500501
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINE2,Glia-derived nexin,10600,35,1.00 [0.61-1.65],0.9996963751538532
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINF1,Pigment epithelium-derived factor,10461,35,0.49 [0.14-1.68],0.2554670168361806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINF2,Alpha-2-antiplasmin,10423,35,0.52 [0.05-5.63],0.5902757338644233
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPING1,Plasma protease C1 inhibitor,10602,35,0.56 [0.09-3.32],0.5234143797765669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINH1,Serpin H1,10425,33,0.94 [0.72-1.21],0.6225958245092641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINI1,Neuroserpin,10372,35,0.79 [0.27-2.32],0.663394623497811
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINI2,Serpin I2,10538,34,1.28 [0.72-2.25],0.3971904535069964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,11815,37,1.34 [0.89-2.02],0.1625642860365517
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SETMAR,Histone-lysine N-methyltransferase SETMAR,11983,39,1.72 [0.74-3.97],0.2073479109038071
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEZ6,Seizure protein 6 homolog,10316,33,1.40 [0.52-3.79],0.505594800795758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEZ6L,Seizure 6-like protein,12159,39,0.57 [0.20-1.63],0.2952539388940252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEZ6L2,Seizure 6-like protein 2,12048,37,1.48 [0.44-5.00],0.5260141158234615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SF3B4,Splicing factor 3B subunit 4,12048,37,1.08 [0.73-1.59],0.7124582513720481
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFRP1,Secreted frizzled-related protein 1,11994,39,1.04 [0.55-1.97],0.9037551777323408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFRP4,Secreted frizzled-related protein 4,10388,35,0.56 [0.25-1.27],0.1640671410795859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFTPA1,Pulmonary surfactant-associated protein A1,11824,39,1.33 [0.95-1.88],0.0980243140741522
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFTPA2,Pulmonary surfactant-associated protein A2,11824,39,0.92 [0.52-1.63],0.7686149408817097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFTPD,Pulmonary surfactant-associated protein D,12108,41,0.62 [0.40-0.94],0.0246787813037683
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SGSH,N-sulphoglucosamine sulphohydrolase,10393,35,1.46 [0.94-2.27],0.0893461675395566
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH2B3,SH2B adapter protein 3,11824,39,0.86 [0.64-1.16],0.3203751410476777
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH2D1A,SH2 domain-containing protein 1A,12076,37,1.34 [0.90-1.98],0.1438825444486641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,10235,33,0.61 [0.28-1.31],0.2076373849437547
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH3BP1,SH3 domain-binding protein 1,10538,34,1.08 [0.57-2.06],0.8166571466468964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH3GL3,Endophilin-A3,10372,33,0.80 [0.54-1.17],0.2430363718241837
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH3GLB2,Endophilin-B2,10586,35,1.47 [0.91-2.36],0.1130061057607944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHBG,Sex hormone-binding globulin,10602,33,0.71 [0.40-1.27],0.2494994772192624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHC1,SHC-transforming protein 1,10208,34,0.86 [0.63-1.17],0.3438703677650007
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHD,SH2 domain-containing adapter protein D,10230,34,1.03 [0.72-1.47],0.8729326040940573
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHH,Sonic hedgehog protein,10295,36,0.43 [0.19-0.98],0.0457094558209396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHISA5,Protein shisa-5,10617,36,0.31 [0.08-1.22],0.0938330100203563
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHMT1,"Serine hydroxymethyltransferase, cytosolic",12139,40,0.96 [0.70-1.33],0.8265108571282994
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHPK,Sedoheptulokinase,10425,33,1.21 [0.60-2.46],0.5903525779052808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIAE,Sialate O-acetylesterase,12140,39,1.03 [0.56-1.89],0.9348965159114178
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC1,Sialoadhesin,12162,40,0.62 [0.36-1.07],0.0846144775765875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC10,Sialic acid-binding Ig-like lectin 10,12076,37,0.69 [0.29-1.66],0.4096730219371953
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC15,Sialic acid-binding Ig-like lectin 15,11815,37,0.73 [0.45-1.20],0.2208440747273506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC5,Sialic acid-binding Ig-like lectin 5,12112,38,1.11 [0.84-1.46],0.4682492414133913
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC6,Sialic acid-binding Ig-like lectin 6,12195,37,0.36 [0.16-0.82],0.0148362923853165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC7,Sialic acid-binding Ig-like lectin 7,12108,41,1.04 [0.37-2.88],0.9428261523487802
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC8,Sialic acid-binding Ig-like lectin 8,10348,34,0.80 [0.38-1.70],0.5671585270130413
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC9,Sialic acid-binding Ig-like lectin 9,12174,37,1.20 [0.44-3.28],0.7237065023655395
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIL1,Nucleotide exchange factor SIL1,10348,34,1.61 [0.87-3.01],0.1318079133349351
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,12140,40,0.94 [0.58-1.53],0.814192357328619
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRPB1,Signal-regulatory protein beta-1,12094,40,0.84 [0.46-1.55],0.5764572147388944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRT1,NAD-dependent protein deacetylase sirtuin-1,10295,36,1.21 [0.92-1.60],0.1739259418803393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRT2,NAD-dependent protein deacetylase sirtuin-2,12048,37,0.96 [0.69-1.34],0.8257517231694447
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",11815,37,0.82 [0.45-1.50],0.5151104493381733
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIT1,Signaling threshold-regulating transmembrane adapter 1,11857,37,0.55 [0.32-0.95],0.03170430283669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SKAP1,Src kinase-associated phosphoprotein 1,11999,39,0.91 [0.61-1.35],0.6450475963638398
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SKAP2,Src kinase-associated phosphoprotein 2,12162,40,0.98 [0.75-1.29],0.9085001130305694
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SKIV2L,Helicase SKI2W,10258,34,1.71 [0.96-3.03],0.0690451240560184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLA2,Src-like-adapter 2,10578,34,0.99 [0.72-1.37],0.9626193753589766
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLAMF1,Signaling lymphocytic activation molecule,11857,37,1.05 [0.64-1.73],0.8488108548099806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLAMF6,SLAM family member 6,11824,39,0.80 [0.37-1.74],0.5746433795254384
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLAMF7,SLAM family member 7,12076,37,0.79 [0.47-1.31],0.3582530030521345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLAMF8,SLAM family member 8,11824,39,0.70 [0.42-1.15],0.1625570300999007
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC12A2,Solute carrier family 12 member 2,10258,34,1.25 [0.54-2.91],0.6050779826866659
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC13A1,Solute carrier family 13 member 1,10542,34,0.94 [0.51-1.71],0.8335548767433576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC16A1,Monocarboxylate transporter 1,11815,37,1.27 [0.85-1.88],0.2432483995225978
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC1A4,Neutral amino acid transporter A,10316,33,1.30 [0.79-2.14],0.293632561587054
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC27A4,Long-chain fatty acid transport protein 4,11815,37,1.00 [0.64-1.58],0.9829695425051622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC28A1,Sodium/nucleoside cotransporter 1,10208,34,1.04 [0.61-1.75],0.8932627319953447
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC34A3,Sodium-dependent phosphate transport protein 2C,10208,34,0.78 [0.36-1.70],0.5364254369347188
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC39A14,Zinc transporter ZIP14,11815,37,0.72 [0.28-1.82],0.488075454149679
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC39A5,Zinc transporter ZIP5,12076,37,0.51 [0.29-0.90],0.0188577803603017
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC44A4,Choline transporter-like protein 4,10316,33,0.81 [0.45-1.46],0.4843786836356665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC4A1,Band 3 anion transport protein,10617,36,1.04 [0.53-2.04],0.9132476900793528
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC51B,Organic solute transporter subunit beta,10258,34,1.30 [0.91-1.87],0.1456291153564513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,10388,35,1.06 [0.72-1.56],0.7596167904464519
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,10538,34,0.82 [0.39-1.76],0.6175084106656517
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",10208,34,1.05 [0.61-1.82],0.8497640013792112
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLIT2,Slit homolog 2 protein,11815,37,1.36 [0.87-2.13],0.1739711497652025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLITRK1,SLIT and NTRK-like protein 1,10295,36,0.88 [0.32-2.44],0.8015409595532925
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLITRK2,SLIT and NTRK-like protein 2,12195,37,0.67 [0.31-1.43],0.2992581371341432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLITRK6,SLIT and NTRK-like protein 6,11861,38,0.51 [0.22-1.22],0.1292999444638451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLK,STE20-like serine/threonine-protein kinase,10425,33,1.22 [0.91-1.63],0.1941098081043952
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLMAP,Sarcolemmal membrane-associated protein,10538,34,0.89 [0.59-1.33],0.5616004913417421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLURP1,Secreted Ly-6/uPAR-related protein 1,10536,36,1.28 [0.63-2.60],0.4971110899775723
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMAD1,Mothers against decapentaplegic homolog 1,11824,39,0.79 [0.55-1.14],0.2165740972973135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMAD2,Mothers against decapentaplegic homolog 2,10542,34,1.29 [0.83-2.03],0.2601313675135179
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMAD3,Mothers against decapentaplegic homolog 3,10542,34,1.31 [0.72-2.40],0.3764605281610927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMAD5,Mothers against decapentaplegic homolog 5,12048,37,1.60 [0.36-7.03],0.5363542661532886
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMARCA2,Probable global transcription activator SNF2L2,11815,37,0.95 [0.62-1.44],0.7972581892730861
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMC3,Structural maintenance of chromosomes protein 3,10208,34,0.54 [0.26-1.13],0.1011471803746292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMNDC1,Survival of motor neuron-related-splicing factor 30,10538,34,1.47 [1.06-2.05],0.0209663633716953
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMOC1,SPARC-related modular calcium-binding protein 1,12195,37,0.47 [0.20-1.13],0.0932961211046922
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMOC2,SPARC-related modular calcium-binding protein 2,12162,40,0.96 [0.45-2.05],0.9200575475081836
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMPD1,Sphingomyelin phosphodiesterase,12143,37,1.45 [0.80-2.62],0.2224490474981331
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMPD3,Sphingomyelin phosphodiesterase 3,10295,36,1.27 [0.83-1.94],0.2662031332674406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,12151,40,1.04 [0.67-1.63],0.8545184895484732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,10542,34,0.80 [0.46-1.39],0.4247215918732406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMS,Spermine synthase,10235,33,1.17 [0.75-1.84],0.49330208464343
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMTN,Smoothelin,10574,35,1.11 [0.81-1.54],0.5133849209081343
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNAP23,Synaptosomal-associated protein 23,12108,41,1.04 [0.75-1.44],0.8257485023935476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNAP25,Synaptosomal-associated protein 25,10235,33,0.98 [0.48-2.01],0.9595200008911746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNAP29,Synaptosomal-associated protein 29,12159,39,0.90 [0.66-1.23],0.5140418309269157
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNAPIN,SNARE-associated protein Snapin,10578,34,0.92 [0.51-1.64],0.774202154056021
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNCA,Alpha-synuclein,10388,35,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNCG,Gamma-synuclein,12020,39,0.78 [0.52-1.17],0.2291679492894011
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",10348,34,0.74 [0.26-2.09],0.5709959535826903
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNRPB2,U2 small nuclear ribonucleoprotein B'',10586,35,1.70 [1.26-2.29],0.0004931603530174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNU13,NHP2-like protein 1,10258,34,1.54 [1.14-2.09],0.0048036584688218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX15,Sorting nexin-15,10388,35,1.02 [0.56-1.86],0.9386521891652512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX18,Sorting nexin-18,10538,34,1.53 [0.86-2.72],0.1463330513709306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX2,Sorting nexin-2,10542,34,0.90 [0.59-1.39],0.6404784583851983
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX5,Sorting nexin-5,10348,34,2.29 [1.01-5.18],0.0470358962451874
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX9,Sorting nexin-9,12108,41,1.12 [0.76-1.67],0.5663918376336594
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOD1,Superoxide dismutase [Cu-Zn],11888,39,1.42 [0.82-2.47],0.2099846080599311
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOD2,"Superoxide dismutase [Mn], mitochondrial",12112,38,1.28 [0.62-2.62],0.5030070035561629
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOD3,Extracellular superoxide dismutase,10602,33,0.78 [0.37-1.68],0.5320593772633244
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SORBS1,Sorbin and SH3 domain-containing protein 1,10578,34,0.67 [0.24-1.84],0.4364971387466292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SORCS2,VPS10 domain-containing receptor SorCS2,11824,39,0.64 [0.29-1.41],0.2694244648077415
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SORD,Sorbitol dehydrogenase,12135,37,1.33 [0.85-2.08],0.2052711292938162
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SORT1,Sortilin,12085,41,0.87 [0.40-1.88],0.7234479808008771
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOST,Sclerostin,12085,41,1.23 [0.60-2.53],0.5692539491353038
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,10316,33,1.16 [0.66-2.01],0.6073648641823346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOX2,Transcription factor SOX-2,10556,34,1.14 [0.28-4.70],0.8517575255330155
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOX9,Transcription factor SOX-9,10316,33,1.55 [0.45-5.35],0.4838567078274185
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,10578,34,1.98 [0.88-4.47],0.1011226890649299
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPAG1,Sperm-associated antigen 1,10578,34,1.67 [1.18-2.35],0.0036214068528048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPARC,SPARC,12159,39,0.81 [0.56-1.19],0.290189105818792
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPARCL1,SPARC-like protein 1,12125,39,0.85 [0.30-2.40],0.7627528577674711
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPART,Spartin,10388,35,1.10 [0.72-1.67],0.6701752681623364
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPESP1,Sperm equatorial segment protein 1,10600,35,1.29 [0.43-3.86],0.6428474595859625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK1,Serine protease inhibitor Kazal-type 1,12112,38,0.92 [0.47-1.81],0.8088541745312982
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK2,Serine protease inhibitor Kazal-type 2,10388,35,0.85 [0.35-2.05],0.7101459545721609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK4,Serine protease inhibitor Kazal-type 4,12076,37,1.01 [0.66-1.56],0.955870828840794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK5,Serine protease inhibitor Kazal-type 5,12112,38,1.47 [0.61-3.54],0.3909232886909367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK6,Serine protease inhibitor Kazal-type 6,12195,37,0.88 [0.52-1.52],0.6578263871798347
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK8,Serine protease inhibitor Kazal-type 8,10258,34,0.85 [0.33-2.21],0.7405398221814579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINT1,Kunitz-type protease inhibitor 1,12082,38,0.76 [0.23-2.51],0.6516343337917287
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINT2,Kunitz-type protease inhibitor 2,12162,40,0.76 [0.41-1.42],0.3899679321692172
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINT3,Kunitz-type protease inhibitor 3,10538,34,1.01 [0.78-1.31],0.9352713538840284
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPOCK1,Testican-1,12020,39,1.52 [0.51-4.58],0.453124717337966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPON1,Spondin-1,12125,40,0.66 [0.27-1.61],0.3613462769633677
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPON2,Spondin-2,12050,41,0.89 [0.40-2.00],0.7857852476343747
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPP1,Osteopontin,12233,40,0.77 [0.44-1.36],0.3742616709577623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",10295,36,1.39 [0.76-2.57],0.2880337651092481
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRING1,SREBP regulating gene protein,10208,34,0.57 [0.26-1.27],0.1694660412953295
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRR1B,Cornifin-B,10425,33,0.85 [0.53-1.38],0.5228680369783539
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRR3,Small proline-rich protein 3,10586,35,1.51 [1.00-2.27],0.0493496605789105
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRY2,Protein sprouty homolog 2,11857,37,0.96 [0.70-1.32],0.806942984231004
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",10235,33,0.85 [0.29-2.52],0.7714404266738983
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPTLC1,Serine palmitoyltransferase 1,10586,35,1.87 [1.17-2.98],0.0084057150445027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRC,Proto-oncogene tyrosine-protein kinase Src,12136,39,0.94 [0.74-1.19],0.6158102046987326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRP14,Signal recognition particle 14 kDa protein,12048,37,1.60 [1.07-2.39],0.0220291369024601
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRPK2,SRSF protein kinase 2,12076,37,1.08 [0.77-1.52],0.6361735821827998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRPX,Sushi repeat-containing protein SRPX,10600,35,1.68 [0.64-4.39],0.289745832821954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSB,Lupus La protein,11815,37,1.13 [0.71-1.80],0.6002598954209295
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",10295,36,0.84 [0.32-2.18],0.7163658380208036
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,12085,41,0.80 [0.60-1.05],0.110518524658434
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,12165,39,1.09 [0.55-2.17],0.7973415751781653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSH3,Protein phosphatase Slingshot homolog 3,10208,34,2.20 [0.97-4.96],0.0578642506242638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSNA1,Sjoegren syndrome nuclear autoantigen 1,10538,34,1.66 [0.95-2.90],0.076185566133812
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST13,Hsc70-interacting protein,10388,35,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",12048,37,1.62 [0.94-2.80],0.0818708312999886
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",12247,40,1.37 [0.53-3.50],0.5164357304265459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",10295,36,1.63 [1.10-2.42],0.0158292791621438
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAB2,Stabilin-2,10617,36,0.38 [0.17-0.86],0.0205533066514971
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAM,Signal transducing adapter molecule 1,10542,34,0.66 [0.25-1.75],0.4031466897720368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAMBP,STAM-binding protein,11999,39,1.02 [0.65-1.60],0.9281010668407644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAT2,Signal transducer and activator of transcription 2,10295,36,1.10 [0.72-1.67],0.6688036921624612
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAT5B,Signal transducer and activator of transcription 5B,12048,37,0.96 [0.78-1.19],0.7329741306103998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,10208,34,1.00 [0.60-1.65],0.9944287495094848
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STC1,Stanniocalcin-1,12201,37,0.58 [0.27-1.25],0.1643284996736769
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STC2,Stanniocalcin-2,12097,38,0.77 [0.26-2.29],0.6330284064041155
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STEAP4,Metalloreductase STEAP4,10235,33,1.19 [0.85-1.68],0.3124313230895428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STIP1,Stress-induced-phosphoprotein 1,12097,38,1.09 [0.71-1.69],0.6803068135610755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STK11,Serine/threonine-protein kinase STK11,11861,38,0.99 [0.66-1.48],0.9468253658391492
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STK24,Serine/threonine-protein kinase 24,11815,37,0.89 [0.55-1.45],0.6477989015216623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STK4,Serine/threonine-protein kinase 4,12108,41,1.04 [0.75-1.43],0.8224477072696534
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STOML2,"Stomatin-like protein 2, mitochondrial",10208,34,0.77 [0.51-1.18],0.2322981130989345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX16,Syntaxin-16,11824,39,0.92 [0.56-1.52],0.7470935380847767
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX1B,Syntaxin-1B,10316,33,0.84 [0.33-2.16],0.7161193624919373
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX3,Syntaxin-3,10586,35,1.33 [0.66-2.67],0.4216879716858176
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX4,Syntaxin-4,12048,37,1.19 [0.78-1.81],0.4118895401467505
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX5,Syntaxin-5,10295,36,1.36 [0.76-2.42],0.3036887458274007
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX6,Syntaxin-6,11824,39,1.13 [0.76-1.67],0.5384807214918124
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX7,Syntaxin-7,10295,36,0.99 [0.52-1.88],0.9702044087791984
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX8,Syntaxin-8,12076,37,1.17 [0.66-2.05],0.5947358390982184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STXBP1,Syntaxin-binding protein 1,10578,34,1.10 [0.71-1.69],0.6670943485187688
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STXBP3,Syntaxin-binding protein 3,11824,39,1.10 [0.59-2.03],0.7717945009112932
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUGP1,SURP and G-patch domain-containing protein 1,10538,34,2.01 [1.08-3.74],0.0276649098312079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUGT1,Protein SGT1 homolog,11824,39,0.86 [0.60-1.23],0.4130919256448718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SULT1A1,Sulfotransferase 1A1,12201,37,1.06 [0.84-1.34],0.623411808560016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SULT2A1,Bile salt sulfotransferase,12076,37,0.94 [0.53-1.66],0.8280783495444479
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUMF1,Formylglycine-generating enzyme,10295,36,0.68 [0.33-1.42],0.306348253079659
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,12201,37,0.98 [0.56-1.73],0.9531721119176306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUOX,"Sulfite oxidase, mitochondrial",10578,34,0.97 [0.57-1.65],0.9032697252690725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUSD1,Sushi domain-containing protein 1,11861,38,1.02 [0.56-1.88],0.9400438832755011
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUSD2,Sushi domain-containing protein 2,12112,38,1.08 [0.42-2.79],0.881065764005402
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUSD4,Sushi domain-containing protein 4,10542,34,1.30 [0.66-2.54],0.4493659896674828
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUSD5,Sushi domain-containing protein 5,10322,35,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SV2A,Synaptic vesicle glycoprotein 2A,10316,33,1.45 [0.99-2.13],0.0588305391167356
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SWAP70,Switch-associated protein 70,10538,34,1.16 [0.48-2.80],0.7422831383537876
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SYAP1,Synapse-associated protein 1,10388,35,1.12 [0.64-1.97],0.6837891902500441
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,10235,33,0.71 [0.35-1.44],0.3464532420309482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SYT1,Synaptotagmin-1,10586,35,1.05 [0.48-2.30],0.9035859721395396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SYTL4,Synaptotagmin-like protein 4,10600,35,0.78 [0.49-1.25],0.3041565173666603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,10425,33,1.07 [0.78-1.47],0.6754221930439579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TACC3,Transforming acidic coiled-coil-containing protein 3,12048,37,0.93 [0.72-1.20],0.5711637726933338
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TACSTD2,Tumor-associated calcium signal transducer 2,10716,31,1.29 [0.46-3.58],0.6296137777131265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TADA3,Transcriptional adapter 3,10542,34,1.17 [0.51-2.67],0.7132839502989721
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAFA5,Chemokine-like protein TAFA-5,12048,37,0.76 [0.33-1.72],0.5045513027008753
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAGLN3,Transgelin-3,10208,34,0.86 [0.48-1.54],0.6106321283624075
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TALDO1,Transaldolase,10564,36,1.46 [0.75-2.83],0.263665139326469
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TANK,TRAF family member-associated NF-kappa-B activator,11857,37,0.92 [0.59-1.41],0.6899266392834595
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAP1,Antigen peptide transporter 1,10425,33,1.45 [1.04-2.03],0.0274977559257073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TARBP2,RISC-loading complex subunit TARBP2,11815,37,0.97 [0.66-1.41],0.8570882814135358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",10316,33,1.14 [0.80-1.63],0.4730160435912908
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",10542,34,1.19 [0.55-2.60],0.6559907384378243
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAX1BP1,Tax1-binding protein 1,10586,35,1.29 [0.81-2.05],0.279353712794516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBC1D17,TBC1 domain family member 17,11815,37,1.47 [0.90-2.41],0.1232899126255028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBC1D23,TBC1 domain family member 23,12048,37,0.93 [0.67-1.30],0.6871324044624905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBC1D5,TBC1 domain family member 5,12076,37,1.16 [0.83-1.63],0.386713611650063
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBCA,Tubulin-specific chaperone A,10388,35,1.10 [0.76-1.60],0.6043716138173061
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBCB,Tubulin-folding cofactor B,12020,39,1.01 [0.76-1.35],0.9426979589938538
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBCC,Tubulin-specific chaperone C,12020,39,1.02 [0.71-1.46],0.917826483277172
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBL1X,F-box-like/WD repeat-containing protein TBL1X,11824,39,0.85 [0.60-1.19],0.3387174362878414
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBR1,T-box brain protein 1,10316,33,1.45 [0.93-2.26],0.1024285643887369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCL1A,T-cell leukemia/lymphoma protein 1A,12003,39,1.09 [0.81-1.46],0.5725831953895553
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCL1B,T-cell leukemia/lymphoma protein 1B,11861,38,0.84 [0.54-1.32],0.4453142912918079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCN1,Transcobalamin-1,10372,32,1.32 [0.51-3.40],0.5686037265025043
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCN2,Transcobalamin-2,12233,40,0.99 [0.39-2.51],0.9800907547990816
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCOF1,Treacle protein,10600,35,2.21 [1.26-3.86],0.0053638336036102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCP11,T-complex protein 11 homolog,10425,33,0.72 [0.33-1.56],0.4093299685559625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCTN3,Tectonic-3,10600,35,1.24 [0.41-3.74],0.7053375144814391
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TDGF1,Teratocarcinoma-derived growth factor 1,11815,37,1.14 [0.94-1.39],0.1738855003819761
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TDO2,"Tryptophan 2,3-dioxygenase",10316,33,1.35 [0.70-2.59],0.3702102334910357
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TDP1,Tyrosyl-DNA phosphodiesterase 1,10542,34,1.35 [0.96-1.91],0.089073253745504
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TDRKH,Tudor and KH domain-containing protein,11815,37,1.08 [0.77-1.52],0.6452418932835213
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TEF,Thyrotroph embryonic factor,10258,34,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TEK,Angiopoietin-1 receptor,12159,39,0.92 [0.24-3.52],0.902725525093861
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TERF1,Telomeric repeat-binding factor 1,10295,36,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TET2,Methylcytosine dioxygenase TET2,10396,32,1.06 [0.78-1.44],0.7076203411340437
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TEX101,Testis-expressed protein 101,10316,33,1.82 [0.92-3.61],0.0849982573770693
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TEX33,Testis-expressed protein 33,10425,33,1.01 [0.44-2.31],0.989010764380289
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TF,Serotransferrin,10623,35,0.58 [0.13-2.62],0.4774577836691954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFAP2A,Transcription factor AP-2-alpha,10235,33,1.21 [0.75-1.95],0.4329044070269372
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFF1,Trefoil factor 1,12049,38,0.87 [0.59-1.28],0.4857524414433525
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFF2,Trefoil factor 2,12139,40,0.92 [0.55-1.53],0.7558630297333759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFF3,Trefoil factor 3,12099,39,0.36 [0.14-0.92],0.0334340585982619
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFPI,Tissue factor pathway inhibitor,12083,39,0.79 [0.30-2.08],0.63402398657111
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFPI2,Tissue factor pathway inhibitor 2,12125,39,1.22 [0.61-2.45],0.5723922465886768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFRC,Transferrin receptor protein 1,12162,39,1.20 [0.56-2.54],0.6392387444130776
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TG,Thyroglobulin,10542,34,1.10 [0.86-1.42],0.4412906448006468
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFA,Protransforming growth factor alpha,12076,37,0.69 [0.35-1.34],0.2709287125214457
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFB1,Transforming growth factor beta-1 proprotein,12201,37,0.77 [0.35-1.68],0.5055063121305831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFB2,Transforming growth factor beta-2 proprotein,10542,34,1.12 [0.62-2.01],0.7174265687514669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFBI,Transforming growth factor-beta-induced protein ig-h3,12039,39,0.80 [0.28-2.29],0.6743798911990978
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFBR1,TGF-beta receptor type-1,10295,36,0.68 [0.14-3.29],0.6338587925912258
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFBR2,TGF-beta receptor type-2,12159,39,0.40 [0.15-1.05],0.0638218169928078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFBR3,Transforming growth factor beta receptor type 3,12247,40,1.03 [0.44-2.39],0.948976161524944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGM2,Protein-glutamine gamma-glutamyltransferase 2,12092,41,1.46 [1.03-2.08],0.0335981515006089
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGOLN2,Trans-Golgi network integral membrane protein 2,10602,33,0.77 [0.22-2.70],0.6828774926131038
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THAP12,52 kDa repressor of the inhibitor of the protein kinase,10190,34,1.07 [0.76-1.50],0.6893700576704809
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THBD,Thrombomodulin,12108,41,0.93 [0.34-2.51],0.8787932444203067
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THBS2,Thrombospondin-2,12112,38,1.57 [0.79-3.14],0.200557911997587
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THBS4,Thrombospondin-4,12116,39,1.14 [0.61-2.13],0.6898102961795272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THOP1,Thimet oligopeptidase,12035,41,2.27 [1.06-4.85],0.0343758031473396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THPO,Thrombopoietin,11861,38,0.84 [0.39-1.79],0.6528017366388842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THRAP3,Thyroid hormone receptor-associated protein 3,10258,34,0.48 [0.43-0.53],5.497579680935366e-44
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THSD1,Thrombospondin type-1 domain-containing protein 1,10208,36,1.09 [0.42-2.80],0.8572101513234954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THTPA,Thiamine-triphosphatase,10529,34,1.12 [0.77-1.62],0.5627767296733124
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THY1,Thy-1 membrane glycoprotein,12201,37,0.54 [0.19-1.55],0.2505505012358935
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIA1,Nucleolysin TIA-1 isoform p40,11719,37,1.00 [0.78-1.28],0.9768663938939262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIE1,Tyrosine-protein kinase receptor Tie-1,12247,40,1.35 [0.63-2.91],0.4392771228146211
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",11794,37,1.33 [0.75-2.33],0.3263415919112408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,10425,33,1.19 [0.49-2.87],0.6970391470593962
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,12165,39,0.90 [0.47-1.71],0.7412661492951927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,10600,35,0.86 [0.38-1.95],0.7240109943081926
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,10586,35,1.13 [0.78-1.64],0.5162532143918612
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP1,Metalloproteinase inhibitor 1,11989,39,0.84 [0.31-2.31],0.7348366951101456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP2,Metalloproteinase inhibitor 2,10600,35,0.14 [0.03-0.65],0.0121466213987356
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP3,Metalloproteinase inhibitor 3,12162,40,0.98 [0.80-1.21],0.8554722569936424
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP4,Metalloproteinase inhibitor 4,12112,38,1.37 [0.72-2.61],0.3358106951774454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TINAGL1,Tubulointerstitial nephritis antigen-like,12065,41,0.69 [0.19-2.46],0.5651670977014134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TJAP1,Tight junction-associated protein 1,12159,39,1.01 [0.71-1.42],0.9670967444444976
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TJP3,Tight junction protein ZO-3,10235,33,1.35 [0.71-2.57],0.3637084060181406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TK1,"Thymidine kinase, cytosolic",10425,33,0.87 [0.39-1.95],0.7339298618777184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TLR1,Toll-like receptor 1,10295,36,1.06 [0.32-3.51],0.9294903946513248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TLR2,Toll-like receptor 2,10425,33,0.62 [0.15-2.60],0.5128826769054815
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TLR3,Toll-like receptor 3,12217,37,0.69 [0.45-1.08],0.1030286706790635
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TLR4,Toll-like receptor 4,10295,36,0.68 [0.21-2.20],0.5256195158330625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,10316,33,1.29 [0.76-2.18],0.3455365369571762
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMED1,Transmembrane emp24 domain-containing protein 1,10425,33,1.05 [0.59-1.87],0.8614922999585484
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMED10,Transmembrane emp24 domain-containing protein 10,10258,34,0.84 [0.37-1.91],0.6790040797810686
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMED4,Transmembrane emp24 domain-containing protein 4,10258,34,1.03 [0.59-1.80],0.926433952955686
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMED8,Protein TMED8,10538,34,1.02 [0.74-1.42],0.8932072052911574
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMEM106A,Transmembrane protein 106A,10542,34,0.78 [0.47-1.29],0.3333466729395153
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMEM132A,Transmembrane protein 132A,10348,34,1.52 [0.97-2.39],0.0671045005822606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMEM25,Transmembrane protein 25,10578,34,1.23 [0.66-2.29],0.5111910614992954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMOD4,Tropomodulin-4,10208,34,1.04 [0.46-2.33],0.9307725918397544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMPRSS11B,Transmembrane protease serine 11B,10235,33,0.92 [0.58-1.48],0.7425843061946303
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMPRSS11D,Transmembrane protease serine 11D,10572,35,1.42 [0.74-2.71],0.2948546265234383
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMPRSS15,Enteropeptidase,12048,37,1.08 [0.79-1.49],0.6207892664390835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMPRSS5,Transmembrane protease serine 5,11969,39,1.12 [0.52-2.38],0.7783335373248008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMSB10,Thymosin beta-10,12112,38,1.05 [0.71-1.55],0.8205128189541564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNC,Tenascin,12165,39,1.08 [0.60-1.94],0.7952606253588754
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNF,Tumor necrosis factor,11838,38,0.47 [0.18-1.19],0.1115259427595096
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,10538,34,1.77 [1.09-2.89],0.0214561012978238
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,11857,37,1.45 [0.75-2.77],0.2667766405391194
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,10388,35,1.29 [0.80-2.08],0.3033383032340568
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,12020,39,0.96 [0.39-2.31],0.9189389080423822
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,12020,39,0.63 [0.24-1.68],0.3559184988263615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,12138,40,0.45 [0.30-0.68],0.000136227143608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,12217,37,0.78 [0.36-1.68],0.5266638159341949
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,12105,40,1.24 [0.47-3.28],0.6589230840875009
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,12159,39,0.55 [0.23-1.33],0.1854056417932337
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,12125,40,0.84 [0.36-1.96],0.6825895473705235
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,11857,37,1.06 [0.53-2.13],0.8609889708941622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,12125,40,0.61 [0.23-1.63],0.3269247992709324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,10388,35,0.93 [0.43-2.03],0.8637817573431688
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,12195,37,0.81 [0.32-2.06],0.6628050041338931
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,12112,38,0.39 [0.13-1.16],0.0903078289812695
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,12112,38,0.63 [0.26-1.52],0.3058411161686071
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,12201,37,0.36 [0.12-1.05],0.0619359659757833
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,12201,37,0.51 [0.22-1.16],0.1087840085362946
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,12020,39,0.54 [0.30-0.95],0.0315705213114486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,12201,37,0.55 [0.28-1.11],0.0956607288336488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,12020,39,0.61 [0.28-1.29],0.195161465509537
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF10,Tumor necrosis factor ligand superfamily member 10,12217,37,0.34 [0.11-1.02],0.0549245715597023
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF11,Tumor necrosis factor ligand superfamily member 11,12076,37,0.82 [0.51-1.34],0.4320350097540901
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF12,Tumor necrosis factor ligand superfamily member 12,12217,37,0.80 [0.29-2.24],0.6765144900412259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF13,Tumor necrosis factor ligand superfamily member 13,12162,40,1.14 [0.40-3.26],0.8081347870092375
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,12231,40,0.31 [0.11-0.91],0.0331935106979228
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF14,Tumor necrosis factor ligand superfamily member 14,12020,39,0.87 [0.52-1.43],0.5720445494032695
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF8,Tumor necrosis factor ligand superfamily member 8,10617,36,0.94 [0.38-2.33],0.9007993202722964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNIP1,TNFAIP3-interacting protein 1,10586,35,1.21 [0.85-1.73],0.288559950525677
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNN,Tenascin-N,10617,36,0.97 [0.47-2.02],0.9428446145144956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNNI3,"Troponin I, cardiac muscle",11861,38,0.83 [0.62-1.11],0.1977776446285978
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNPO1,Transportin-1,10425,33,1.42 [0.71-2.83],0.3156855363953316
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNR,Tenascin-R,12020,39,1.14 [0.58-2.23],0.7050433182650482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNXB,Tenascin-X,12112,38,2.03 [0.64-6.43],0.2289776918694462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,10600,35,0.93 [0.62-1.41],0.7485309165508902
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOP1,DNA topoisomerase 1,10538,34,1.20 [0.88-1.62],0.2509082318680919
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOP1MT,"DNA topoisomerase I, mitochondrial",10208,34,0.49 [0.21-1.12],0.0915176431417392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOP2B,DNA topoisomerase 2-beta,10295,36,1.35 [0.94-1.94],0.1090033993815513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOR1AIP1,Torsin-1A-interacting protein 1,10348,34,1.55 [1.01-2.37],0.0434144494536489
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP53,Cellular tumor antigen p53,11824,39,0.74 [0.37-1.48],0.3993779160860212
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP53BP1,TP53-binding protein 1,10295,36,0.99 [0.69-1.42],0.9492988266554144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP53I3,Quinone oxidoreductase PIG3,10168,35,1.40 [0.78-2.53],0.2638470955273375
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP53INP1,Tumor protein p53-inducible nuclear protein 1,11861,38,1.38 [0.76-2.50],0.2877122550837846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP73,Tumor protein p73,10316,33,1.63 [0.64-4.16],0.3103768250940452
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPBGL,Trophoblast glycoprotein-like,10316,33,1.27 [0.62-2.60],0.5052945206003169
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPD52L2,Tumor protein D54,10388,35,0.98 [0.72-1.34],0.9171969279789092
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPK1,Thiamin pyrophosphokinase 1,10600,35,0.53 [0.16-1.77],0.3030165865138448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPM3,Tropomyosin alpha-3 chain,10258,34,1.76 [1.00-3.09],0.0492744912882836
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPMT,Thiopurine S-methyltransferase,11824,39,1.11 [0.76-1.61],0.5908982071789846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPP1,Tripeptidyl-peptidase 1,12019,40,0.89 [0.46-1.74],0.7425371289166771
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPPP2,Tubulin polymerization-promoting protein family member 2,10425,33,0.72 [0.43-1.19],0.1968393062194102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPPP3,Tubulin polymerization-promoting protein family member 3,11815,37,1.50 [0.92-2.45],0.1069530921524576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPR,Nucleoprotein TPR,10258,34,1.47 [0.98-2.20],0.0606336265591218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPRKB,EKC/KEOPS complex subunit TPRKB,10208,34,0.66 [0.33-1.29],0.2242973642046913
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPSAB1,Tryptase alpha/beta-1,12200,37,1.16 [0.67-2.03],0.5946564915064496
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPSD1,Tryptase delta,10578,34,1.15 [0.51-2.58],0.7372996395457486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPSG1,Tryptase gamma,10295,36,0.67 [0.19-2.42],0.5401375932846564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPT1,Translationally-controlled tumor protein,11857,37,1.06 [0.71-1.60],0.7676111936110557
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRAF2,TNF receptor-associated factor 2,12076,37,1.12 [0.74-1.69],0.5790679055235117
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRAF3,"TNF receptor-associated factor 3, Isoform 2",10295,36,1.56 [0.75-3.22],0.2304653120618639
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,10258,34,1.13 [0.62-2.05],0.691025826470233
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,10425,33,1.29 [0.96-1.75],0.0950953788071764
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREH,Trehalase,10617,36,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREM2,Triggering receptor expressed on myeloid cells 2,12105,40,1.44 [0.84-2.45],0.1821459128855863
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREML1,Trem-like transcript 1 protein,10602,33,0.91 [0.48-1.72],0.7772591746613184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREML2,Trem-like transcript 2 protein,12112,38,0.38 [0.16-0.92],0.0320657174729964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIAP1,TP53-regulated inhibitor of apoptosis 1,12195,37,1.08 [0.68-1.71],0.7580142954218672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM21,E3 ubiquitin-protein ligase TRIM21,12076,37,1.39 [0.96-2.02],0.0849474160192883
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM24,Transcription intermediary factor 1-alpha,10405,33,1.51 [0.99-2.32],0.0567964537617202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,10538,34,1.15 [0.85-1.56],0.3755255286100424
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM26,Tripartite motif-containing protein 26,10208,34,1.24 [0.77-2.00],0.3837106829398228
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM40,E3 ubiquitin ligase TRIM40,10316,33,1.12 [0.71-1.75],0.6305968203742516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM5,Tripartite motif-containing protein 5,12076,37,1.13 [0.80-1.60],0.4830521993936875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM58,E3 ubiquitin-protein ligase TRIM58,10542,34,0.97 [0.67-1.41],0.8760383771902773
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRPV3,Transient receptor potential cation channel subfamily V member 3,10258,34,0.84 [0.39-1.79],0.6478896407908296
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSC1,Hamartin,10295,36,1.20 [0.85-1.70],0.291566960355847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSC22D1,TSC22 domain family protein 1,10578,34,0.98 [0.60-1.60],0.9298964254022004
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSHB,Thyrotropin subunit beta,12108,41,1.03 [0.75-1.42],0.8369479292547664
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSLP,Thymic stromal lymphopoietin,11861,38,0.60 [0.32-1.13],0.1132652732555091
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSNAX,Translin-associated protein X,10258,34,1.51 [0.69-3.31],0.301739572644783
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPAN1,Tetraspanin-1,11861,38,0.76 [0.23-2.47],0.6476991636371141
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPAN15,Tetraspanin-15,10258,34,1.06 [0.56-2.02],0.8488887625293454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPAN7,Tetraspanin-7,10235,33,1.15 [0.84-1.58],0.3946498894423457
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPAN8,Tetraspanin-8,10538,34,1.11 [0.82-1.51],0.5031282892888969
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPYL1,Testis-specific Y-encoded-like protein 1,10295,36,0.85 [0.38-1.91],0.6917232531960562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TST,Thiosulfate sulfurtransferase,11788,37,1.04 [0.70-1.53],0.8528538849287784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TTF2,Transcription termination factor 2,10316,33,1.41 [0.75-2.65],0.2900382719812476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TTN,Titin,10258,34,1.20 [0.79-1.82],0.3884279339944524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TTR,Transthyretin,10505,35,1.64 [0.45-6.06],0.4558986661432638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TUBB3,Tubulin beta-3 chain,10235,33,1.62 [0.61-4.31],0.3314733897148872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TWF2,Twinfilin-2,10617,36,1.01 [0.68-1.48],0.9727386332960763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXK,Tyrosine-protein kinase TXK,10425,33,0.64 [0.34-1.20],0.1628191970552353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXLNA,Alpha-taxilin,12020,39,1.02 [0.73-1.41],0.9175462429845568
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXN,Thioredoxin,10430,33,1.39 [0.79-2.44],0.2545571149328736
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNDC15,Thioredoxin domain-containing protein 15,12159,39,0.99 [0.35-2.83],0.9844070222284488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNDC5,Thioredoxin domain-containing protein 5,12201,37,0.91 [0.58-1.41],0.6667134600021261
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNDC9,Thioredoxin domain-containing protein 9,10586,35,1.16 [0.65-2.07],0.618508934543379
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNL1,Thioredoxin-like protein 1,10213,33,nan [nan-nan],
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",12112,38,1.38 [0.75-2.51],0.2995051987297116
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TYMP,Thymidine phosphorylase,12021,40,1.09 [0.71-1.67],0.6841359119093087
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TYRO3,Tyrosine-protein kinase receptor TYRO3,12108,41,1.71 [0.64-4.56],0.2875564454184074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",10295,36,1.10 [0.66-1.85],0.7075537552506677
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBAC1,Ubiquitin-associated domain-containing protein 1,12048,37,1.80 [0.80-4.05],0.1564068356661388
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBE2B,Ubiquitin-conjugating enzyme E2 B,10542,34,1.58 [0.57-4.33],0.3768587988488425
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,10600,35,1.03 [0.61-1.75],0.906819849984864
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,10295,36,1.44 [0.96-2.17],0.0767737552292272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBQLN3,Ubiquilin-3,10258,34,1.34 [0.77-2.33],0.3050934975159077
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBXN1,UBX domain-containing protein 1,10388,35,1.13 [0.71-1.80],0.6121481832698055
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,10538,34,1.02 [0.80-1.30],0.8565863628004604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UGDH,UDP-glucose 6-dehydrogenase,10258,34,0.90 [0.60-1.33],0.5915513945184206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UHRF2,E3 ubiquitin-protein ligase UHRF2,10258,34,1.08 [0.48-2.45],0.8530234786163076
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ULBP2,UL16-binding protein 2,12020,39,1.05 [0.49-2.25],0.896201948729807
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UMOD,Uromodulin,12215,40,1.30 [0.76-2.23],0.3426518901002634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UNC5D,Netrin receptor UNC5D,10295,36,0.75 [0.21-2.73],0.6640492627180503
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UNC79,Protein unc-79 homolog,10208,34,1.16 [0.68-1.98],0.5916416169341867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UNG,Uracil-DNA glycosylase,10542,34,0.66 [0.24-1.83],0.421947935635659
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UPB1,Beta-ureidopropionase,10600,35,0.79 [0.54-1.15],0.2267002532494301
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UPK3A,Uroplakin-3a,10235,33,0.72 [0.35-1.49],0.3753955028712683
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UPK3BL1,Uroplakin-3b-like protein 1,10402,33,1.47 [1.09-1.98],0.0107503712572633
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UROD,Uroporphyrinogen decarboxylase,10388,35,1.21 [0.77-1.91],0.4120151938179592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UROS,Uroporphyrinogen-III synthase,10316,33,1.11 [0.72-1.73],0.628891171327993
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USO1,General vesicular transport factor p115,12048,37,0.91 [0.66-1.26],0.5617129707174668
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USP25,Ubiquitin carboxyl-terminal hydrolase 25,10542,34,1.34 [0.85-2.10],0.2064798075659734
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USP28,Ubiquitin carboxyl-terminal hydrolase 28,10586,35,1.71 [0.97-3.01],0.0632948709995411
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USP47,Ubiquitin carboxyl-terminal hydrolase 47,10258,34,0.94 [0.63-1.40],0.7584907920038025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USP8,Ubiquitin carboxyl-terminal hydrolase 8,11861,38,1.13 [0.84-1.52],0.4204424156065872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UXS1,UDP-glucuronic acid decarboxylase 1,11824,39,0.78 [0.45-1.37],0.3894058384914486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VAMP5,Vesicle-associated membrane protein 5,11861,38,1.08 [0.67-1.72],0.7554961510307088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VAMP8,Vesicle-associated membrane protein 8,10295,36,1.04 [0.73-1.50],0.815658945289433
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VASH1,Tubulinyl-Tyr carboxypeptidase 1,12076,37,0.97 [0.68-1.39],0.8824662073911282
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VASN,Vasorin,11929,38,0.49 [0.17-1.46],0.1997645047522462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VASP,Vasodilator-stimulated phosphoprotein,10602,33,0.99 [0.63-1.57],0.9692076278143114
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,12048,37,0.86 [0.20-3.72],0.8355864545439702
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VAV3,Guanine nucleotide exchange factor VAV3,10235,33,1.14 [0.81-1.59],0.4515984763887599
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VCAM1,Vascular cell adhesion protein 1,12139,39,0.92 [0.32-2.64],0.8694320896259862
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VCAN,Versican core protein,12201,37,0.47 [0.18-1.25],0.1293352328697447
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VCPKMT,Protein-lysine methyltransferase METTL21D,10208,34,1.02 [0.70-1.49],0.9109134157275808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VEGFA,Vascular endothelial growth factor A,12177,37,0.72 [0.43-1.22],0.2234742685474754
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VEGFB,Vascular endothelial growth factor B,10295,36,1.00 [0.32-3.12],0.9936099943913216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VEGFC,Vascular endothelial growth factor C,12159,39,0.81 [0.49-1.34],0.4085241613175239
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VEGFD,Vascular endothelial growth factor D,12194,37,0.72 [0.31-1.69],0.4543431377549703
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VGF,Neurosecretory protein VGF,10578,34,0.74 [0.26-2.14],0.5819542421339235
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VIM,Vimentin,11861,38,1.18 [0.91-1.54],0.2193666947682384
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VIPR1,Vasoactive intestinal polypeptide receptor 1,10348,34,3.67 [1.72-7.81],0.000742273338609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VIT,Vitrin,10600,35,1.03 [0.43-2.48],0.941853751488122
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VMO1,Vitelline membrane outer layer protein 1 homolog,12048,37,1.10 [0.70-1.73],0.6688986429208983
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VNN1,Pantetheinase,10602,33,1.26 [0.78-2.06],0.3446258129528168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VNN2,Vascular non-inflammatory molecule 2,12048,37,0.63 [0.35-1.14],0.1263489861050178
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VPS28,Vacuolar protein sorting-associated protein 28 homolog,10425,33,1.08 [0.66-1.76],0.7612417032047016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VPS37A,Vacuolar protein sorting-associated protein 37A,12048,37,1.07 [0.74-1.53],0.7286438899450643
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VPS4B,Vacuolar protein sorting-associated protein 4B,10542,34,1.09 [0.77-1.55],0.6165453867451777
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VPS53,Vacuolar protein sorting-associated protein 53 homolog,12048,37,1.04 [0.71-1.52],0.835697104897249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIG10,V-set and immunoglobulin domain-containing protein 10,10542,34,0.96 [0.36-2.59],0.938759784767564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,10258,34,1.19 [0.45-3.15],0.7304346156458492
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIG2,V-set and immunoglobulin domain-containing protein 2,10542,34,0.87 [0.50-1.52],0.6262037618655405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIG4,V-set and immunoglobulin domain-containing protein 4,12097,38,0.73 [0.35-1.55],0.4173637125020091
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,12087,41,0.91 [0.57-1.44],0.6784308682791753
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSNL1,Visinin-like protein 1,10586,35,0.99 [0.41-2.37],0.9815137347727086
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSTM1,V-set and transmembrane domain-containing protein 1,11815,37,0.93 [0.51-1.70],0.8175058766688788
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSTM2B,V-set and transmembrane domain-containing protein 2B,10425,33,0.79 [0.31-2.02],0.6254463188500126
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,11861,38,0.63 [0.36-1.11],0.1085604679372078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,12201,37,1.08 [0.73-1.61],0.6988333748873898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VTCN1,V-set domain-containing T-cell activation inhibitor 1,11824,39,1.24 [0.51-3.02],0.6282241879135452
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,10388,35,1.06 [0.62-1.82],0.8337341404310002
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWA1,von Willebrand factor A domain-containing protein 1,12169,37,0.82 [0.40-1.66],0.575986677038277
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWA5A,von Willebrand factor A domain-containing protein 5A,10208,34,1.04 [0.69-1.55],0.859597069191065
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWC2,Brorin,11984,39,0.80 [0.38-1.67],0.5541028191416573
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWC2L,von Willebrand factor C domain-containing protein 2-like,10578,34,0.74 [0.30-1.82],0.5174744133326897
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWF,von Willebrand factor,12247,40,1.04 [0.71-1.53],0.8341056265561428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WARS,"Tryptophan--tRNA ligase, cytoplasmic",12112,38,0.91 [0.42-1.95],0.8082580769158291
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WAS,Wiskott-Aldrich syndrome protein,11857,37,0.62 [0.40-0.97],0.0376527746781388
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WASF1,Wiskott-Aldrich syndrome protein family member 1,11861,38,1.00 [0.73-1.37],0.988261760256629
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WASF3,Wiskott-Aldrich syndrome protein family member 3,11815,37,1.08 [0.77-1.54],0.6462468283383884
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WASHC3,WASH complex subunit 3,10586,35,1.16 [0.78-1.74],0.4649095014720097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WASL,Neural Wiskott-Aldrich syndrome protein,10295,36,1.04 [0.63-1.72],0.8827700413818268
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WDR46,WD repeat-containing protein 46,10542,34,1.69 [0.92-3.10],0.0887210032263761
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFDC1,WAP four-disulfide core domain protein 1,10321,33,0.40 [0.16-1.03],0.0587234132638987
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFDC12,WAP four-disulfide core domain protein 12,12181,37,1.00 [0.64-1.55],0.9851239173769326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFDC2,WAP four-disulfide core domain protein 2,11500,37,0.43 [0.17-1.07],0.0685348216657186
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",11983,39,1.15 [0.58-2.28],0.6954355788313613
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",12125,40,0.46 [0.20-1.05],0.063703323006137
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WIF1,Wnt inhibitory factor 1,12195,37,0.58 [0.25-1.35],0.204432546324712
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WNT9A,Protein Wnt-9a,11857,37,0.86 [0.30-2.48],0.7845737977776255
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,12020,39,1.16 [0.69-1.96],0.5763929690059879
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XCL1,Lymphotactin,12195,37,0.71 [0.40-1.27],0.2448835195597846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XG,Glycoprotein Xg,12189,40,0.70 [0.28-1.80],0.4624503952137019
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XIAP,E3 ubiquitin-protein ligase XIAP,10295,36,1.23 [0.72-2.11],0.4434816460376569
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XPNPEP2,Xaa-Pro aminopeptidase 2,12159,39,1.12 [0.81-1.56],0.5001849305364099
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XRCC4,DNA repair protein XRCC4,11815,37,1.48 [0.78-2.83],0.2323567235964905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YAP1,Transcriptional coactivator YAP1,10586,35,0.40 [0.11-1.43],0.1599988961243473
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",10538,34,1.01 [0.80-1.27],0.9450016153225396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YES1,Tyrosine-protein kinase Yes,12048,37,0.92 [0.71-1.19],0.5075218895674514
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YJU2,Splicing factor YJU2,10542,34,1.40 [0.58-3.34],0.4543440948454798
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YOD1,Ubiquitin thioesterase OTU1,10258,34,1.14 [0.68-1.90],0.6250712605414663
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YTHDF3,YTH domain-containing family protein 3,11857,37,0.98 [0.69-1.40],0.9187671697848724
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YWHAQ,14-3-3 protein theta,10388,35,1.13 [0.73-1.75],0.5919288064113662
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YY1,Transcriptional repressor protein YY1,10295,36,2.53 [1.22-5.24],0.0122086330906955
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZBP1,Z-DNA-binding protein 1,10295,36,1.80 [1.15-2.81],0.010130788863374
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZBTB16,Zinc finger and BTB domain-containing protein 16,11824,39,0.93 [0.62-1.40],0.7263308680802818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZBTB17,Zinc finger and BTB domain-containing protein 17,11861,38,1.64 [1.04-2.57],0.0330586944845995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZCCHC8,Zinc finger CCHC domain-containing protein 8,10258,34,1.46 [1.05-2.04],0.0260199889972012
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZFYVE19,Abscission/NoCut checkpoint regulator,10538,34,1.11 [0.77-1.60],0.5686687336255628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZHX2,Zinc fingers and homeoboxes protein 2,10586,35,1.96 [1.27-3.04],0.0023662351281506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNF174,Zinc finger protein 174,10295,36,1.43 [0.78-2.61],0.2451744429501773
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNF75D,Zinc finger protein 75D,10425,33,0.99 [0.58-1.68],0.9632108030291168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNF830,Zinc finger protein 830,10542,34,1.26 [0.91-1.75],0.1651236866074853
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNRD2,Protein ZNRD2,10538,34,1.05 [0.66-1.67],0.831318749195532
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,10542,34,1.16 [0.67-2.01],0.6031471902998669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZP3,Zona pellucida sperm-binding protein 3,10348,34,0.98 [0.86-1.10],0.6970099386299287
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZP4,Zona pellucida sperm-binding protein 4,10208,34,1.58 [0.97-2.58],0.0682555205901717
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZPR1,Zinc finger protein ZPR1,10235,33,1.19 [0.90-1.56],0.2215799534477822
